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 INTRODUCTION1. 
Use of Pancreas powder in medicine - history and presence1.1 
In the ancient world, the term pán kréas (“totally from meat”) emerged. Although the position 
and the glandular constitution of the pancreas had been well known for a long time, the function 
was not really understood. Only a protective function of adjacent vessels was attributed to 
the pancreas by Aristoteles [384-322 B.C.] or a sustaining function by Galen [129-199 A.C.]. 
This undervaluation might be a reason for the lack of research in the following centuries 
(Kuhlmann, 1999). Opinions partially changed in the middle of the 17th century, when Moritz 
Hofmann and Johann Georg Wirsüng discovered the excretory duct without understanding 
its function. Few decades later,  François de le Boë Sylvius argued that pancreas secretion 
intermingles with nutrition to serve the “fermentatio”. Concurrently, the fi rst pancreas 
secretion was obtained from living animals via a fi stula (Kuhlmann, 1999). With the birth 
of endocrinology in the second half of the 18th century, in-vitro experiments with pancreas 
secretion were undertaken. Later, imitated digestive juices were prepared by Eberle (1834). 
However, it was not until the middle of the 19th century, when pancreas secretion was fi rst 
described as the universal digestion juice. Claude Bernard considered the pancreas secretion 
important for the cleavage of saccharides, proteins as well as fats, in contrast to gastric juice 
or saliva. Furthermore, he showed that the active ingredient was precipitable with alcohol. The 
precipitate was named Pancreatin (Kuhlmann, 1999).
Fles (1864) successfully treated pancreas insuffi ciency in a patient by dispensing an extract of 
minced bovine pancreas to each meal. Langdon-Down achieved the same result with purchasable 
Pancreatin. However, criticism of purchasable Pancreatin was extensive. For example, Ewald 
(1880) regarded it as completely ineffective due to the loss of enzyme activity during stomach 
passage. At the beginning of the 20th century, the Rhenania AG (Aachen) launched a potent 
preparation containing Pancreatin partially associated with tannin, which was resistant 
to gastric juice in vitro (Pankreon®). Since the tannin was split off insuffi ciently due to the 
slightly alkaline pH in the duodenum, the high concentrations of active enzymes in Pankreon® 
instead of the association to tannin emerged as reason for the potency of the preparation in vivo 
(Kuhlmann, 1999). In order to ensure no release in the stomach (pH below 4) and an immediate 
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release of enzymes in the proximate duodenum (pH of 5.5 to 6), enteric-coated pancreatin 
preparations have been established soon after introduction of Pancreon® (Kuhlmann, 1999, 
Creon International Scientifi c Brochure, 2007).
Pancreatin is indicated in cases of Pancreatic Exocrine Insuffi ciency (PEI) as a consequence 
of chronic pancreatitis or pancreatectomy (e.g. due to alcohol abuse or cystic fi brosis), after 
gastric resection (e.g. due to gastric cancer) as well as after acute pancreatitis (Lankisch, 1999; 
Böhme et al., 2006).  Malfunction of pancreatic lipases is accompanied by steatorrhea owing to 
the diminished fat digestion (Ruyssen & Lauwers, 1978). Pancreatin eliminates the steatorrhea 
and its accessory symptoms, such as reduction of weight, meteorism and fl atulence. If 
patients show persisting steatorrhea, a low duodenal pH may be the reason (Lankisch, 1999). 
Disturbances in protein digestion merely occur in severe cases of pancreatic insuffi ciency as 
pepsin ensures gastric proteolysis. Amylase defects are not considerable (Böhme et al., 2006). 
Diabetis mellitus (Frier et al., 1976; Semakula et al., 1996) or Human Immunodefi ciency Virsus 
Infection (Carroccio et al., 2001) have also shown symptoms of PEI. 
The dose of Pancreatin-containing preparations depends on the severity of PEI and the 
composition of the meal, especially the content of fat. In severe cases of steatorrhea, cystic 
fi brosis and after pancreas extirpation a dose of 0.5 up to 1 gram of Pancreatin per meal may be 
necessary (Ruyssen & Lauwers, 1978), a total loss of pancreatic function requires doses up to 
2 grams of Pancreatin per meal (Böhme et al., 2006).
Definition and properties1.2 
According to European Pharmacopoeia (Ph.Eur.), “Pancreas powder” is prepared from fresh 
or frozen mammalian pancreases and contains various enzymes having proteolytic, lipolytic 
and amylolytic activities. It is a slightly brown or cream colored, amorphous powder, 
which is incompletely soluble in water and practically insoluble in 96 % (v/v) ethanol (Ph.
Eur.; Ryssen & Lauwers, 1978). The United States Pharmacopoeia (USP) differentiates two 
compounds in quality: “Pancreatin” and “Pancrelipase”. From here forth, the term “pancreas 
powder” will be used according to Ph.Eur. defi nition.
The dosage strength of a preparation containing pancreas powder is usually defi ned by its 
active lipase content as this is considered to be the most important and most sensitive digestive 
enzyme of the pancreas. In order to ensure product quality, the pharmacopoeias give analysis 
methods and specifi cation limits for each of the three enzyme classes (proteases, lipases 
and amylases). Since enzyme mass is not related to drug effect, pancreatic enzyme activity 
with defi ned substrates is determined. Ph.Eur. methods are based on methods developed by 
the International Pharmaceutical Federation (FIP). Thus, Ph.Eur. and FIP use the same units. 
In spite of specifying the same substrates, USP methods vary for all three enzyme classes. 
The defi nition of one amylase or protease activity unit (USP-unit) is different whereas lipase 
activity according to USP is approx. equivalent to lipase activity given in Ph.Eur. units 
INTRODUCTION
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(Böhme et al., 2006; Creon International Scientifi c Brochure, 2007). Ph.Eur. and USP describe 
convention methods and thus a strict compliance with conditions described in the monographs 
is required to obtain comparable results. Relative enzyme activities are determined using a 
pancreas powder reference standard.
The minimum enzyme activity of the Active Pharmaceutical Ingredient (API) varies according 
to each Pharmacopoeia (Table 1). 
Table 1. Enzyme activities in 1 mg of pancreas powder according to Ph.Eur. and USP. In order to compare the enzyme 
activities, USP-units were converted to Ph.Eur.-units based on conversion factors according to Martindale (1993). In the USP, 
free proteases are declared, while the Ph.Eur. refers to total proteases including free and zymogens of the proteases which are 
activated by enterokinase (n.l.t. = not less than, API = Active Pharmaceutical Ingredient).
Lipolysis in the gastrointestinal tract is an interplay of different types of lipases, mainly 
gastric and pancreatic triacylglycerol lipases. In addition, lower proportions of pancreatic 
carboxylester lipase (equal to cholesterol esterase) and Phospholipase A2 are present 
(Ruyssen & Lauwers, 1978). Except for carboxylester lipase, the other lipases have natural 
substrates which are water insoluble. Maximum activity is observed when the lipase is adsorbed 
to an oil/ water interface. Thus, it is the substrate amount available at the interface which 
represents the effective substrate concentration for the enzyme. Due to the heterogeneous 
reaction, digestion of lipids takes more time than the degradation of carbohydrates and proteins. 
The coprotein colipase optimizes pancreatic lipase activity by formation of a stable complex 
with triacylglycerol lipase enabling it to penetrate the interface (Creon International Scientifi c 
Brochure, 2007). Furthermore, the colipase neutralizes the inhibitory effect of high bile salt 
concentrations (Borgström & Erlanson, 1973). At optimum bile salt concentrations, they enlarge 
the water/ lipid interface and stabilize the substrate emulsion, leading to an increased velocity 
of the lipase reaction (Creon International Scientifi c Brochure, 2007).
Pancreatic lipases are described as sn-1,3-specifi c, which means that they hydrolyze triglycerides 
to 1,2-diglycerides and 2-monoglycerides (Ryssen & Lauwers, 1976). According to the 
pharmacopoeias, olive oil is often used as substrate to determine lipase activity in titration 
methods. Another substrate frequently used is triolein which leads to a tenfold higher activity 
than olive oil (Tietz et al., 1989). However, the most commonly used substrate in lipase assays 
is still tributyrin (Beisson et al., 2000), in spite of the negative strong odor of butyric acids. 
According to Ph.Eur. and USP, lipase activity is determined as follows: The triglycerides of 
Definition and properties 
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Phases of pharmacopoeia assays (Ph.Eur. and USP) to determine amylase activity in pancreas powder. The substrate Figure 1. 
starch and the enzyme are incubated for 10 min at 25°C. The enzyme reaction is stopped with hydrochloric acid. Upon addition 
of iodine and sodium hydroxide, sodium hypoiodite is formed (disproportionation of iodine) which oxidizes the released 
reducing end groups of the terminal glucose units. Additionally, iodine forms a blue/ violet clathrate with the non-cleaved 
starch. The excess iodine is titrated with thiosulfate until colorless.
olive oil, which is emulsifi ed in a gum acacia and bile salts-containing solution, are cleaved 
to glycerol and free fatty acids. The fatty acids are titrated with sodium hydroxide solution at 
pH 9 (pH stat-method) and 37°C. The lipolytic activity of pancreas powder is determined by 
comparing the rate at which a suspension of pancreas powder hydrolyzes a substrate of olive oil 
emulsion with the rate at which a suspension of a pancreas powder reference standard hydrolyzes 
the same substrate under the same conditions (Ph.Eur.). One Ph.Eur.-unit and one USP-unit, 
respectively, of lipase activity is equivalent to the amount of pancreas powder that liberates 1.0 
micro equivalent of acid per min at pH 9.0 and 37°C under the conditions of the assay for lipase 
activity described in Ph.Eur. and USP, respectively (Böhme et al., 2006; USP).
α-Amylase, systematically named α-1,4-glucan-glucanohydrolase, is an endoamylase that 
hydrolyzes α-1,4-glucan links in polysaccharides which contain a minimum of three α-1,4-linked 
D-glucose units, e.g. starch (Ruyssen & Lauwers, 1976). Figure 1 shows the phases of the 
pharmacopoeia assays (Ph.Eur. and USP) to determine amylase activity in pancreas powder 
and pancreas powder-containing material. In addition to the titrations of samples and reference 
standards, blank values are required. The substrate starch and the enzymatic material are 
incubated for 10 min at 25°C. The enzyme reaction is stopped with hydrochloric acid. Upon 
addition of iodine and sodium hydroxide, sodium hypoiodite is formed (disproportionation 
of iodine) which oxidizes the released reducing end groups of the terminal glucose units. 
Additionally, iodine forms a blue/ violet clathrate with the non-cleaved starch. The excess iodine 
is then titrated with thiosulfate until colorless. The amylolytic activity of pancreas powder is 
determined by comparing the rate at which a suspension of pancreas powder hydrolyzes a 
substrate of starch solution with the rate at which a suspension of a pancreas powder reference 
standard hydrolyzes the same substrate under the same conditions (Ph.Eur.). One Ph.Eur.-unit 
and one USP-unit, respectively, of amylase activity is equivalent to the amount of pancreas            
INTRODUCTION
6
powder that decomposes starch at an initial rate such that 1.0 micro equivalent (0.16 micro 
equivalent, respectively) of glycosidic linkage is hydrolyzed per minute under the assay 
conditions described in Ph.Eur. and USP, respectively (Böhme et al., 2006; USP). 
Pancreatic proteases are a mix of several endo- and exopeptidases, for example carboxypeptidase 
A and B, elastase, trypsin or chymotrypsin. In order to protect the pancreatic gland from self 
digestion, fresh pancreatic juice contains inactive pro-enzymes. Enzyme activation is started by 
enterokinase released from the intestinal mucosa, thrombin or trypsin itself. The zymogen 
trypsinogen is converted to trypsin, which in turn activates all other pro-enzymes 
(Ryssen & Lauwers, 1976; Creon International Scientifi c Brochure, 2007). In pancreas powder, 
the proteases are partially, but not completely activated. Thus, two kinds of proteolytic activities 
are distinguished:
Free protease activity considers only the already activated proteases (USP) ▪
Total protease activity considers full activation after pre-incubation with enterokinase  ▪
(Ph.Eur)
Casein (used in the pharmacopoeia assays) and hemoglobin are substrates commonly introduced 
in protease assays. Figure 2 shows the phases of the pharmacopoeia assays to determine free 
or total protease activity in pancreas powder. According to Ph.Eur., total protease activity is 
determined by initially activating the sample with enterokinase for 15 min at 35°C, whereas 
the sample is introduced without pre-incubation in the USP method to obtain free protease 
activity. 
Phases of pharmacopoeia assays to determine total protease activity (Ph.Eur) or free protease activity (USP) in Figure 2. 
pancreas powder. Proteolysis is started by adding casein solution to the unactivated (USP) or activated (Ph.Eur.) enzyme. After 
incubation for 30 min (60 min USP) at 35°C (40°C USP), the reaction is stopped using trichloroacetic acid (TCA). Precipitated 
proteins are separated via fi ltration. Using a spectrophotometer, the UV absorption of soluble peptides remaining in the fi ltrate 
is measured at 275 nm (280 nm USP) (TCA = Trichloroacetic acid, Ph.Eur = European Pharmacopoeia, USP = United States 
Pharmacopoeia)
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In addition to the determination of samples and reference standards, blank values are also 
required. All solutions are tempered. Proteolysis is started by adding casein solution. After 
incubation for 30 min (USP: 60 min) at 35°C (USP: 40°C) the reaction is stopped using 
trichloroacetic acid (TCA). Precipitated proteins are separated via fi ltration whereas soluble 
peptides remain in the fi ltrate. Using a spectrophotometer, the UV absorption in the fi ltrate is 
measured at 275 nm and 280 nm, respectively. The proteolytic activity of pancreas powder is 
determined by comparing the quantity of non-precipitable peptides released per minute from a 
substrate of casein solution with the quantity of such peptides released by a pancreas powder 
reference standard from the same substrate under the same conditions (Ph.Eur.). One unit of 
protease activity is equivalent to the amount of pancreas powder that hydrolyzes casein under 
the conditions of the assay for protease activity described in Ph.Eur. and USP, respectively, at 
an initial rate such that there is liberated per minute an amount of non-precipitable peptides that 
gives the same absorbance at 275 nm (280 nm USP) as 1 μmol and 15 nmol, respectively, of 
tyrosine (Böhme et al., 2006; USP).
Ph.Eur. and USP describe different methods for determining trypsin activity. According to 
Ph.Eur., trypsin activity is determined by comparing the rate at which the trypsin-containing 
sample hydrolyzes N-benzoyl-L-arginine ethyl ester (BAEE) hydrochloride with the rate at 
which trypsin reference standard hydrolyzes the same substrate under the same conditions 
(Ph.Eur.). BAEE is cleaved to ethanol and benzoylarginine, which is titrated with sodium 
hydroxide solution at pH 8 (pH stat-method) and 25°C. In contrast, the USP method measures 
the hydrolysis of BAEE using a spectrophotometer. The hydrolysis of BAEE causes an increase 
in optical density at 253 nm (Sacks et al., 1971). 
Human pancreatic juice resembles porcine pancreatic secretion. Both pancreatic juices contain 
high portions of lipase and α-amylase. In contrast, more proteases are found in sheep and bovine 
pancreas (Peschke, 1991). Porcine pancreas accumulates as by-product in slaughterhouses in 
great quantities and thus it is conceivable that porcine pancreas is conveniently used for the 
manufacturing of pancreas powder. Except for muslime countries, bovine pancreas has become 
less important in the period of BSE and other infectious diseases (Böhme et al., 2006). In 
order to obtain pancreas powder,  raw material (fresh or frozen pancreas glands) is minced. 
Mechanical or proteolytic cell disruption then releases pancreatic enzymes into an aqueous, 
buffered medium. For example, hydrolysis is undertaken in an alkaline aqueous medium 
(GB 1328202, 1973) or in a neutral buffered medium (EP 0115023, 1984). After separation 
of solid components (cell debris, fi bers), pancreatic enzymes are precipitated, for example by 
the addition of ethanol. The fat-containing supernatant is separated. The precipitate is washed 
and dried, yielding the API. Pancreas powder of a higher digestive power may be labeled as 
a whole-number multiple of the three minimum activities or diluted to the desired activity by 
mixing with lactose, sucrose or pancreas powder of lower digestive power (USP). Finally, the 
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enzyme mixture is formulated to either enteric-coated pellets or mini tablets, which are fi lled in 
gelatine capsules or sachets (drug product). Enzyme activity of the API depends on the origin 
of the glands (i.e. the strain and feed of the pigs) and thus there may be high variability between 
batches. Due to the sensitivity of pancreatic enzymes, the conditions of all manufacturing steps, 
such as composition of the extraction agent or temperature during drying, infl uence the fi nal 
quality of the pancreas powder (Peschke, 1991; Böhme et al., 2006).
Process Analytical Technology (PAT)1.3 
Definition and requirements1.3.1 
The quality of a pharmaceutical product (API and drug product) is infl uenced by the characteristics 
of the raw materials, as well as by the manufacturing process. In 2004, the Food and Drug 
Administration (FDA), specifi cally the FDA’s Center for Drug Evaluation and Research 
(CDER) released guidelines for manufacturing companies to ensure quality of pharmaceutical 
products. In these guidelines, the term Process Analytical Technology (PAT) was defi ned as “(...) 
a system for designing, analyzing, and controlling manufacturing through timely measurements 
(i.e. during processing) of critical quality and performance attributes for raw and in-process 
materials and processes with the goal of ensuring fi nal product quality. (...) The goal of PAT 
is to enhance understanding and control the manufacturing process, (...)” (FDA, Guidance for 
Industrie: PAT – A Framework for Innovative Pharmaceutical Development, Manufacturing 
and Quality Assurance, 2004). 
PAT  leads to a better process understanding, which consequently results in the optimized use 
of resources. Furthermore, the continuous monitoring of the manufacturing process allows for 
early intervention upon failures. Thus, rejections of batches can be prevented. If a correlation 
between in-process and release testing can be established, release testing of the fi nal product 
(API and drug product) may be minimized or eliminated. 
The FDA identifi ed the following tools as being qualifi ed for implementation of PAT in the 
pharmaceutical industry: 
Process analyzers ▪
Process control tools ▪
Multivariate tools for design, data acquisition and analysis ▪
Continuous improvement and knowledge management tools ▪
Non-destructiveness, low costs, short analysis times, real-time monitoring and the possibility 
for automation are general requirements of potential in-process analysis and control (IPC) 
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techniques. The method applied needs to be robust, discriminatory and able to identify failures. 
Furthermore, no or marginal sample preparation is favored. 
Based on sampling methods and location of the analytical instrumentation, process analyzers 
are differentiated as follows (FDA, 2004; Kessler, 2006):
Off-line: After manual sampling, the sample is transported to a remote laboratory to be 
analyzed (discontinuous measurement).
At-line: After manual or (semi-)automated sampling, the sample is transported to an 
analyzer within the manufacturing area to be analyzed in close proximity to the 
process stream.
On-line: The sample is automatically diverted from the process and transferred to an 
automatic analyzer. Afterwards the sample may be returned to the process 
stream (by-pass).
In-line:  The sample is not removed from the process stream. The probe head is directly 
located in the process stream (invasive) or only separated by a window 
(noninvasive) from the process stream. 
In the following sections, process analysis, especially the determination of enzyme activities, 
is introduced in detail with respect to the manufacturing process of pancreas powder. As there 
is no need for sample taking, transport, preparation and disposal, the in-line measurement is 
generally the best form of process analysis. Simple in-line analytics of parameters, such as 
temperature, pH, weighing or fl ow, which represent process quality only indirectly can be easily 
adopted without disrupting the manufacturing process. In contrast, determination of enzyme 
activity (direct target) cannot be done by in-line analysis, as the addition of a substrate solution 
to the sample is required. Therefore, enzyme activities are mostly analyzed  off-line, but at-line 
or on-line techniques (without by-pass) are also conceivable. A branch line from the product 
stream to an analyzer would be required, where the sample is merged with the substrate solution 
and an analyzer monitors the enzyme reaction, in real- time.
In view of PAT, enzyme assays should be adoptable for IPC samples (liquid or solid) and 
for fi nal release of API and drug product. Even though all samples harbor several pancreatic 
enzyme types, one enzyme or enzyme group needs to be determined selectively. Liquid samples 
obtained from the beginning of the manufacturing process contain a lot of potentially disturbing 
substances in the sample matrix, such as fi bers, ethanol, other proteins or fat. Consequently, 
those samples are assumed to be the worst case.  For the purpose of developing a PAT method, 
the used technique should be applicable for the determination of pancreatic amylases, proteases 
and lipases. In contrast, the pharmacopoeias apply different methods to determine pancreatic 
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enzyme activities in pancreas powder: Amylase activity is determined in a redox titration, lipase 
activity in an acid base titration and protease activity by using UV absorption (1.2). Nevertheless, 
in order to maintain proximity to the pharmacopoeia methods, the same substrates (starch, 
casein, olive oil) should be used. They are complex substances of natural origin with varying 
specifi cations. 
Analytical methods for determining pancreatic enzyme activities suitable for 1.3.2 
PAT approach
Pharmacopoeia methods are time-consuming due to multi-step-procedures and sample 
preparation (e.g. dilution steps). Methods for the determination of enzyme activity used as 
in-process control are rarely found in the literature. Kroner (1988) reviewed and screened 
analytical methods regarding their suitability for on-line analysis of enzymes. Considering 
samples of high turbidity, only the electrochemical indication methods (potentiometry, 
amperometry, conductometry) were deemed appropriate. These methods are universally 
applicable to indicate end points of titrations, but not to follow the whole course of an enzyme 
reaction. Many reports on PAT related to bioprocesses, particularly fermentation processes, are 
available (Arnold et al., 2002; Lopes et al., 2004; Känsäkoski et al., 2006; Rathore et al., 2010; 
Workman et al., 2007). Such bioprocesses usually have higher demands on the used method 
compared to enzyme reactions considering e.g. temperature changes, matrix substances or 
agitation. In the following, several methods are illuminated with respect to their applicability 
to determine pancreatic enzyme activities on the one hand and their availability as in-process 
control on the other hand. Kasten (2008) reviewed generally used in-line process techniques, but 
not concerning enzymes. Relating to liquid and aqueous samples (substrate/ sample mixture), 
the following techniques are of special interest in the context of the digestive enzymes in 
pancreas powder:
Near-infrared (NIR) transmission spectroscopy and Middle-infrared (MIR)/ Attenuated  ▪
total refl ectance (ATR) spectroscopy
Ultraviolet- visible (UV/ Vis) spectroscopy ▪
Ultrasonic measurements ▪
In reviews concerning PAT, applications of NIR and MIR spectroscopy are widely discussed. 
NIR spectroscopy uses the near-infrared region of the electromagnetic spectrum (0.8 to 2.5 μm) 
and is based on molecular overtone and combination vibrations of the basic vibration in the MIR 
region (2.5 to 20 μm) (Kasten, 2008). MIR absorption bands are typically ten to hundredfold 
stronger than the weak NIR absorption bands, due to the higher energy and lower coeffi cients 
of absorption by NIR. The weak absorption of NIR often allows direct analysis of strongly 
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absorbing and high light-scattering matrices, such as fermentation broths. Therefore, dilution 
steps, short optical path lengths or dispersion in non-absorbing matrices are not required in the 
majority of cases (Arnold et al., 2002). However, NIR absorption bands are typically very broad 
(up to 100 nm band widths) and highly overlapped, leading to complex spectrums. In addition 
to improvements in instrumentation, multivariate data analysis (e.g. partial least squares 
(PLS) and principle components regression (PCR)) have been developed to fi lter the required 
information. Thus, correlations between changes in calibration spectrums and variations in the 
calibration samples (e.g. concentration of the components) are defi ned (Kasten, 2008). The 
most critical aspect is to ensure that calibration models are representative for future variations 
in the samples (Arnold et al., 2002). Besides, the process calibration is very laborious. Due to 
the strong absorbance of water, particularly in the MIR region, the water content in fermentation 
samples may cause problems (Känsekoski et al., 2006). Water infl uences can be avoided by 
using ATR (attenuated total refl ectance) spectroscopy in the MIR region or Raman Spectroscopy 
(Känsäkoski et al., 2006, Kasten, 2008).
Determination of enzyme activity using NIR or MIR can be fi gured as follows: The sample is 
fi rst added to the substrate solution before the mixture is transferred to a spectrometer or testing 
probe. Spectrums are generated in defi ned time intervals. Chemometric analysis using reference 
calibration data would yield the change of substrate and product concentration.
The use of IR spectroscopy to determine enzyme activity is frequently described in the 
literature, but not in context of in-process control and PAT (Barth, 2007). Enzyme assays are 
carried out either in an organic environment (Thoenges & Barth, 2002) or in aqueous media 
using heavy water D2O (Wright & Vanderkooi, 1997; Pacheco et al., 2003; Karmali et al., 
2004). Walde & Luisi (1989) developed an assay for determining lipolysis using Fourier 
transform infrared spectroscopy (FTIR). The authors prepared Aerosol OT (Dioctyl sodium 
sulfosuccinate)-reversed micelles with triglyceride (C6-C10) and vegetable oil (e.g. olive oil) in 
isooctane. Lipases were of mammalian and fungal origin (e.g. porcine pancreatic lipase). FTIR 
spectra of the entire reaction mixture were recorded and followed over time. For quantitative 
analysis, the authors chose isosbestic points in the spectrum: Peak of the formed fatty acids 
(comparatively large changes during reaction) and of the fatty acid esters.  They showed that 
hydrolysis of triglycerides can be followed continuously with high reproducibility (1-2 %). 
O’Connor & Cleverly (1994) investigated human milk lipase using similar reversed micelles. 
The substrate was triolein, and bile salts were added to the mixture. A strong dependence of 
the reaction rate on water content in the reversed micelles was observed. However, use of an 
organic environment is not completely comparable with the pharmacopoeia methods. Using 
ATR-FTIR, Snabe & Peterson (2001) investigated a method for monitoring enzymatic activity 
on surface-attached substrate fi lms in an aqueous environment. They monitored hydrolysis of 
triolein by lipase (native Fusarium solani pisi cutinase) and degradation of starch by Bacillus 
amyloliquefaciens α-amylase over time. The method consists of three steps: a) substrate fi lm 
application, b) hydration of the fi lm and c) addition of the enzyme. The long time required for 
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fi lm hydration (up to 40 min) was only necessary to monitor enzymatic activity on surface-
attached substrate fi lms. Thus, considarable shorter analysis times are assumed using ATR-
FTIR for determination of pancreatic enzyme activities. 
FTIR for determination of α-amylase activity in aqueous solutions of starch (2-6 % (w/v)) 
proposed by Krieg et al. (1995) appears to be the most interesting method. Hydrolysis was 
carried out at 37 °C taking samples at defi ned time intervals to record FTIR spectra. Difference 
spectra were determined by subtracting the spectrum recorded immediately after adding the 
enzyme to the starch solution from the ones recorded subsequently 5 to 120 min later. That 
way, unspecifi c absorption of the matrix can be eliminated, and thus the determination of 
enzyme activity in a complex matrix (human sera) was possible. The authors observed a linear 
correlation between amylase activity and spectra intensities evaluating the sum of the differences 
in absorption at two pairs of wave numbers (1072 - 1157 cm-1 and 1115 - 1018 cm-1) after 20 
min incubation. Such long incubation times are not suffi cient for PAT purpose. Provided that 
shorter analysis times (e.g. 5 min) also led to signifi cant changes in absorption, this method 
would imply a high potential for PAT. In principle, application of IR is conceivable based on 
Snabe & Peterson (2001) and Krieg et al. (1995). 
In the UV/ Vis region of the electromagnetic spectrum, molecules undergo electronic transitions. 
Organic compounds with a high degree of conjugation (aromatics or unsaturated hydrocarbons) 
absorb in the UV/ Vis region. In order to determine pancreatic enzyme activity by UV/ Vis 
spectroscopy, either UV/ Vis-active substrates/ products (Pencreac’h et al., 2002) or coupling 
with a second reaction that leads to a conjugated system (Rejeb et al., 2004) is required. Mostly 
high dilutions and fi ltration steps are also necessary.
Turbidity measurements are another application of UV/ Vis spectroscopy. Turbidity is measured 
by determining the attenuation of light caused by scattering or absorption. Turbidimetric and 
nephelometric determinations of starch and amylopectin degradation have been described in 
the literature (Peralta & Reinhold, 1955; Shipe & Savory, 1972; Malkus et al., 1977). However, 
these methods have not gained great importance (Lorentz, 1979). Lipase-catalyzed hydrolysis 
diminishes turbidity in olive oil or triolein emulsion. The turbidimetric or nephelometric 
determination of lipase activity, especially in serum, has been widely discussed in the literature 
and steadily improved (Rick & Hockeborn, 1982; Kannisto et al., 1983; Tietz et al., 1987). 
In the meantime, turbidimetric determination of lipase in clinical applications has been well 
established.
However, clinical samples often do not exhibit a linear increase or even lead to an increase of 
turbidity caused by matrix effects (Rick & Hockeborn, 1982; Kannisto et al., 1983). Although 
the methods are simple, poor substrate stability and the necessary calibration curve due to the 
lack of absolute lipase activity values hampered a wide diffusion of turbidimetric methods 
(Brobst, 1997; Beisson et al., 2000). Concerning lipase, the production of an emulsion with 
reproducable droplet size is expected to be diffi cult (Schelong et al., 2001). 
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Kawai et al. (1999) developed a turbidimetric assay to determine protease activity in the presence 
of 2 % (w/v) casein. After 2 h incubation, the turbidities were measured at a wavelength of 
595 nm. The authors evaluated their method as fast, easy and economical. However, coagulating 
proteases were not measurable due to turbidity changes. Calcium in the samples changed the 
turbidity and pH variation led to unreliable results.
Thus, turbidimetry has two important demands which may limit the use as PAT method: First, 
a very stable substrate preparation is required, which does not coagulate or precipitate during 
measurement. Secondly, side reactions such as precipitation of calcium soaps or a simultaneous 
enzyme reaction may not occur as they can adulterate the results. 
In addition to electromagnetic waves, acoustic waves can be applied as an analytic tool. Acoustic 
signals in the audible frequency region of 16 Hz to 20 kHz are named audible sound, above 
20 kHz they are called ultrasound and are inaudible for humans (DEGA, 2006). However, 
many animals utilize ultrasound for navigation, as well as to fi nd and characterize their food. 
According to Povey & Mason (1998), main ultrasound applications can be divided into two 
categories, depending on power (intensity) and frequency of the adopted ultrasound:
At low power and high frequencies (> 1 MHz) as analytical tool ▪
At high power and low frequencies (20 to 100 kHz) to assist processing ▪
High-intensity ultrasound using extremely high power levels (up to 1,000 W·cm-2) causes 
physical disruptions in the sample or promote chemical reactions (McClements, 1995). High-
intensity ultrasound has been established as a means of generating emulsions or enhancing 
cleaning and dissolving processes. More recently, the use of ultrasound for the inactivation or 
activation of enzymes has been described (Shaw & Gupta, 2008; Mawson et al., 2011). Using a 
probe system with a diameter of 6 mm, Liu et al. (2011) observed that ultrasonic pre-treatment 
(40 - 140 W, 6 min) altered the conformation of porcine pancreatic lipase and enhanced 
the specifi c activity. Tian et al. (2004) found a decrease of trypsin activity with increasing 
power (20 kHz, 85 - 425 W/ cm2). Using ultrasound at appropriate frequencies and intensity 
levels often leads to an enhancement of enzyme activity due to e.g. optimized mass-transfer 
(Mawson et al., 2011). 
Low-intensity ultrasound typically uses very small power levels (below 1 W·cm-2). It 
is non-destructive because no physical or chemical changes of the sample occur while the 
waves pass through. Due to destructiveness and the possible inhibiting or activating effect on 
enzymes at high powers, only ultrasound with low power is adaptable for determining enzyme 
activity. The feasibility to determine enzyme activity based on changes of ultrasonic velocity 
or attenuation caused by changes in the sample (e.g. substrate degradation) has often been 
reported in the literature (Povey & Rosenthal, 1984; Kudryashov et al., 2003; Born et al., 2009). 
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Several characteristics of low-intensity ultrasound make this technique a high-potential tool for 
the determination of different enzyme activities in API, IPC samples or drug product. It is fast, 
automatable and does not need any sample preparation as it can be applied to concentrated and 
turbid samples. Due to the real-time monitoring of the enzyme reaction, the enzyme activity 
is determined quickly. According to pharmacopoeia methods, additional reagents are needed 
e.g. to stop the enzyme reaction (protease: TCA) or to determine non-cleaved substrate or the 
reaction product (amylase: iodine, thiosulfate). For ultrasonic measurements such reagents are 
not required. In  contrast to UV/ Vis spectroscopy, conjugated systems in the substrates are not 
required. Therefore, complex mixtures of substrates as those used for pharmacopoeia methods 
and turbid preparations can be applied. The use of complex substrates with high molecular 
weight can even be advantageous for the ultrasonic measurement due to multiple degradation 
and structural changes (Born et al., 2009).
 
Low-intensity ultrasonic measurements1.4 
Basics1.4.1 
Ultrasonic Spectroscopy uses high-frequency acoustic waves propagating through the sample. 
In liquid media, ultrasound propagates as longitudinal sound. The direction of the pulse is 
parallel to the oscillation direction of the molecules and their arrangements resulting in a local 
compression and decompression of the media.  
Ultrasonic parameters1.4.2 
The most important parameters measured in ultrasonic experiments are ultrasonic velocity and 
attenuation. Together with refl ectance, they form the primary acoustic response.
The density and the compressibility of the medium determine ultrasonic velocity. Compressibility, 
which is the reciprocal bulk modulus, describes the reduction of volume by pressure. The Wood 
equation, also named Laplace equation (Nomura et al., 1987), describes the relationship between 
the ultrasonic velocity and the material constants as follows:  
         
  Ultrasonic velocity (m/s)
  Adiabatic compressibility (Pa-1)
 Density (kg/m3)
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This relationship is only effective for low-
attenuation fl uids (Coupland, 2004). The 
equation was complemented for dispersions 
of solid particles considering the volume 
fraction of the dispersed phase (Povey, 1997). 
Given its relation to density, the ultrasonic 
velocity in liquids depends on temperature. 
Unlike most fl uids, the ultrasonic velocity in 
pure water and aqueous solutions increases 
with ascending temperature to a maximum 
at 74°C (Figure 3). Since the velocity in 
water varies by approx. 3 m·s-1·°C-1 at 20 °C an error in temperature of 0.1°C will produce an 
error in velocity of 0.3 m·s-1 (Povey, 1997). Ultrasonic velocity is only marginally affected by 
the frequency (Dukhin et al., 2005). The ultrasonic velocity can be determined in two ways: 
Either the wavelength is determined at known frequency or the time needed for a wave to travel 
a known distance. (McClements, 1995).
Ultrasonic attenuation means the loss of energy and the decrease of amplitude of the ultrasonic 
wave as it passes through the sample. It is highly frequency-dependent and nearly unaffected by 
temperature changes (Dukhin et al., 2005). The major causes of amplitude and phase alteration 
are absorption and scattering (McClements, 1995). Absorption implies the conversion of sound 
energy into heat, due to viscosity, thermal conductivity or molecular relaxation. Scattering 
occurs in heterogeneous materials. A discontinuity, such as a droplet in an emulsion or a particle 
in a suspension, causes scattering of the ultrasonic wave into directions which are different from 
that of the incident wave. In contrast to light detectors, ultrasound transducers cannot detect a 
signal in which the phases between different parts of the signal have been mixed up due to the 
phase sensitivity (Povey, 1997). This can lead to an extensive loss in the detected signal. Thus, 
measurements of attenuation are often less reliable than ultrasonic velocity measurements. 
Dukhin et al. (2005) investigated the sensitivity of ultrasonic velocity and attenuation to chemical 
composition. Using the transmission pulse-technique, both parameters were measured in water 
with various concentrations of different chemicals. While ultrasonic velocity was shown to 
be very sensitive to addition of chemicals (approx. 2 % from 1500 m·s-1 to 1530 m·s-1 at a 
concentration of 0.3 mol·l-1 calcium chloride), the attenuation was less sensitive. It only changed 
signifi cantly for highly charged ions and with concentrations varying by more than 0.1 mol·l-1. 
However, the authors observed a dramatic change in attenuation with composition of the 
dispersed phase during analysis of various dairy products. They concluded that sound velocity is 
useful for characterizing chemical compositions or reactions that occur on the molecular level, 
whereas attenuation is more suitable for characterizing effects related to heterogeneity and 
Temperature dependency of ultrasonic velocity Figure 3. 
in pure water. Maximum ultrasonic velocity is found at 
74 °C (From: Povey, 1997).
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phase composition. Other authors came to the same conclusions (McClements, 1995; Povey, 
1997; Capote & Castro, 2007).
 Experimental techniques and instrumentation1.4.3 
Ultrasonic instruments use either pulsed or continuous-wave ultrasound based on the form 
in which the ultrasound is applied to the sample (McClements, 1995; McClements, 1996; 
Kaatze et al., 2008). McClements (1996) grouped the commonly used techniques into three 
categories (Figure 4). A fourth category can be defi ned by taking devices into account that are 
currently on the market (Table 2).
Classifi cation of ultrasonic techniques according to type of applied ultrasound (Letters in parentheses refer Table 2. 
to Figure 4). 
A typical experimental confi guration is 
composed of the measurement cell, which 
contains the sample, a pulse generator, an 
ultrasonic transducer and an oscilloscope 
or personal computer. A signal generator 
produces an electrical signal which is 
applied to the transducer converting the 
signal into ultrasound. The sound propagates 
through the sample in the measurement cell. 
Afterwards, the ultrasound is converted back 
into an electrical signal by the transducer 
acting as receiver. After digitalization by 
an analog-to-digital converter, the signal is 
displayed on the screen of an oscilloscope or 
personal computer (McClements, 1996). Transducers are generally composed of piezoelectric 
materials (e.g. lithium niobate or quartz crystals), which convert mechanical stress into an 
electrical voltage. Conversely, a mechanical deformation is produced when an electrical voltage 
is applied.
For Through Transmission Technique (Figure 4, A), the measurement cell is located between 
two ultrasonic transducers. One transducer acts as generator, the second as a receiver. The 
ultrasonic velocity (v) is equal to the cell length (d) divided by time needed for travelling the 
distance (t) (Clements, 1996): 
Principle setup of three of the most common Figure 4. 
measurement cells to measure ultrasonic properties. A 
shows the Through Transmission Technique, B shows 
the Pulse Echo Technique and C shows an Interferometer 
(G = Generator transducer, R = Receiver transducer, 
d = length of sample cell), for explanation see text 
(From: McClements, 1996)
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v Ultrasonic velocity (m· s-1)
d Length of sample cell (m)
t Time (s)
Pulse Echo Technique (Figure 4, B) contains a single transducer that is used for generating and 
receiving the ultrasonic pulses. The ultrasound propagates through the sample and is refl ected 
back to the transducer on the opposite wall. This technique is convenient for the determination 
of ultrasound in small volumes (Voleišienė & Voleišis, 2008). The time interval between the 
echo is the time required for the pulse to travel twice the cell length (Clements, 1995):
            
v Ultrasonic velocity (m· s-1)
d Length of sample cell (m)
t Time (s)
Interferometers (Figure 4, C) are also equipped with one single transducer, but together with a 
movable refl ector plate. The generated ultrasonic wave is refl ected back und forth between the 
generator and transducer inducing a standing wave in the sample. When the refl ector plate is 
moved vertically through the sample, destructive and constructive interference occur leading to 
amplitude minima and maxima of the signals received by the transducer. This interferometric 
technique is suitable for precise absolute measurements (Voleišienė & Voleišis, 2008). However, 
it is more time consuming than pulsed techniques since measurements must be carried out 
separately for each frequency (McClements, 1996).
Resonances can also be generated in reverse. Instead of changing the path length while holding 
a constant frequency, the frequency is changed while a constant path length is ensured. Most 
modern resonance-based ultrasonic devices 
use this principle (Coupland, 2004). Here, 
ultrasound passes through the sample and 
generates a standing wave by being refl ected 
on the other side (Figure 5). Resonance 
occurs when the length (distance between 
generator and analyzer) is an integer number 
of the half wave length: Principle setup of resonance-based ultrasonic Figure 5. 
devices. For explanation see text (From: Buckin et al., 
2003)
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d Distance (cell length) [m]
 Wavelength [m]
n Integer number
High amplitudes are caused by the interference phenomenon. By measuring resonance at high 
amplitudes, a higher precision is observed compared to pulsed techniques.
At least one resonance peak is defi ned prior to the measurement. The ultrasonic velocity is 
directly calculated from the frequency:
   
     
 Resonance frequency [s-1]
v Ultrasonic velocity [m· s-1]
 Wavelength [m]
Thus each resonance peak is defi ned by the peak order number:
                   
n Integer number (Peak order number)
d Distance (cell length) (m)
 Resonance frequency (s-1)
v Ultrasonic velocity (m· s-1)
Attenuation causes a broadening of the resonance peaks and can be calculated from the 
half-height width of the resonance peak (Coupland, 2004). In ultrasonic devices, the bandwith 
(3 dB) is generally used to calculate attenuation, in other words, the width at 70.71 % height of 
amplitude or the width at a point equal to the maximum amplitude divided by the square root 
of two. 
Pulsed methods are the most widely used techniques due to their operating simplicity and 
rapidness of measurements (McClements, 1995). In addition, they have lower equipment 
expenditure and are often more robust compared to resonance methods (Coupland, 2004). 
However, as the path length of interactions of the ultrasonic fi eld with the sample is virtually 
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increased by multiple refl ections, continuous-wave techniques have a higher sensitivity. This 
allows high resolution measurements on small liquid volumes to become possible, at least in 
a limited frequency range (Kaatze et al., 2008). Resonance cells can easily be constructed to 
measure volumes less than 1 ml while long path lengths (large samples) are required to measure 
changes in pulsed measurements. A pulsed method achieves maximum reproducibility within 
0.1 m·s-1, whereas resonators can reach up to fi ve orders of magnitude higher reproducibility. 
The precision of attenuation measurements is typically somewhat poorer for both techniques as 
compared to ultrasonic velocity measurements (Coupland, 2004). 
Commercial instruments for high-resolution ultrasonic measurements are offered by 
TF Instruments GmbH (Ultrasonic Resonator Technology, URT) and Sonas Technologies Ltd. 
(High-Resolution Ultrasonic Spectroscopy, HR-US). Although the basic principle is identical, 
the instruments differ in cell volume, thermostat system and frequency range. Table 3 shows a 
comparison of both devices. 
Differences between commercially available high-resolution ultrasound-based instruments (* differential regime)Table 3. 
The HR-US spectrometer provides a broader frequency range as compared to the ResoScan 
Research System. The ResoScan Research System facilitates the selection of the best resonance 
peak by evaluating the quality of the peaks concerning symmetry and amplitude during 
“initialization”. In contrast, the operator has to ascertain voltage input (signal amplitude) 
and resonance peak manually using the HR-US spectrometer. The temperature control of the 
ResoScan Research System is carried out by a peltier element. The heating elements heat upon 
any temperature decrease, e.g. when the cell is opened. Therefore, the system quickly reaches 
the constant set temperature, as needed for reliable ultrasonic spectroscopic measurements. The 
cells in the HR-US102 P spectrometer are surrounded by fl owing tempered water coming from 
a connected external water bath. The system cannot react on temperature changes in the cell 
block, leading to longer equilibration times. Due to heat loss during the circulation process, the 
real temperature in the cell block is not precisely known. Both devices are equipped with two 
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measurement cells. Therefore, reference measurements can be carried out. When performing 
enzyme kinetic measurements, both cells are fi lled with substrate solution. To one of the cells 
the enzyme solution is added. As only the change of velocity difference between both cells is 
considered, changes in temperature during measurement do not signifi cantly affect the results, 
assuming same temperature variabilities in both cells. In the present study, measurements of 
ultrasonic velocity were possible with both devices although the instruments were run in non-
conditioned rooms. 
Determination of enzyme activity based on ultrasound 1.4.4 
Enzymes are characterized by a high substrate and reaction specifi city. They accelerate 
biochemical reactions by reducing the activation energy of the reaction. The enzyme binds the 
substrate in the active centre according to the “lock and key” model forming a stable enzyme-
substrate complex. After chemical transformation the enzyme is regenerated and the products 
are released. A change of compressibility in the sample is assumed to lead to a change of 
ultrasonic velocity during enzyme reaction. According to Nölting & Sligar (1993), the adiabatic 
compressibility of e.g. proteins in aqueous solution is inter alia due to
the intrinsic compressibility of the molecule ▪
the difference in compressibility in the hydration shell relative to bulk water. ▪
Intrinsic compressibility results from an imperfect packing of the molecule. Relaxation leads 
to an increase of adiabatic compressibility, which is only signifi cant if the relaxation is not 
much slower than the period of sound (Sarvazyan & Kharakoz, 1979). Hydration water shows 
less adiabatic compressibility as compared to bulk water leading to an increase of ultrasonic 
velocity. While in earlier papers (Gekko & Noguchi, 1979; Eden et al., 1982) the prevailing 
view was that the compressibility of hydration water is close to the compressibility of ice, 
Kharakoz & Sarvazyan (1993) assessed that the compressibility of water in hydration shells is 
only 20 % lower than that of bulk water.
The change of ultrasonic velocity during enzyme reaction (schematically). Enzyme binding and substrate degradation Figure 6. 
lead to a change in extension of the surrounding hydration shells, which results in a change of ultrasonic velocity:  A Properties 
of substrate solution determine the measured ultrasonic velocity. B After adding enzyme solution, the enzyme binds to the 
substrate leading to a release of hydration water and consequently to a reduction of ultrasonic velocity. C The substrate is 
cleaved to its single components leading to an increase of  hydration water. Effects B and C interfere with each other. During 
hydrolysis reactions, a total increase of ultrasonic velocity is mostly observed (modifi ed from TF-instruments).
Low-intensity ultrasonic measurements 
21
Ultrasonic determination of amylase, lipase and protease activity described in the literature.Table 4. 
Figure 6 demonstrates schematically the assumed change of ultrasonic velocity during an 
enzymatic hydrolysis reaction. As the compressibility of molecules bound in hydration shells is 
smaller than in unbound water, ultrasonic velocity depends on the extension of hydration shells 
in the system. The binding of a protein to a ligand initially causes a release of hydration water 
and thereby a decrease of ultrasonic velocity (Buckin et al., 2003). Due to hydrolysis of the 
substrate, the hydration shell expands again and the ultrasonic velocity increases. Both effects 
interfere with each other leading mostly to a total increase of ultrasonic velocity during hydrolyis 
(Buckin & Kudryashov, 2002). The feasibility of ultrasonic measurements for determination of 
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enzyme activity has been widely discussed in the literature. Table 4 summarizes references 
concerning the ultrasonic determination of amylase, lipase and protease activities.
The ultrasonic detection of starch degradation (5 % in water, pH 6.8) by α-amylase has been 
previously described (Povey & Rosenthal, 1984). Using the ultrasonic pulse-echo technique, 
the authors observed a linear dependency of ultrasonic attenuation on amylase activity due 
to the reduction in viscosity. Ultrasonic velocity was unaffected by amylase activity in their 
experiment, supposably due to low resolution of the pulsed technique (Povey & Rosenthal, 
1984). Using a high resolution device (HR-US), Kudryashov et al. (2003) demonstrated that 
amylolytic activity can also be followed by measuring the ultrasonic velocity. 
For enzymatic proteolysis, Buckin & Craig (2005) investigated the use of HR-US. Ultrasonic 
velocity increased over time as intrinsic compressibility was lost and hydration increased during 
degradation of three tested substrates. Born et al. (2009) determined the degradation of casein 
by different proteases using URT. The reactions were carried out mostly at pH 8.0, 37°C and 
stopped by additon of TCA based on the pharmacopoeias. Precipitated proteins were separated. 
The supernatant was used for ultrasonic measurements at 25°C measured as difference to a 
blank. The blank was prepared by adding TCA before the addition of the enzyme solution. 
With respect to precision and other analytical parameters, URT was compared to the UV/ 
Vis/ ninhydrin assay. The URT method was up to sixfold less precise than the chromogenic 
assay, possibly due to high high salt concentrations. This can cause high background signals 
due to large hydration shells around the ions interfering with the signal of casein hydrolysis 
(Born et al., 2009).
The determination of lipase activity using ultrasonic measurements is rarely discussed in the 
literature. According to TF Instruments GmbH (company information), the activity of lipase in 
a non-specifi ed olive oil preparation was determined. A linear relationship between ultrasonic 
velocity and enzyme concentration was observed for each enzyme. However, no information 
about enzyme source and procedure were given. Van Dijk et al. (2007) patented a method for 
screening enzymes using HR-US. Matrices like milk, cheese curd or wheat fl our suspension 
allowed the screening of lipase, amylase, protease, oxidase and xylanase activity in the same 
matrix (US 0264670). Due to non-specifi city of the substrates, the described method is not 
suitable for determining activity of a single enzyme in an enzyme mixture such as Pancreas 
Powder. The charts provided in the paper to prove the method should be considered critically. 
The authors observed a difference in ultrasonic velocity between substrate solution and 
substrate/ enzyme mixture, but an enzyme kinetic curve were often not monitored. Differences 
in ultrasonic velocity can be caused by an enzyme reaction, but also by the enzyme itself or the 
enzyme matrix. Therefore, no reliable information about the enzyme reaction can be derived.
Most investigations reviewed in the previous paragraphs were of qualitative nature. Using the 
Through Transmission Technique, Resa et al. (2009) followed a more quantitative approach by 
developing an ultrasonic velocity assay of extracellular invertase in living yeasts. The authors 
succesfully determined the effects of substrate concentration (Michaelis-Menten approach), 
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temperature, pH and enzyme concentration on the increase of ultrasonic velocity and  enzyme 
activity, respectively. Using HR-US, Resa & Buckin (2011) investigated the characteristics of 
β-glucosidase (cellobiase) which hydrolyzes the O-glycosyl bond of cellobiose whereupon two 
glucose molecules are released. The authors focused on the “translation” of ultrasonic reaction 
profi les into reaction progress curves (evolution of concentrations of reactants and products 
with time) and reaction rate profi les. They calculated the specifi c concentration increments of 
ultrasonic velocity of  glucose (product), aP, and cellobiose (substrate), aS , obtained from the 
measured values of ultrasonic velocity in aqueous solutions of these compounds as follows:
                   
ai Specifi c concentration increment of component i
wi Concentration of component i
v0/ i Ultrasonic velocity in pure solvent (v0 ) and in the solution of component i (vi )
Ultrasonic velocity can be presented as a sum of contributions of its components 
(Resa & Buckin, 2011):
     
     
v0 Ultrasonic velocity in pure solvent 
ai Specifi c concentration increment of ultrasonic velocity of component i 
wi Concentration (mass fraction) of component i
In order to describe the change in ultrasonic velocity in a hydrolysis reaction, the values of ai 
and wi  represent the specifi c concentration increments of ultrasonic velocity and concentrations 
of substrate, product and solvent, whereupon the concentrations of reactants are linked with 
each other. Thus, the concentration increment of ultrasonic velocity of the reaction ∆ a is given 
by (Resa & Buckin, 2011):
          
v0 Ultrasonic velocity in pure solvent 
ap/ w/ s Specifi c concentration increment of product (ap ), solvent (aw ) and substrate (as ) 
Mp/ w/ s Molar mass of product (Mp ), solvent (Mw ) and substrate (Ms )
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Ultrasonic determination of emulsion stability1.4.5 
In order to determine lipase activity, a substrate emulsion is needed allowing lipases to adsorb 
to the oil/ water interface. Instabilities of emulsions can be caused by four mechanisms 
(Kutz et al., 2011):
Creaming and Sedimentation ▪  are universal in emulsions where oil and aqueous 
phases signifi cantly differ in densities, resulting in an upward or downward movement 
of the droplets. The rate of creaming or sedimentation increases with droplet size and is 
intensifi ed by coalescence. While the degree of dispersion remains constant the process 
is reversible.
Flocculation ▪  refers to the aggregation of droplets that occurs when dropets meet 
during continuous movement due to a lack of repulsive forces. The process is initially 
reversible.
Coalescence ▪  is a consequence of a strong approximation of the droplets and refers to the 
unifi cation of two or more droplets to one enlarged droplet. The process is irreversible.
Breaking ▪  results from proceeding coalescence and refers to complete phase 
separation.
Low intensity ultrasound has been repeatedly 
discussed as a means of analyzing stability 
of dispersions. Howe et al. (1986) described 
a technique to measure emulsion creaming 
by monitoring the velocity of ultrasound 
through an emulsion at different heights and 
times. A concentration profi le of the dispersed 
phase (6.7 MHz) was obtained for the 
creaming behaviour of hexadecane-in-water 
emulsions stabilized by nonionic surfactant 
in the presence and absence of hydroxyethyl 
cellulose. Buckin et al. (2002) monitored the 
destabilization of a water-in-oil emulsion 
with a mean droplet size of 0.5 μm induced 
by temperature rise using different 
frequencies in the range from 2-15 MHz. An 
increase of attenuation at 44°C was attributed 
to the fl occulation of dispersed aqueous 
droplets induced by heating (Figure 7). The 
Characterization of the heat stability of a Figure 7. 
water-in-oil emulsion in a HR-US 102 spectrometer. 
Ultrasonic velocity and attenuation were monitored at 
6 MHz over ascending temperature: The increase of 
attenuation and the decrease of velocity at 44°C indicate 
the fl occulation of the system (from Buckin et al., 2002)
Low-intensity ultrasonic measurements 
25
ultrasonic velocity, which depends on 
temperature, deviated from the decreasing 
baseline at the same temperature (44°C). 
This demonstrates the sensitivity of the 
ultrasonic parameters to characterize the 
stability of emulsions. Dukhin et al. (2005) 
studied the use of acoustic spectroscopy to 
monitor droplet size and fat content in dairy 
products by measuring ultrasonic attenuation. 
The authors concluded that attenuation 
measurements at frequencies below 50 MHz 
depended on droplet size and thus droplet 
size can be calculated. A linear correlation 
between fat content and attenuation was found for frequencies above 50 MHz. The process of 
coagulation led to a decrease of velocity due to protein aggregation (reduced hydration shells) 
(Dukhin et al., 2005). Buckin et al. (2002) reported the monitoring of sedimentation in a 
perfl uorocarbon emulsion (aqueous, 10 % (v/v)) at 25°C. Sedimentation and coalescence were 
triggered by the higher density of perfl uoro-carbon as compared to water. The sedimentation 
processes were monitored continuously over 9 h measuring ultrasonic velocity and attenuation 
in the middle of the cell in the area of the ultrasonic beam. The ultrasonic velocity was used to 
calculate the volume fraction in the beam, and particle size was calculated from the attenuation 
(Figure 8). Similar experiments were conducted to investigate the effect of different polymer 
coatings on the sedimentation rate (Kudryashov et al., 2005). Due to the sensitivity of ultrasonic 
velocity and attenuation towards emulsion instabilities, the use of a stable substrate emulsion is 
mandatory for an ultrasonic lipase method to ensure a reliable monitoring of the hydrolyis 
reaction without including instability processes. 
Quality of analytical methods1.5 
In order to judge and to ensure quality and reliability of analytical results, method validation 
is required to confi rm that an analytical procedure is suitable for its intended purpose. Many 
regulatory requirements exist to ensure high standards for analytical methods (ICH Q2 (R1), 
1994; U.S. FDA, 2000; CITAC/ Eurachem, 2002). According to ICH, specifi city, linearity, 
range, accuracy, precision and robustness are validation characteristics for  assays.
 
Specifi city ▪  is the ability to determine the content or potency of an analyte in the presence of 
components which may be expected to be present (ICH Q2 (R1), 1994; U.S. FDA, 2000). 
Nearly the same meaning has often been given to selectivity (U.S. FDA, 2001; 
CITAC/ Eurachem, 2002). In accordance with IUPAC recommendations, specifi city is 
Characterization of the sedimentation of a Figure 8. 
perfl uoro-carbon emulsion in a HR-US 102 spectrometer. 
Ultrasonic velocity and attenuation were monitored over 
time in a perfl uoro-carbon emulsion to calculate volume 
fraction in the beam and particle size. Decrease of volume 
fraction and particle size indicate the sedimentation of 
perfl uoro-carbon (from: Buckin et al., 2002).
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the ultimate  of selectivity. Thus, selectivity can be graded, but a method is either specifi c 
or unspecifi c (Vessman et al., 2001). Both terms will be used in the present thesis, based 
on the defi nitions given above.
Precision ▪  of an analytical procedure expresses the degree of scatter between several 
measurements obtained from multiple sampling of the same homogeneous sample. ICH 
discriminates between three forms with respect to the source of variation: Repeatability 
(measurement under same operating conditions over a short time interval), intermediate 
precision (within-laboratory variations such as different days, operators or equipment) 
and reproducibility (between laboratories) (ICH Q2 (R1),  1994). 
Accuracy ▪  expresses the closeness of agreement between an accepted reference value 
(e.g. obtained with pharmacopoeia methods) and the value found (ICH Q2 (R1), 1994). 
Linearity  ▪ of an analytical procedure is its ability to yield results which are directly 
proportional to the concentration or potency of the analyte. The range of an analytical 
method is the interval between the upper and lower concentration of analyte for which a 
suitable precision, accuracy and linearity has been demonstrated (ICH Q2 (R1), 1994). 
Robustness  ▪ shows the reliability of the analysis with respect to deliberate variations 
in method parameters (ICH Q2 (R1), 1994). Given the relation of ultrasonic velocity 
to temperature, variation of temperature is one important robustness test within the 
validation of ultrasonic methods. 
Aim of thesis1.6 
The well-known methods for determination of amylase, lipase and protease activity in pancreas 
powder have persistently remained in the pharmacopoeias, although new methods for enzyme 
assays have consistently been described in the literature. Based on traditional techniques, the 
pharmacopoeia methods are optimally adjusted to the demands of pancreas powder analysis and 
have led to reliable results for many decades. However, they have one essential disadvantage 
concerning in-process control: They are time-consuming due to multi-step procedures and need 
extensive sample preparation (e.g. dilution steps or fi ltering). With the recent development of 
high-resolution ultrasonic devices, a new technique is available to measure enzyme activity by 
a simple and fast procedure. Most of the earlier investigations regarding ultrasonic monitoring 
of enzyme activities are qualitative descriptions. The aim of the present thesis was to evaluate 
the ultrasonic technique as a tool for the quantitative determination of a single enzyme activity 
in an enzyme mixture (pancreas powder). 
In particular, the feasibility of ultrasonic measurements to determine amylase, lipase, protease 
and trypsin (single protease) activities was tested and methods were developed that resemble 
those in the pharamcopoeias with respect to substrates and other conditions. Since ultrasonic 
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velocity is sensitive to reactions on the molecular level, the focus was on the application of 
ultrasonic velocity for the determination of pancreatic enzyme activities. In order to evaluate 
the newly developed methods, the key validation parameters, which have not been described in 
the literature to date, were determined. Due to the complex nature of in-process samples, various 
robustness measurements were needed for the following conditions and sample compositions:
 
Temperature  ▪
pH of sample matrix ▪
Salt concentration in sample matrix ▪
Isopropanol content in sample matrix ▪
Fat content in sample matrix ▪
Protein content in sample matrix. ▪
Due to the sensitivity of ultrasonic velocity towards emulsion instabilities, special attention 
was given to the preparation of a stable substrate formulation for the ultrasonic spectroscopic 
lipase assay. Applicability of the prepared emulsions was based on measuring stable baselines 
of ultrasonic velocity. Microscopic analysis and determination of droplet sizes using laser 
diffraction provided further information. Optimization of the fi nal method were verifi ed by 
repetition of earlier measurements under newly defi ned conditions.
While pancreas powder (API) was used for feasibility studies, the fi nal methods were also 
adopted for pancreas powder-containing products and in-process material. The main focus was 
on in-process material from early process steps to ensure maximum heterogeneity (worst case 
scenario). Reference measurements with a working standard were used to correlate with the 
pharmacopoeia assays, which confi rmed the working of the developed assays.
Particular attention was given to investigations on assessing ultrasonic measurements as PAT 
technique. Besides robustness measurements, time consumption and automation options were 
examined to determine the feasibility of ultrasonic measurements as in-process control. Finally, 
the application of ultrasonic measurements for release testing instead of using the traditional 
pharmacopoeia methods had to be illuminated.
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MATERIAL AND METHODS2. 
Materials2.1 
Enzymes – Reference standards and samples2.1.1 
For feasibility tests a pancreas powder working standard was used. It was standardized to the 
offi cial, commercially available FIP and USP standards. The working standard was also applied 
as reference for the determination of amylase, lipase, protease and trypsin activities in porcine 
pancreas powder-containing samples to calculate enzyme activity. 
Amylase, lipase and protease activity of working standard determined according to Ph.Eur.Table 5. 
The activity label claim of the working standard based on the Ph.Eur. methods described in the 
monograph ‘Pancreas Powder’ is shown in Table 5. For trypsin tests, the offi cial FIP standard 
(42,400 FIP/ Ph.Eur.-u/g) was used.
Description of porcine pancreas powder-containing drug products used in the present thesis for feasibility tests of Table 6. 
determining total protease activity and for an inter-laboratory test (cps = capsule)
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Porcine pancreas powder-containing product was used for feasibility tests of determining total 
protease activity due to higher activation potential compared to the working standard (Table 6). 
Additional drug products were used to determine enzyme activity by ultrasonic measurements 
to subsequently compare the results with the pharmacopoeia method results (Table 6 and 
Table 7).
Description of porcine pancreas powder-containing enteric coated capsules (cps) used for ultrasonic determination Table 7. 
of enzyme activity in drug product in order to compare with pharmacopoeia results
Drug substance (API) was determined using material from the end of the manufacturing 
process of pancreas powder, in composition and appearance comparable to working standard.
In-process samples from the beginning of the manufacturing process of pancreas powder were 
determined: 
Proteolysis material I, three batches ▪
Proteolysis material II, three batches ▪
Proteolysis-like material, which is similar to proteolysis material in consistency and  ▪
appearance, but differs in salt concentration, isopropanol content and enzyme composition 
(e.g. enhanced trypsin activity).
All in-process samples were liquid aqueous material, containing isopropanol, several salts, fats, 
proteins and fi bers. The in-process material was either frozen immediately after sampling or 
freshly used on the day of sampling (stored on ice).  Prior to ultrasonic measurements, frozen 
samples were unfrozen. Fibers of highly fi bred samples were partially separated using a crude 
sieve continuing with the ‘fi ltrates’. The samples were weighed and diluted to 5.0, 10.0 or 
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20.0 ml with the respective sample solvent (volumetric fl ask). Prior to the transfer into a beaker 
the suspension was shaken shortly. The sample solution was stirred for approx. 10 minutes on 
ice. 
List of reagents2.1.2 
N-Benzoyl-L-arginine ethyl ester hydrochloride (BAEE) (Calbiochem/ Merck,  ▪
Darmstadt, Germany)
Boric acid p.a. (Riedel-de Haën/ sigma aldrich, Seelze, Germany) ▪
Calcium chloride dihydrate p.a. (Merck, Darmstadt, Germany) ▪
Casein Bovine Milk (Calbiochem/ Merck, Darmstadt, Germany) ▪
Dextrin 5/ 10/ 20 from maize starch (Fluka/ sigma aldrich, Buchs, Switzerland) ▪
Enterokinase, 0.5 u/ 1 mg (FIP, Int. Commission on Pharmaceutical Enzymes, Centre of  ▪
standards, Gent, Belgium) 
Ethanol absolute (Mallinckrodt Baker B.V., Deventer, Netherlands) ▪
Glyceryl trioctanoate min. 99% (sigma-aldrich, Steinheim, Germany) ▪
Gum arabic spray-dried, Ph. Eur. (Merck, Darmstadt, Germany) ▪
Hydrochloric acid 1M (Merck, Darmstadt, Germany) ▪
Iodine solution 0.05M Titripur® (Merck, Darmstadt, Germany) ▪
Lipase activating mixture Ph.Eur. (FIP/ Ph.Eur.) [“Galle dispert”] ▪
Maleic anhydride, pure (Fluka/ sigma aldrich, Buchs, Switzerland) ▪
Olive oil (Roth, Karlsruhe, Germany) ▪
Pancreatic amylase (56,300 u/g), lipase (41,400 u/g) and protease (1,480 u/g) (FIP, Int.  ▪
Commission on Pharmaceutical Enzymes, Centre of   standards, Gent, Belgium)
Pancreatin amylase and protease/ Pancreatin lipase (USP, Basel, Switzerland) ▪
Potassium phosphate monobasic p.a. (sigma aldrich, Seelze, Germany) ▪
2- Propanol 99 % (Merck, Darmstadt, Germany) ▪
Sodium chloride p.a. (Merck, Darmstadt, Germany) ▪
di-Sodium hydrogen phosphate anhydrous p.a. (Merck, Darmstadt, Germany) ▪
di-Sodium hydrogen phosphate dihydrate p.a. (Merck, Darmstadt, Germany) ▪
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Sodium hydroxide solution 1M Titripur® (Merck, Darmstadt, Germany) ▪
Sodium hydroxide solution 0.02M Titripur® (Merck, Darmstadt, Germany) ▪
Sodium thiosulfate solution 0.1M Titripur® (Merck, Darmstadt, Germany) ▪
di-Sodium tetraborate decahydrate p.a. (Riedel-de Haën/ sigma aldrich, Seelze,  ▪
Germany)
Starch, soluble p.a. (Merck, Darmstadt, Germany)  ▪
Sulfuric acid 95-97 % (sigma aldrich, Seelze, Germany) ▪
Titrisol® concentrate for sodium hydroxide solution 0.1 mol/l (Merck, Darmstadt,  ▪
Germany)
Trichloroacetic acid (TCA) p.a. (sigma Aldrich, Seelze, Germany) ▪
Tris(hydroxymethyl) aminomethane (TRIS) p.a. (Merck, Darmstadt, Germany) ▪
Triton X 100, pure (Roth, Karlsruhe, Germany) ▪
Trypsin, 42,400 u/g (FIP, Int. Commission on Pharmaceutical Enzymes, Centre of  ▪
standards, Gent, Belgium)
Working standard (according to 2.1.1) ▪
Deionized water was used (resistance > 0.18 MΩ·m, organic carbon < 0.5 mg/l).
Preparation of buffers and solutions2.1.3 
Reagents for determination of amylase activity2.1.3.1 
Amylase solution (URT/HR-US)
Working standard (20 mg) or a porcine pancreas powder containing sample containing approx. 
1870 FIP/ Ph.Eur.-units, respectively), and accurately weighed, were dissolved in 40.0 ml 
Phosphate buffer solution (URT/ HR-US) for approx. 15 min in ice. 
Amylase solution (URT/HR-US)
Working standard (20 mg) or a porcine pancreas powder containing sample containing approx. 
1870 FIP/ Ph.Eur.-units, respectively), and accurately weighed, were dissolved in 40.0 ml 
Phosphate buffer solution 0.2 M (URT/ HR-US) for approx. 15 min in ice. 
Phosphate buffer solution (URT/ HR-US)
100 ml of phosphate buffer 0.2 M (Ph.Eur./ USP) pH 6.8 and 33.5 ml of sodium chloride 
solution 0.2 M (Ph.Eur./ USP) were diluted to 1000 ml water.
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Phosphate buffer solution 0.2 M (URT/ HR-US)
392 mg of sodium chloride were dissolved in 1000 ml Phosphate buffer 0.2 M pH 6.8 (Ph.Eur/ 
USP).
Starch solution 6 %/ 3 % (w/v) (URT/ HR-US)
A portion of starch, equivalent to 3.0/ 6.0 g of dried substance, was grinded with approx. 10 ml 
Phosphate buffer solution (URT/ HR-US). The mixture was added to approx. 70 ml boiling 
Phosphate buffer solution (URT/ HR-US), stirring on a heating plate (Hot plate RCT basic, 
IKA Werke GmbH & Co. KG, Staufen, Germany). The starch solution was boiled again and 
was cooled down to room temperature subsequently. The solution was diluted to 100.0 ml with 
Phosphate buffer solution (URT, HR-US). Higher volumes of starch solution were heated by an 
immersion heater (e.g. Rommelsbacher Elektro-Hausgeräte GmbH, Dinkelsbühl, Germany).
Amylase solution (Ph.Eur./ USP)
A quantity of substance, equivalent to about 1500 Ph.Eur-units (or 20 mg of USP Pancreatin 
Amylase and Protease according USP or quantity equivalent to this activity), accurately weighed, 
were triturated with 60 ml (30 ml according USP) of Phosphate buffer 0.2 M pH 6.8 (Ph.Eur/ 
USP) for 15 min. The solution was transferred to a volumetric fl ask and diluted to 100.0 ml 
(50.0 ml according USP) with Phosphate buffer 0.2 M pH 6.8 (Ph.Eur./ USP). 
Phosphate buffer 0.2 M pH 6.8 (Ph.Eur/ USP)
Approx. 49 ml of di-sodium hydrogen phosphate dehydrate solution (35.6 g/l, Ph.Eur.) or 
approx. 49 ml of anhydrous dibasic sodium phosphate solution (28.4 g/l, USP) were added to 
51 ml of monobasic potassium phosphate solution (27.2 g/l). The solution was stirred and the 
pH was controlled until pH 6.8 was achieved.
Sodium chloride solution 0.2 M (Ph.Eur./ USP)
Sodium chloride (11.7 g) was dissolved to 1000 ml water.
Starch solution 1 % (w/v) (Ph.Eur./ USP)
A portion of starch, equivalent to 10.0 g of dried substance, was grinded with approx. 10 ml water. 
This mixture was added to approx. 700 ml boiling water (Immersion heater, e.g. Rommelsbacher 
Elektro-Hausgeräte GmbH, Dinkelsbühl, Germany). The beaker was rinsed with water and the 
washings were added to the hot solution. The starch solution was boiled again and was cooled 
down to room temperature subsequently. The solution was diluted to 1000.0 ml with water. 
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Reagents for determination of lipase activity 2.1.3.2 
Bile salts solution (URT/ HR-US)
“Galle dispert” (lipase activating mixture Ph.Eur.) (1263 mg) was dissolved in 100.0 ml lipase 
buffer.
Maleate buffer solution pH 7.0 (URT/ HR-US)
Sodium chloride (10.0 g), TRIS (6.06 g) and maleic anhydride (4.90 g) were dissolved in 900 ml 
water. The pH was adjusted with sodium hydroxide solution to pH 7.0. The solution was diluted 
to 1000.0 ml with water (equivalent to Ph.Eur.).
Lipase solution (URT/ HR-US)
Working standard (15 mg) or a porcine pancreatic powder containing sample containing approx. 
1428 FIP/ Ph.Eur.-units, respectively, and accurately weighed, were dissolved in 5.0 ml Maleate 
buffer solution pH 7.0 (URT/ HR-US) for approx. 15 min in ice.
Olive oil emulsion (URT/ HR-US) (used for initial experiments)
Triton X 100 (780 μl) was dissolved in approx. 220 ml of TRIS buffer solution (URT/ HR-US) 
for determination of Trypsin activity. Olive oil (15 ml) was added and diluted to 250.0 ml with 
TRIS buffer solution (URT/ HR-US) for determination of Typsin activity. This dispersion was 
transferred into a blender (BL 450, Kenwood Limited, Havant, United Kingdom) and mixed 
at the fi rst grade for 15 min. After one to two hours the pre emulsion was processed using 
a Microfl uidizer® 110-EH Processor (Microfl uidics, Lampertheim, Germany) with cooling at 
1200 bar and three passages. Interaction chambers F12Y upstream and H30Z downstream were 
used. This emulsion (25 ml) was diluted with 25 ml of Reagents mixture (Ph.Eur./ USP).
Olive oil emulsion (URT/ HR-US) (fi nal emulsion)
Triton X 100 (2.0 ml) was dissolved in approx. 220 ml of TRIS buffer solution (URT/ HR-US) 
for determination of Lipase activity. Olive oil (15 ml) was added and diluted to 250.0 ml with 
TRIS buffer solution (URT/ HR-US) for determination of Lipase activity. This dispersion was 
transferred into a blender (BL 450, Kenwood Limited, Havant, United Kingdom) and mixed 
at the fi rst grade for 15 min. After one to two hours the pre emulsion was processed using 
a Microfl uidizer® 110-EH Processor (Microfl uidics, Lampertheim, Germany) with cooling at 
1000 bar and four passages. Interaction chambers F12Y upstream and H30Z downstream were 
used. This emulsion (25 ml) was diluted with 25 ml of bile salts solution.
TRIS buffer solution (URT/ HR-US) for determination of lipase activity
Calcium chloride dihydrate (17.64 g) and TRIS (73.2 g) were dissolved in approx. 1800 ml 
water. The pH was adjusted to 7.2 with hydrochloric acid at 37 °C. The solution was diluted to 
2000.0 ml with water at room temperature.
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Maleate buffer solution pH 7.0 (Ph.Eur.)
Sodium chloride (10.0 g), TRIS (6.06 g) and maleic anhydride (4.90 g) were dissolved in 900 ml 
water. The pH was adjusted with sodium hydroxide solution to pH 7.0. The solution was diluted 
to 1000.0 ml with water (equivalent to URT/ HR-US).
Lipase solution (Ph.Eur/ USP)
According to Ph. Eur. a quantity of substance, equivalent to about 2500 Ph.Eur-units, accurately 
weighed, were triturated with 1 ml of cooled maleate buffer solution pH 7.0 and diluted with cold 
maleate buffer solution pH 7.0 stirring for 15 min. The solution was qualitatively transferred 
to a volumetric fl ask and diluted to 100.0 ml. According to USP Lipase solution using USP 
Pancreatin Lipase or a quantity equivalent to this activity, was prepared as described above, but 
water was used as solvent and the volume was measured in a measuring cylinder.
Olive oil stock emulsion (Ph.Eur./ USP)
Olive oil (40 ml), 10 % (w/v) acacia solution (330 ml) and water (ice, 30 ml) were fi lled in the 
cup on an electric blender (BL 450, Kenwood Limited, Havant, United Kingdom) and were 
mixed for 15 min at high speed.
Reagents mixture (Ph.Eur./ USP)
“Galle dispert” (Lipase activating mixture Ph.Eur.) (100 ml) or USP Bile salts solution (8 % 
(w/v), 450 ml water and 400 ml of  a 5 mM TRIS solution, containing 40 mM sodium chloride, 
were mixed.
Reagents for determination of free protease activity2.1.3.3 
Borate buffer pH 7.5 (URT/ HR-US)
Sodium chloride (12.5 g), di-sodium tetraborate decahydrate (14.25 g) and boric acid (52.5 g) 
were dissolved in approx. 4500 ml water. The pH was adjusted to 7.5 with hydrochloric acid or 
sodium hydroxide solution. The solution was diluted to 5000.0 ml with water.
Casein solution 1.25 % pH 8.0 (URT/ HR-US)
Casein, equivalent to 1.25 g of dried substance was suspended in 5 ml of water. Sodium 
hydroxide solution 0.1 M (10 ml) was added and stirred for 1 min. Water (60 ml) was added 
and stirred with a magnetic stirrer until the solution was practically clear (approx. 1 h). The pH 
was adjusted to 8.0 with 0.1 M sodium hydroxide or 0.1 M hydrochloric acid. The solution was 
diluted to 100.0 ml with water (equivalent to USP). For initial experiments, a 0.625 % Casein 
solution was prepared in the same way using 0.625 g casein.
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Free protease solution (URT/ HR-US)
Working standard (25 mg) or a porcine pancreatic powder containing sample containing 
approx. 113 FIP/ Ph.Eur.-units, respectively, were dissolved in 5.0 ml of Borate buffer pH 7.5 
(URT/ HR-US) for approx. 15 min in ice.
Casein solution 1.25 % pH 8.0 (USP)
Casein, equivalent to 1.25 g of dried substance was suspended in 5 ml of water. Sodium 
hydroxide solution 0.1 M (10 ml) was added and stirred for 1 min. Water (60 ml) was added 
and stirred with a magnetic stirrer until the solution was practically clear (approx. 1 h). The pH 
was adjusted to 8.0 with 0.1 M sodium hydroxide or 0.1 M hydrochloric acid. The solution was 
diluted to 100.0 ml with water (equivalent to URT/ HR-US).
Free protease solution (USP)
A quantity of USP Pancreatin Amylase and Protease or substance, which conformed to an end 
concentration of 2.5 USP-units per milliliter in the diluted solution, accurately weighed, was 
added to 100.0 ml of Phosphate buffer solution (USP) and stirred in ice. This solution (2.0 ml) 
was diluted in a volumetric fl ask with phosphate buffer solution pH 7.5 to 100.0 ml.
Phosphate buffer solution (USP)
Monobasic potassium phosphate (6.8 g) and sodium hydroxide (1.8 g) were dissolved in 950 ml 
water in a 1000 ml volumetric fl ask. The pH was adjusted to 7.5 ± 0.2, using 0.2 M sodium 
hydroxide. The volume was adjusted with water. 
Trichloroacetic acid solution (USP)
Trichloroacetic acid (50 g) was dissolved in 1000 ml of water.
Reagents for determination of total protease activity2.1.3.4 
Calcium chloride solution 0.02 M (URT/ HR-US)
Calcium chloride dihydrate (14.7 g) was dissolved in water (approx. 4500 ml). The pH was 
adjusted to 6.1 ± 0.1 by hydrochloric acid or sodium hydroxide solution. The solution was 
diluted to 5000.0 ml with water. 
Casein solution 1.25 % pH 8.0 (URT/ HR-US) 
Casein, equivalent to 1.25 g of dried substance was suspended in 5 ml of water. Sodium 
hydroxide solution 0.1 M (10 ml) was added and stirred for 1 min. Water (60 ml) was added 
and stirred with a magnetic stirrer until the solution was practically clear (approx. 1 h). The pH 
was adjusted to 8.0 with 0.1 M sodium hydroxide or 0.1 M hydrochloric acid. The solution was 
diluted to 100.0 ml with water (equivalent to Ph.Eur.).
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Enterokinase solution (URT/HR-US)
Enterokinase (330 mg) was dissolved in 20.0 ml of a 0.02 M Calcium chloride solution (URT/ 
HR-US) in an ice bath. The solution was stored in ice.
Total protease solution (URT/ HR-US)
As reference 25 mg of working standard were dissolved in 10.0 ml of 0.02 M Calcium chloride 
solution  (URT/ HR-US) for approx. 15 min in ice.
In order to activate the pro enzymes, a substance amount containing approx. 280 (activated) FIP/ 
Ph.Eur.-units was dissolved in 5.0 ml of a 0.02 M Calcium chloride solution (URT/ HR-US). 
Ice-cold enterokinase solution (2.0 ml) was tempered for 5 min at 35 °C ± 1°C. After adding 
0.5 ml of the ice-cold enzyme solution, the sample was activated for 15 min at 35 °C ± 1 °C. 
Subsequently, the activated sample was stored in ice.
Borate buffer pH 7.5 (Ph.Eur.)
Sodium chloride (12.5 g), di-sodium tetraborate decahydrate (14.25 g) and boric acid (52.5 g) 
were dissolved in approx. 4500 ml water. The pH was adjusted to 7.5 with hydrochloric acid or 
sodium hydroxide solution. The solution was diluted to 5000.0 ml with water. 
Calcium chloride solution 0.02 M (Ph.Eur.)
Calcium chloride dihydrate (14.7 g) was dissolved in water (approx. 4500 ml). The pH was 
adjusted to 6.1 ± 0.1 by hydrochloric acid or sodium hydroxide solution. The solution was 
diluted to 5000.0 ml with water. 
Casein solution 1.25 % pH 8.0 (Ph.Eur.) 
Casein, equivalent to 1.25 g of dried substance was suspended in 5 ml of water. Sodium 
hydroxide solution 0.1 M (10 ml) was added and stirred for 1 min. Water (60 ml) was added 
and stirred with a magnetic stirrer until the solution was practically clear (approx. 1 h). The pH 
was adjusted to 8.0 with 0.1 M sodium hydroxide or 0.1 M hydrochloric acid. The solution was 
diluted to 100.0 ml with water (equivalent to URT/ HR-US).
Enterokinase solution (Ph.Eur.)
Enterokinase (50 mg) were dissolved in Calcium chloride solution 0.02 M (Ph.Eur.). The 
solution was diluted to 50.0 ml with the same solvent.
Total protease solution (Ph.Eur.)
As reference a substance amount, containing approx. 130 Ph.Eur.-units, were triturated in approx. 
90 ml of cooled Calcium chloride solution 0.02 M (Ph.Eur.). After adjusting the pH to 6.1 ± 
0.1 the solution was quantitatively transferred into a volumetric fl ask and diluted to 100.0 ml 
with Calcium chloride solution 0.02 M (Ph.Eur.). This solution (5.0 ml) was diluted with Borate 
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buffer pH 7.0 (Ph.Eur.) to 100.0 ml. To activate the pro enzymes, a substance amount containing 
approx. 260 Ph.Eur.-units was triturated in approx. 90 ml of cooled Calcium chloride solution 
0.02 M (Ph.Eur.). After adjusting the pH to 6.1 ± 0.1 the solution was quantitatively transferred 
into a volumetric fl ask and diluted to 100.0 ml with calcium chloride solution 0.02 M (Ph.Eur.). 
Enterokinase solution (Ph.Eur.) (5.0 ml) was tempered to 35°C ± 1°C. After adding 5.0 ml of 
the ice cold enzyme solution and subsequently mixing the sample was activated for 15 min at 
35°C ± 1°C. Afterwards the activated sample was cooled down in ice. This solution (5.0 ml) 
was diluted with Borate buffer pH 7.0 (Ph.Eur.) to 100.0 ml.
Trichloroacetic acid solution (Ph.Eur.)
Trichloroacetic acid (50 g) was dissolved in 1000 ml of water.
Reagents for determination of free trypsin activity2.1.3.5 
Hydrochloric acid 1 mM (URT/ HR-US)
Hydrochloric acid 1 M (1 ml) was dissolved to 1000.0 ml with water. 
Triton X 100 solution (URT/ HR-US)
Triton X 100 (0.6 mM) was diluted in 1000 ml Hydrochloric acid 1 mM (URT/ HR-US).
TRIS buffer (URT/ HR-US) for determination of Trypsin activity
TRIS (12.2 g) and calcium chloride dihydrate (2.94 g) were dissolved in 800 ml water. The pH 
was adjusted to 7.8 at 37 °C. The solution was diluted to 1000.0 ml with water.
BAEE solution (URT/HR-US)
BAEE (20 mg) was dissolved to 10.0 ml with TRIS buffer (URT/ HR-US) for determination of 
Trypsin activity.
Trypsin solution (URT/ HR-US)
Working standard (50 mg) or a porcine pancreas powder containing sample or containing 
approx. 65 FIP/ Ph.Eur.-units or 1.5 mg of FIP Trypsin Reference Standard, respectively, was 
dissolved in 5.0 ml of Triton X 100 solution (URT/ HR-US) for approx. 15 min in ice.
Borate buffer 0.0015 M pH 8.0 (Ph.Eur.)
Borax (572 mg) and calcium chloride dihydrate (2.94 mg) were dissolved in 900 ml water. After 
adjusting the pH to 8.0 the solution was diluted to 1000.0 ml with water.
Calcium chloride solution 0.02 M (Ph.Eur.)
Calcium chloride dihydrate (14.7 g) was dissolved in approx. 4500 ml water. The pH was 
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adjusted to 6.1 ± 0.1 by hydrochloric acid or sodium hydroxide solution and diluted to 5000.0 ml 
with water. 
BAEE solution 0.02 M (Ph.Eur.)
BAEE (171.3 mg) were dissolved in 25 ml water. 
Trypsin solution (Ph.Eur.)
FIP Trypsin Reference Standard (12 mg) or a porcine pancreas powder containing sample 
containing approx. 509 FIP/ Ph.Eur.-units, respectively, was dissolved in 50.0 ml of Calcium 
chloride solution 0.02 M (Ph.Eur.). 
Methods2.2 
Ultrasonic measurements2.2.1 
General2.2.1.1 
Ultrasonic measurements were performed with a ResoScan® Research System from 
TF Instruments GmbH (Heidelberg, Germany) using Ultrasonic Resonator Technology (URT) 
and with a HR-US 102 P spectrometer from Sonas Technologies Ltd. (Dublin, Ireland). Both 
are high resolution devices based on resonance (build-in systems). Considering automation, 
a Flow-Through System HR-US EX-FTC (Sonas Technologies Ltd., Dublin, Ireland) was 
tested. 
Ultrasonic measurements using the ResoScan Research System (URT)2.2.1.2 
The ResoScan® Research System is equipped with two closed sample cells with a path length 
of 7.0 mm and a volume of approx. 200 ml. Evaporation of the sample is prevented by gas-tight 
lids. In the cells, the samples are tempered with a rate of 0.10 to 0.35 °C per min via Peltier 
elements. The absolute accuracy of the thermostat temperature is 0.01 °C. The resolution of the 
ultrasonic velocity is 0.001 m/s and the resolution of ultrasonic attenuation is 1-3 %, depending 
on the extent of attenuation.
URT initialization settings for determination of pancreatic enzyme activity. Italics in brackets indicate the Table 8. 
corresponding frequence of the resonance peak.
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Prior to measurement a master peak is defi ned via initialization. The master peak is used for 
calculation of the ultrasonic parameters. For this, the frequency range of about 7 to 9 MHz is 
scanned obtaining a series of resonance peaks. The software evaluates the series of resonance 
peaks concerning deviation from real resonator frequencies and amplitude. The master peak can 
be defi ned prior to initialization by entering the peak order number. 
To achieve suffi cient amplitudes of the resonance peaks the applied voltage input needs to be 
adapted depending on the sample properties. The amplitude is controlled by varying the power. 
Used settings of initialization are listed in Table 8. 
Determination of enzyme kinetic was performed as follows: 
The operating temperature was 37°C. Both cells were fi lled with 180 μl tempered substrate 
solution using a Multipette stream (Eppendorf AG, Hamburg, Germany) and closed. The 
difference in ultrasonic velocity between both cells was measured until steady state (baseline 
check). One of the cells was opened again to inject 4 μl of either amylase, lipase or free protease 
solution or 8 μl of either trypsin or total protease solution using a Multipette stream or pipette 
research (Eppendorf AG, Hamburg, Germany). The content in the cell was mixed carefully to 
avoid creating air bubbles with a pipette reference (Eppendorf AG, Hamburg, Germany). After 
closing the cell, the ultrasonic measurement was started. The change of ultrasonic velocity 
(m/s) over time (s) was determined twice for each enzyme solution.
Alternatively, the sample cell was fi lled by using the pre-mix method:
1800 μl tempered substrate solution and 40μl of either amylase solution, lipase solution or free 
protease solution or 80 μl of either trypsin solution or total protease solution were pre-mixed 
(gentle shaking for 5 sec). The sample cell was fi lled with 184 μl or 188 μl of this pre-mix using 
a Multipette stream (Eppendorf AG, Hamburg, Germany).
ResoPump I RCU (Tf Instruments GmbH, Heidelberg, Germany) was used for cell draining. 
After each measurement, cleaning and pre-conditioning were carried out by rinsing the system 
as follows:
1. Tempered low concentrated surfactant (commercial dish liquid) solution for approx. 
10 sec
2. Tempered pure water for approx. 10 sec
3. 180 μl tempered substrate solution (substrate refi lling)
Ultrasonic velocity (m·s-1) was plotted over time (s). Due to temperature instabilities the fi rst 
data points after injection (40 sec) were excluded. The data points of the next 200 sec were 
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used to calculate the slope (m·s-2) per linear regression. The arithmetic mean and the standard 
deviation of the two replicates were calculated. The slope was used to determine enzyme activity 
based on the slope obtained with reference standards (see 2.2.1.7).
Ultrasonic measurements using the HR-US 102 P spectrometer2.2.1.3 
The HR-US 102 P spectrometer is equipped with two closed sample cells with a volume of 
approx. 1500 μl. In the cells, the samples are tempered via external programmable water 
bath C25P with drop-in circulator phoenix II P1 (Thermo Scientifi c GmbH, Karlsruhe). The 
absolute accuracy of the thermostat temperature is 0.01 °C. The differential regime allows a 
resolution of 0.0002 m/ s for the ultrasonic velocity and 0.2 % for ultrasonic attenuation.
Prior to measurement, a peak scan is performed to defi ne the master peak, which is used for 
calculation of the ultrasonic parameters. Therefore a defi ned frequency range (between 2 and 
15 MHz) is scanned obtaining a series of resonance peaks. One peak is chosen to transfer the 
peak settings to the system for the following measurements. 
To achieve suffi cient amplitudes of the resonance peaks the applied voltage input needs to be 
adapted depending on the sample properties. The amplitude is controlled by varying the input 
voltage. Used settings of the peak scan are listed in Table 9.
HR-US and HR-US FTS peak scan settings for determination of pancreatic enzyme activity. Table 9. 
Enzyme activity was determined as follows: 
The water bath was set to 37°C. Both cells were fi lled with 1050 μl degassed substrate solution 
using a Multipette stream (Eppendorf AG, Hamburg, Germany) and closed. The difference 
in ultrasonic velocity between both cells was measured until steady state (baseline check). 
One of the cells was opened again to inject 20 μl of either amylase, lipase, protease or trypsin 
solution using a Multipette stream (Eppendorf, Hamburg, Germany). The content in the cell 
was mixed carefully to avoid creating air bubbles with a pipette reference (Eppendorf AG, 
Hamburg, Germany). After closing the cell, the ultrasonic measurement was started. The change 
of ultrasonic velocity (m/s) over time (s) was determined twice for each enzyme solution.
An injection of the enzyme solution using a syringe through a septum was also possible.
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Schematic water, substrate and sample fl ow for Figure 9. 
HR-US 102P and HR-US EX-FTS (Resonator technique 
is omitted). In contrast to the HR-US 102, in the FTS the 
sample is pre-tempered before reaching the measurement 
cell (MC). The FTS is a closed system, whereas the cell 
in the HR-US 102 P has to be opened for fi lling (Sonas 
Technologies Ltd.).
Alternatively, the sample cell was fi lled by using the pre-mix method: 1800 μl tempered substrate 
solution and 40μl of either amylase, lipase or free protease solution or 80 μl of either trypsin 
or total protease solution were pre-mixed (gentle shaking for 5 sec). The sample cell was fi lled 
with 1050 μl of this pre-mix using a Multipette stream (Eppendorf AG, Hamburg, Germany).
A pump Laboport KT18 for vacuum system (KNF Neuberger AG, Balterswil, Switzerland) was 
used for cell draining. After each measurement cleaning and pre-conditioning were carried out 
by rinsing the system as follows:
1. Low concentrated surfactant (commercial dish liquid) solution for approx. 10 sec
2. Pure water for approx. 10 sec
3. Ethanol absolute for drying (few droplets)
Ultrasonic velocity (m·s-1) was plotted over time (s). Due to temperature instabilities the fi rst 
data points after injection (250 sec) were excluded. The data points of the next 200 sec were 
used to calculate the slope (m·s-2) per linear regression. The arithmetic mean and the standard 
deviation of the two replicates were calculated. The slope was used to determine enzyme activity 
based on the slope obtained with reference standards (see 2.2.1.7).
Ultrasonic measurements using the Flow-Through System HR-US EX-FTS2.2.1.4 
In order to test automation opportunities of ultrasonic velocity measurements, a Flow-Through 
System (FTS) was tested. The Flow-Through System HR-US FTS is equipped with two Flow 
through cells with a cell volume of 1 ml. Figure 9 shows water, substrate and sample fl ow for the 
HR-US 102 P and for the FTS in comparison 
(for the sake of clarity the resonator technique 
in the instruments is omitted in Figure 9). The 
systems differ in the operating procedure as 
explained below. 
Working basically with the HR-US 102 P 
spectrometer, there are two possibilities to 
fi ll the cell before measurement:
1. Adding enzyme solution after 
baseline check
2. Adding substrate and enzyme 
solution simultaneously after pre-
mixing
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Using the FTS allows only the second option (pre-mixing).
For the tubes used at the inlet and outlet as well as the inside of the FTS instrument, the material 
Tygon® 2275 was chosen. A four-channel microprocessor-controlled dispensing pump (Ismatec 
Laboratoriumstechnik GmbH, Wertheim-Mondfeld, Germany) served for fi lling the cells. The 
pump was operated with two Tygon® 3607 tubes. 
The fl ow rate was adjusted to 13.3 ml/ min (+/- 0.9 %) for starch solution, 13.5 ml/ min 
(+/- 1.4 %) for casein solution and 11.9 ml/ min (+/- 3.5 %) for olive oil emulsion. One channel 
was used for fi lling the reference cell, the other channel for fi lling the sample cell. 
The operating temperature was 37 °C. First both cells were fi lled with degassed substrate 
solution (55 sec). Degassed substrate solution (15.75 ml) and 300 μl of either amylase, lipase, 
protease or trypsin solution were mixed in a sample tube (50 ml) for 45 sec using a pipette 
reference (Eppendorf AG, Hamburg, Germany). This pre-mix was pumped into the measuring 
cell (55 sec). The reference cell was rinsed with pure degassed substrate solution with backfl ow. 
The ultrasonic measurement was started as soon as the pump stopped. Each enzyme solution 
was determined twice. 
Cleaning was carried out by rinsing the system as follows:
1. Low concentrated surfactant (commercial dish liquid) solution for approx. 30 sec
2. Pure water for approx. 30 sec
Ultrasonic velocity (m·s-1) was plotted over time (s). Due to temperature instabilities the fi rst 
data points after injection (100 sec) were excluded. The data points of the next 200 sec were 
used to calculate the slope (m·s-2) per linear regression. The arithmetic mean and the standard 
deviation of the two replicates were calculated. The slope was used to determine enzyme activity 
based on the slope obtained with reference standards (see 2.2.1.7).
Ultrasonic methods for determination of amylase, lipase, protease and trypsin 2.2.1.5 
activity using URT, HR-US or HR-US EX FTS
The general performance of ultrasonic measurements to determine enzyme activity using URT, 
HR-US or HR-US EX FTS are described in the preceding chapters (2.2.1.2 - 2.2.1.3). The 
ultrasonic methods   for determination of amylase, lipase, protease and trypsin activity differ in 
used substrate and enzyme solution. Introduced combinations are summarized in Table 10. 
The ultrasonic methods defi ned in Table 10 were validated. In order to determine specifi city, 
ultrasonic velocity change over time was measured in samples to which either substrate or 
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enzyme had not been added as well as in complete samples (positve control). Two working 
standard solutions (two replicates each) per case were determined. Additionally, specifi city was 
tested by adding substances (sodium chloride, calcium, isopropanol, protein, fat and emulsifying 
agents) to the working standard solutions, which were expected to be present in in-process 
samples. Table 11 shows the used reagents and sample solvent preparation.
Repeatability was determined by measuring six enzyme solutions (two replicates each) the 
same day by one operator. The standard deviation and CV of the six determinations were 
calculated. The intermediate precision was determined by measuring two enzyme solutions 
(two replicates each) by three operators at different days. The standard deviation and the CV of 
the six determinations were calculated. Both tests were performed by using different methods 
of enzyme addition (Pre-mixing method and cell injection using a pipette (after opening the 
cells) or a syringe (via septum)). Special repeatability experiments were  done with highly 
concentrated samples or process material.
Combinations of substrate solution and enzyme solution used for ultrasonic methods to determine pancreatic Table 10. 
amylase, lipase, protease and trypisn activity.
Reagents and sample solvent preparation for specifi city tests concerning matrix substances which are expected in Table 11. 
in-process samples.
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Overview of experimental sequences for the determination of pancreatic enzyme activity in proteolysis-like Table 12. 
material, proteolysis material, API and drug products. US-X-URT/HR-US describes the ultrasonic methods according to 
Table 10 (rep = replicates).
In order to evaluate repeatability and intermediate precision, the CVs for ultrasonic velocity 
changes for the six measurements were calculated (no calibration with working standard for 
determination of repeatability or intermediate precision).
Linearity tests were performed by using differently concentrated working standard solutions 
measuring two samples per concentration (two replicates each).
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In order to evaluate robustness of methods, temperature, concentration and stability of 
analytical solutions, extraction time, activation parameters (total proteases) and parameters for 
emulsion preparation (lipases) were investigated. Robustness measurements were carried out 
by measuring two enzyme solutions (two replicates each) per tested condition.
In order to determine pancreatic enzyme activity in porcine pancreas and porcine pancreas 
powder-containing samples, defi ned sequences of enzyme solutions (working standard and 
samples) were measured, as shown in Table 12.
Application of titration equipment to HR-US 102 P2.2.1.6 
The following information regarding material of the titration equipment (Sonas Technologies 
Ltd., Dublin, Irleand) was provided:
Tubing: PEEK (polyetheretherketone) ▪
Stirring tale: PEEK (polyetheretherketone) ▪
Valve:  PTFE (polytetrafl uorethylene) ▪
Syringe lock: Polypropylene ▪
PEEK is known as biocompatible. Using the titration equipment, the dosing cap was connected 
via a tube (length 0.6 m) with a syringe (Microliter, Hamilton AG, Bonaduz, Switzerland), located 
in the dosing apparatus (Syringe dispenser PB-600-1 (Hamilton AG, Bonaduz, Switzerland) and 
fi lled with enzyme solution. The system was rinsed to remove air bubbles. The cell, fi lled with 
substrate, was closed with the dosing cap. Mixing was carried out by a small stirring tale, fi xed 
at the dosing cup.
A linearity experiment was carried out to test the enzyme stability in the system. Periodic 
injections using the titration equipment and a syringe dispenser (Hamilton) were compared 
with experiments in which the enzyme solution was injected only once. In periodic intervals, 4 
μl of the enzyme solution were added to the cell via titration equipment. In comparison, defi ned 
volumes of enzyme solution were injected into freshly prepared substrate solution once. When 
using periodic injection, the enzyme solution remained in the titration system for different 
time intervals before it was added to the cell. To control the enzyme stability, single injections 
were done with enzyme solution that had been kept in the dosing system for different time 
intervals. 
Calibration with reference standard2.2.1.7 
In order to determine enzyme activity, ultrasonic measurements were performed with sample 
and reference standard. For one-point calibration, sample and reference standard weights were 
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chosen to obtain approx. identical slopes for both measurements. Generally, three independent 
reference standard solutions (two replicates each) were measured. Activities of unknown 
samples were calculated via rule of proportion using the average slopes of reference standard 
and sample measurements and the activity label claim of the reference standard. For three-point 
calibration, three independent reference standard solutions of different concentrations (within 
tested linear range) were measured (two replicates). A calibration line was calculated via linear 
regression. Using the linear equation of the calibration line and the activity label claim of the 
reference standard the activity in the sample was calculated.
Equations2.2.1.8 
Linear slope
The equation of a line is y = mx + b. The linear slope m was calculated as follows:
 
     
  Means of x-, y-values
Arithmetic mean
The arithmetic mean    was calculated as follows.
 Number of values
 
Standard deviation (stdev)
The standard deviation s was calculated as follows:
 
 Mean of x-values
 Number of values
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Coeffi cient of Variation (CV)
The CV was calculated as follows:
s Standard deviation
 Mean of x-values
Percentage deviation D (of enzyme activity determined by using ultrasonic spectroscopy in 
relation to activity based on reference method (pharmacopoeia))
D was calculated as follows:
AUS Enzyme activity (determined by using ultrasonic spectroscopy) (u/g)
ARM Enzyme activity (determined by using reference method (pharmacopoeia)) (u/g)
Determination of enzyme activity in pancreas powder according to 2.2.2 
pharmacopoeias
Determination of amylase activity in pancreas powder (Ph.Eur. and USP)2.2.2.1 
Four 250 ml conical fl asks were marked (S, U, BS and BU). Starch solution 1 % (Ph.Eur./ USP) 
(25 ml), 10 ml of Phosphate buffer 0.2 M pH 6.8 (Ph.Eur./ USP) and 1 ml of Sodium chloride 
solution  0.2 M (Ph.Eur./ USP) were pipetted into each fl ask. After inserting the stoppers, 
the contents were mixed. The fl asks were placed in a water bath maintained at 25 ± 0.1°C to 
equilibrate (Huber variostat CC, Peter Huber Kältemaschinenbau GmbH, Offenburg, Germany). 
Hydrochloric acid 1 M (2 ml) were added to BU and BS. After mixing the fl asks were returned 
to the water bath. Amylase sample solution (1.0 ml) was added to U and BU, 1.0 ml of amylase 
reference solution was added to S and BS. After mixing, the fl asks were returned to the water 
bath. After 10 min, accurately timed from the addition of the enzyme, 2 ml portions of 1 M 
hydrochloric acid were added to the fl asks S and U followed by mixing. Iodine solution 0.05 M 
(10.0 ml) were added to each fl ask with continuous stirring. Immediately, 45 ml of 0.1 M 
sodium hydroxide solution were added to each fl ask. The fl asks were placed in the dark at a 
temperature between 15 and 25°C for 15 min. After addition of 4 ml of sulphuric acid (2 N 
according to USP, 20 % (v/v) according to Ph.Eur.), the excess of iodine was titrated with 0.1 M 
sodium thiosulfate solution to the disappearance of the blue colour (Piston burette Titronic 
universal, Schott Instruments Analytics GmbH, Mainz, Germany). 
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The amylase activity was calculated as follows in units per milligram:
100 · (CS/ WU) · (VBU-VU)/ (VBS-VS)               
in which CS is the amylase activity of the reference standard solution (u·ml
-1), WU is the amount 
of pancreas powder taken (mg), and VU, VS, VBU and VBS are volumes of 0.1 N sodium thiosulfate 
consumed in the titration of the solutions in fl asks U, S, BU and BS, respectively. 
Determination of lipase activity in pancreas powder (Ph.Eur. and USP)2.2.2.2 
Olive oil stock emulsion (Ph.Eur./ USP) (10 ml) and 19 ml of Reagents mixture (Ph.Eur./ USP) 
were fi lled in a jacketed glass vessel of about 50-ml capacity, the outer chamber of which 
was connected to a thermostatically controlled water bath (Huber ministat CC, Peter Huber 
Kältemaschinenbau GmbH, Offenburg, Germany). The mixture was covered and stirred 
continuously with a mechanical stirring device. With the mixture maintained a temperature of 
37°C ± 0.1 °C, 0.1 M sodium hydroxide solution, from a auto microburet inserted through an 
opening in the cover, was added to adjust the pH to 9.0 (Ph. Eur.) or 9.2 (USP), respectively, 
potentiometrically using a calomel-glass electrode system. Lipase solution (Ph.Eur./ USP) was 
added (1.0 ml). Then, the addition of 0.1 M sodium hydroxide solution was continued for 5 min 
to maintain the pH at 9.0 (718 STAT Titrino, Metrohm AG, Herisau, Switzerland). The volume 
of 0.1 M sodium hydroxide solution after each min was determined.
The lipase activity was calculated as follows in units per milligram:
                              
n Average volume of 0.1 M sodium hydroxide solution used per min during titration of the test solution in ml
n1 Average volume of 0.1 M sodium hxdroxide solution used per min during the titration of the reference solution  
 in ml
m Mass of substance to be examined in mg
m1 Mass of reference solution in mg
A Activity of pancreas powder reference in Ph.Eur.-units per mg
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Determination of total protease activity in pancreas powder (Ph.Eur.)2.2.2.3 
Tubes in duplicate were marked T, Tb (samples), S1, S1b, S2, S2b, S3, S3b (standard series), one 
tube was marked B. Borate buffer solution pH 7.5 (Ph.Eur.) was added as follows:
 B:    3.0 ml
 S1 and S1b:  2.0 ml
 S2, S2b, T and Tb: 1.0 ml
Reference solution (Total protease solution (Ph.Eur.)) was added to the tubes as follows:
 S1 and S1b:  1.0 ml
 S2 and S2b:  2.0 ml
 S3 and S3b:  3.0 ml
Test suspension (Total protease solution (Ph.Eur.)) were added to tubes T and Tb (2.0 ml). 
5.0 ml of Trichloroacetic acid solution (Ph.Eur.) were added to tubes B, S1b, S2b, S3b and Tb 
and mixed by shaking. Tubes and the Casein solution (Ph.Eur.) were placed in a water bath at 
35°C ± 0.5 °C, burdened by a glass rod or ball. When temperature equilibrium was reached, 
2.0 ml of the Casein solution (Ph.Eur.) were added to the tubes B, S1b, S2b, S3b and Tb. At time 
zero, casein solution was added successively and at intervals of 30 sec to tubes S1, S2, S3 and 
T. Immediately after each addition the content was mixed. Exactly 30 min after addition of the 
Casein solution (Ph.Eur.) 5.0 ml of Trichloroacetic acid solution (Ph.Eur.) was added to tubes 
S1, S2, S3 and T and the contents were mixed. The tubes were withdrawn from the water bath 
and allowed to stand at room temperature for 20 min.
The contents of each tube were fi ltered. Absorbance of the fi ltrates was measured at 275 nm 
using the fi ltrate obtained from tube B as compensation liquid (Lambda 25 UV/ Vis spectrometer, 
Perkin Elmer, Waltham, USA). The average of absorbance values for the fi ltrates obtained from 
tubes S1, S2, S3 were corrected by subtracting the average values obtained for the fi ltrates from 
tubes S1b, S2b, S3b respectively. A calibration curve was drawn of the corrected values against the 
volume of used reference solution.
Using the corrected absorbance for the test suspension (T, Tb) and the calibration curve and 
taking into account the dilution factors, the activity of the substance was determined.  The test 
was not valid unless the corrected absorbance values were between 0.15 and 0.60.
Determination of free protease activity in pancreas powder (USP)2.2.2.4 
The procedure was similar to the determination of total protease activity (Ph.Eur.). Differences 
are described in the following. 
MATERIAL AND METHODS
52
Phosphate buffer solution pH 7.5 (USP) was added as follows:
 B:    3.0 ml
 S1 and S1b:  2.0 ml
 S2, S2b, T and Tb: 1.5 ml
 S3 and S3b:  1.0 ml
Reference solution (Free protease solution (USP)) was added to the tubes as follows:
 S1 and S1b:  1.0 ml
 S2 and S2b:  1.5 ml
 S3 and S3b:  2.0 ml
Test suspension (Free protease solution (USP)) were added to tubes T and Tb (1.5 ml). 
Trichloroacetic acid solution addition was performed as described for the determination of total 
protease activity (Ph.Eur.). 
Tubes and the casein solution were placed in a water-bath at 40°C, burdened by a glass rod or 
ball. When temperature equilibrium was reached, 2.0 ml of the Casein solution (USP) were 
added to each tube. Exactly 60 min after addition of the Casein solution (USP), 5.0 ml of 
trichloroacetic acid solution (USP) was added to tubes S1, S2, S3 and T and the contents were 
mixed. The tubes were withdrawn from the water bath and allowed to stand at room temperature 
for 10 min.
The contents of each tube were fi ltered. Absorbance of the fi ltrates was measured at 280 nm 
using the fi ltrate obtained form tube B as compensation liquid (Lambda 25 UV/ Vis spectrometer, 
Perkin Elmer, Waltham, USA). Evaluation was done as described for the determination of total 
protease activity (USP).
Determination of trypsin activity in pancreas powder (Ph.Eur.)2.2.2.5 
Borate buffer 0.0015 M pH 8.0 (30.0 ml) and 3.0 ml of BAEE solution (Ph.Eur.) were fi lled in 
a jacketed glass vessel of about 50-ml capacity, the outer chamber of which was connected to 
a thermostatically controlled water bath (Huber ministat CC, Peter Huber Kältemaschinenbau 
GmbH, Offenburg, Germany). The mixture was covered, and stirred continuously with a 
mechanical stirring device. With the mixture maintained a temperature of 25°C, 0.02 M 
sodium hydroxide solution, from an auto microburet inserted through an opening in the cover, 
was added to adjust the pH to 8.0 potentiometrically using a calomel-glass electrode system. 
Trypsin solution (Ph.Eur.) was added (750 μl). Then, the addition of 0.02 M sodium hydroxide 
solution was continued for 5 min to maintain the pH at 8.0 (718 STAT Titrino, Metrohm AG, 
Herisau, Switzerland). The volume of 0.02 M sodium hydroxide solution after each min was 
determined.
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The trypsin activity was calculated as follows in units per milligram:
                      
n Average volume on 0.02M sodium hydroxide solution used per min during titration of the test solution in   
 ml
n1 Average volume of 0.02 M sodium hxdroxide solution used per min during the titration of the reference solution  
 in ml
m Mass of substance to be examined in mg
m1 Mass of reference solution in mg
A Activity of trypsin reference in Ph.Eur.-units per mg
Emulsion preparation and characterization (Lipase)2.2.3 
High-pressure homogenization2.2.3.1 
In order to determine lipase activity by means of ultrasonic measurements, a stable substrate 
preparation was required. Stable emulsions can be processed in high-pressure homogenizers. 
They generally function as follows: A high pressure pump compresses the pre-emulsion to 
the desired homogenization pressure. Afterwards the emulsion expands in the homogenization 
valve. Thereby, the droplets of the pre-emulsion are reduced in the homogenization nozzle 
(Schubert, 2005). High pressure homogenizers are classifi ed according to their kind of nozzle: 
Radial diffuser, aperture plate, jet disperser or opposed jet disperser (Schubert, 2005).
In this work, a Microfl uidizer®110-EH processor (Microfl uidics Intern. Corp., MA-Newton, 
USA), with an opposed jet disperser was used to prepare emulsions with high pressure. 
The pre-emulsion was pressed through micro channels within an interaction chamber. A special 
fi xed geometry leads to small droplet sizes, tight particle size distributions and, consequently, to 
a high stability of the emulsion. Changes in chamber type, channel diameter, process pressure 
and number of passages infl uence particle size and distribution. 
Two main general types of chambers are available named according their geometry:
In ‚z‘ chambers the channels feature a zigzag form (Figure 10 A) in which the product  ▪
zigzags through the interaction chamber
In ‚y‘ chambers the form resembles the alphabetic character (Figure 10 B) in  ▪
which the product stream is divided into two streams that impinge upon each other 
(Küchler et al., 2006).
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Table 13.  Overview of methods used for the preparation of olive oil emulsions with Microfl uidizer® and performed analytics 
to evaluate the emulsion quality.
Due to the small diameter and the geometry, the product stream accelerates to high velocities. 
High shear forces caused by the fi xed geometry and impact forces resulting from collisions of 
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the particles with walls and themselves are important for the intense particle size reduction. 
High turbulences play a major role (Küchler et al., 2006). The disruption is primarily caused by 
inertial forces in turbulent stream (Schubert, 2005).
Additionally to the interaction chamber (IXC), an auxiliary processing module (APM), which 
is always a ‘z’ chamber, can be placed in-line downstream. Back pressure generated in this way 
enhances the life time of the chamber and supports the particle disruption. Insertion of the APM 
upstream supports the pre-dispersion (Microfl uidics, 2008). Nearly constant pressure and the 
fi xed geometry of the micro channels lead to uniform results.
  
A  Chamber type ‚z‘, B Chamber type ‘y’ (Microfl uidics, 2008)Figure 10. 
For the experiments, an F12Y or F20Y (75 μm minimum dimension) IXC was used, whereas 
an H30Z (200 μm minimum dimension) chamber was placed downstream as APM. During 
emulsion development operating pressures were varied from 500 to 1500 bar and number of 
passages from 1 to 12. The emulsions were cooled after each passage to maintain a temperature 
below 20°C. In Table 13 the different methods used during emulsion development are shown.
Determination of droplet size using static light scattering2.2.3.2 
To characterize and control the prepared emulsions, the Laser Scattering Particle Size Distribution 
Analyzer Horiba LA-950 (Retsch Technology GmbH, Haan, Germany) was used. It permits the 
determination of particle sizes in the range of 0.01 μm to 3000 μm. 
An alternative common name for static laser scattering is laser diffraction. The instrument detects 
the correlation between the intensity and the angle of the light scattered from the particle. 
At large particles (diameter > wavelength) the laser light is diffracted in small angles. The 
diffracted signals are captured in front relative to the light source. This phenomenon is described 
by the Fraunhofer theory. Optic properties of the investigated particles are irrelevant.
At small particles (several μm or less, diameter < wavelength) the laser light is scattered 
ascendingly in large angles. Therefore the scattered signals are captured at the sides and rear 
relative to the light source. This phenomenon is described in the Mie theory. For calculation of 
the particle size the diffraction and the absorption of the sample material was essential.
The Horiba LA-950 consists of two light sources, a red laser diode (650 nm) and a blue light 
emitting diode LED (405 nm) and an array of photodiodes to detect the scattered light over a 
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wide range of angles. Using the automatic sampling system, few droplets of the emulsion were 
dispersed in 160 ml of water (stirrer: grade 4). Agglomerates were broken up by ultrasound 
during sample addition. The particle size distribution of the sample was automatically calculated 
using the Mie theory. The refraction index of olive oil of 1.469 (Song et al., 2002) for the 
dispersed phase was taken into account. Salts in the continuous phase were neglected due to 
strong dilution. Consequently, properties of water for the continuous phase was adopted. For 
gum-acacia stabilized emulsions, the refraction index was set to 1.600. Iterations were 15 for 
acacia gum-stabilized emulsions and 150 for Triton X 100-containing emulsions. Each sample 
was determined in triplicate, and the mean was calculated.
Microscopic analysis of emulsions2.2.3.3 
As the pharmacopoeias stipulate microscopic analysis of the olive oil emulsions used for lipase 
assay, microscopy was also used for emulsion evaluation in this work. Microscopic analysis 
was done using a Microscope Cx41 (Olympus GmbH, Hamburg, Germany) in combination 
with a digital camera C-4040Z (Olympus GmbH, Hamburg, Germany). One ocular (zoom 10 x) 
and three objectives (zoom 10 x, 30 x, 100 x) were available. According to pharmacopoeia, 
10 ml of the stock emulsion containing 10 % (v/v) olive oil were diluted to 100 ml with gum 
acacia solution. Emulsions containing no gum acacia were inspected without dilution. The 
diluted or undiluted emulsions were pipetted to the object plate (5 μl) and covered with a cover 
slip. Due to small droplet sizes the highest zoom (1000 x) was chosen to inspect the prepared 
emulsions. 
Determination of solid content in proteolysis material2.2.4 
The solid content was determined in order to identify optimal precipitation conditions for 
processing after proteolysis. At a solid content of less than 15 %, the proteolysis was generally 
stopped. The proteolysis suspension (10 g) was weighed into a beaker (50 ml) and 5.5 ml of 
85 % (w/w) isopropanol were added. After stirring for 1 min with a glass rod, fi bers were 
removed. After addition of further 20 ml of 85 % (w/w) isopropanol, the suspension was stirred 
for 1 min using a magnetic stirrer. Two graduated centrifugation glasses were fi lled with 10 ml 
of the suspension and centrifuged for 2 min at 700 rpm at room temperature (Megafuge 1.0S, 
Heraeus Instruments GmbH, Hanau, Germany). The solid content was read off from the 
graduation. 
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RESULTS3. 
Emulsion development for determination of lipase activities by ultrasonic 3.1 
spectroscopy
Emulsions containing olive oil and gum acacia based on pharmacopoeia3.1.1 
As described in an earlier section (1.4.5), ultrasonic measurements are very sensitive to 
emulsion instabilities. Therefore, an adequate stability of the emulsion was required. The aim 
of the studies described in this section was to prepare an emulsion which shows no effect 
on ultrasonic velocity during ultrasonic spectroscopic measurements. To judge whether an 
emulsion was suitable, a baseline check was done measuring the difference in velocity between 
the measurement cells, both fi lled with emulsion. Obtaining a stable difference between both 
cells indicated an emulsion of suitable stability. Pre-tests showed that the stability of the olive 
oil emulsion prepared in a blender according to pharmacopoeia was not suffi cient to obtain 
stable baselines during ultrasonic velocity measurements. Thus, a high pressure homogenizer 
Microfl uidizer® M-110 EH processor was used. In the majority of cases, the addition of 
reagents mixture after high-pressure homogenization of the olive oil stock emulsion led to 
instable baselines (Table 13, emulsifi cation methods Ia and Ib). The droplet sizes enlarged with 
increasing number of passages immediately after fi rst passage using emulsifi cation method Ia 
(Table 13, household blender). Some of the emulsions prepared by using a propeller mixer 
(Table 13, emulsifi cation method Ib) showed stable baselines. But using low rotations/ min, 
phase separation was observed immediately after stopping mixing or after fi lling the inlet 
reservoir of the homogenizer. Consequently, the amount of olive oil in the fi nal emulsion was 
not defi ned. With increasing pressure and passages the droplet sizes increased (Appendix A I).
Figure 11 shows the dependency of the droplet size on the quality of the pre-emulsion. The 
strong dependency on the rotations/ min proves low robustness of the method using the power 
propeller mixer for preparing the pre-emulsion (Table 13, emulsifi cation method Ib). Working 
with low pressures, the enlargement of droplet size with ascending numbers of passages was 
reduced (Figure 12). Changing the interaction chamber F12Y against a JR20Z, the enlargement 
of droplet size was also minimized (Appendix A I).
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Addition of bile salts solution before high pressure homogenization was done by using 
emulsifi cation methods IIa and IIb (Table 13). The pre-emulsion prepared with emulsifi cation 
method IIa was very instable. Phase separation was observed immediately after the propeller 
mixer was stopped. After microfl uidization all passages showed stable baselines in the ultrasonic 
spectrometer (URT). The signal after enzyme injection was higher than in earlier tests. The 
means of droplet diameter showed high values, but a decrease of droplet size was observed with 
increasing number of passages. The content of oil was not defi ned due to phase separation in 
the inlet reservoir of the Microfl uidizer®. Using emulsifi cation method IIb, again the emulsions 
from all passages showed stable baselines and the droplet diameter decreased with increasing 
number of passages. In a second trial more passages were performed using the same conditions. 
(Appendix A II). 
Infl uence of pre-emulsifi cation on droplet size Figure 11. 
of an emulsion of olive oil in water. Pre-emulsions were 
prepared using a propeller mixer at 800 rpm (square), 
850 rpm (triangle) or 950 rpm (circle) for 15 minutes.
The Microfl uidizer was operated at 1200 bar with a F12Y-
chamber upstream and a H30Z-chamber downstream (four 
passages each). The grey-marked series represents data 
obtained with double volume of emulsion during pre-
emulsifi cation (950 rpm). Shown are means of 3 replicates 
from a single experiment. Standard deviations are below 
0.01 μm.
Infl uence of homogenization pressure on droplet Figure 12. 
size of an emulsion of olive oil in water. Pre-emulsions 
were prepared using a propeller mixer at 950 rpm.The 
Microfl uidizer was operated at 900 bar (square), 1000 
bar (triangle), 1100 bar (circle), 1200 bar (line), or 1500 
bar (cross) with a F12Y-chamber upstream and a H30Z-
chamber downstream (four passages each). Shown are 
means of 3 replicates from a single experiment. Standard 
deviations are below 0.01 μm.
Infl uence of olive oil Figure 13. 
content, homogenization pressure and 
number of passages  on droplet size of 
an emulsion of olive oil in water. Olive 
oil stock emulsions were diluted with 
Reagents mixture (pre emulsion). The 
Microfl uidizer was operated at 600 to 
1800 bar with a F20Y-chamber upstream 
and a H30Z-chamber downstream (1 
to 5 passages). Shown are means of 3 
replicates from two experiments. Pre- 
emulsifi cation times of 5 and 15 min 
are not distinguishable from each other 
due to equal symbol forms and colors.
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Additional experiments were done considering content of olive oil, homogenization pressure, 
number of passages and time of emulsifi cation  of stock emulsions (emulsifi cation method III). 
Complete data are shown in Appendix A II. In Figure 13, the results are summarized. More 
passages caused smaller droplet diameters for high as well as low content of olive oil. High 
pressure led also to smaller droplet diameters for high as well as low content of olive oil. 
High standard deviations were observed for emulsions with a low content of olive oil (2.5 % 
olive oil in stock emulsion). Intermediate preparation conditions (10 min emulsifi cation of 
stock emulsion, olive oil content 6.3 %, homogenization pressure 1200 bar) led to highest 
reproducibility with respect droplet sizes. The time of mixing the stock emulsions showed no 
signifi cant effect on the droplet size. The ultrasonic signal after addition of working standard 
solution decreased with increasing olive oil content. Although the emulsions with high olive oil 
content prepared with highest pressure showed an adequate reproducibility in droplet size, they 
were not considered to be best due to the little ultrasonic signal during lipase reaction and the 
high stress of the homogenizer. Concerning the high reproducibility regarding droplet size, the 
emulsions prepared with intermediate conditions (10 min emulsifi cation of stock emulsion, olive 
oil content 6.3 %, homogenization pressure 1200 bar) were chosen for further experiments. 
Calcium chloride was added to the emulsion either before or after microfl uidization. The droplet 
size increased extremely with ascending calcium content. During ultrasonic measurements 
no stable baselines were observed using a calcium containing emulsion (Appendix AII). 
Furthermore, linearity was tested. Initially, the lipase emulsion was tempered at 37°C continuously 
during measurements. No linearity and high standard deviations were observed. Therefore, 
the experiment was repeated, but the emulsion was tempered only for 5 min separately for 
each measurement. Linearity was observed in the range of 0.02 to 0.18 % reference standard 
solutions (Appendix AII). Both tests showed that the stability towards calcium and temperature 
was limited.
Ultrasonic and Figure 14. 
simultaneous microscopic 
observation of lipase 
reaction over time in 
an olive oil emulsion 
stabilized with gum acacia. 
The emulsion was prepared 
with a Microfl uidizer. Both 
measurement cells (URT) 
were fi lled with emulsion 
(180μl) After checking 
stability of the baseline, 
4 μl of working standard 
solution (1.0 % (w/v)) were 
added to one of the cells. 
The measurement was 
carried out at 30°C.
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Figure 14 shows the time dependency of ultrasonic velocity after enzyme injection.
Simultaneously, a second sample was monitored outside the instrument by microscopy. The 
change of ultrasonic velocity after approx. 18 min did not follow a general enzyme reaction 
curve. Rather, an extreme decrease of 
ultrasonic velocity occured after 18 min, 
accompanied by a fast droplet growth with a 
fi nal emulsion breaking.
In order to ascertain the infl uence of the 
sample matrix (proteases) on the gum acacia-
stabilized emulsion, 5 % (w/v) gum acacia 
was added to 0.3 % (w/v) casein solution. 
Working standard solution (1.0 % (w/v)) was 
injected into casein solution in the presence 
or absence of  5 % gum acacia (Figure 15). In 
the gum acacia-containing casein solution the 
protease activity was minimally enhanced. 
The degradation of gum acacia by pancreatic 
proteases can be suggested.
Emulsions containing olive oil and Triton X 1003.1.2 
Using Triton X 100 as emulsifi er, the pre-emulsion was prepared in TRIS buffer (URT/ HR-US) 
for determination of Trypsin activity. After high-pressure homogenization, the emulsion was 
diluted with Reagents mixture (Ph.Eur./ USP) (Table 13, emulsifi cation method IV). The 
ultrasonic velocity during lipase reaction showed a regular course over time in opposite to the 
gum acacia-stabilized emulsions. In order to test quality of the emulsion and suitability for 
the ultrasonic spectroscopic determination of lipase activity, several parameters were varied. 
Lipase activities as well as droplet sizes were determined for the emulsions. In the following 
section, the modal means of droplet size are presented instead of arrithmetic means because 
diminutive second maxima at higher particle diameters were observed, supposably caused by 
impurities in the measuring cell of the Horiba LA 950.
Repeatability
The repeatability was 3.08 %.
Number of passages
The number of passages was varied from one to four passages. From the fi rst to the second 
passage a reduction of modal droplet size was observed. More passages led to no further 
decrease. Initial slopes were unaffaceted by the number of passages (Appendix A III).
Infl uence of gum acacia on the protease reaction Figure 15. 
in 0.3 % (w/v) casein. URT-measurements were done in the 
presence (dashed) and the absence (continuous) of gum 
acacia (5 % (w/v)) at 37°C. Working standard solution 
(1.0 %, 4 μl) was  injected into 180 μl substrate solution
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Concentration of olive oil
The olive oil concentration in the homogenized emulsion was varied from 1 % to 6 % (v/v), 
equivalent to fi nal concentrations of 0.5 % to 3 % (v/v) after dilution with bile salts solution 
(Figure 16). No further increase of the initial slopes was observed at concentrations about 
2 % (v/v). The droplet size increased with enhanced content of olive oil. A concentration of 
6 % (v/v) olive oil, equivalent to 3 % (v/v) olive oil after dilution with bile salts solution was 
defi ned for the following experiments. Thus, the olive oil content used was equal to the fi nal 
content in the pharmacopoeia emulsion (Appendix A III).
Concentration of Triton X 100
The concentration of Triton X 100 in the homogenized emulsion was varied from 1 to 7 mM, 
equivalent to a fi nal concentration of 0.5 to 3.5 mM after dilution with bile salts solution. At 
concentrations higher than 3 mM, lipase activity reached a plateau.  
A concentration of 5 mM was defi ned for further experiments. Droplet sizes decreased with 
increasing Triton X 100 concentration (Appendix A III).
Concentration of calcium chloride in emulsion
The calcium concentration in the emulsion was varied from 5 to 400 mM, equivalent to fi nal 
concentrations of 2.5 to 200 mM (Figure 17). Saturation was achieved at concentrations above 
100 mM (50 mM in fi nal emulsion). No further increase of initial slopes was observed. The 
droplet size was not dependent on the content of calcium (Appendix A III).
 Infl uence of olive oil content in emulsion on Figure 16. 
ultrasonic velocity change (URT) and droplet size during 
lipase determination. Pre-emulsion was prepared in 100 
mM TRIS pH 7.8 with 5 mM Triton X 100 and 20 mM 
calcium chloride. For homogenisation the Microfl uidizer 
was operated at 1200 bar for 3 passages.  Pre-emulsion and 
reagents mixture were mixed in equal parts (fi nal emulsion). 
URT-measurements were carried out with 180 μl of fi nal 
emulsion and 4 μl of working standard solution (0.3 %) at 
37 °C. Left axis (grey) shows the inital slopes (URT): mean 
+/- stdev, n =2 (2 rep) (0.5 - 1 % olive oil),     n =1 (2 rep) 
(2 - 3 % olive oil). Dashed lines are limits of +/- 3 s (s = 
3.08%). Right axis (black) shows the modal droplet size 
(n = 1 (3 rep)).
Infl uence of calcium content in emulsion on Figure 17. 
ultrasonic velocity change (URT) and droplet size during 
lipase determination. Pre-emulsion was prepared with 6 % 
(w/v) olive oil in 100 mM TRIS pH 7.8 with 5 mM Triton X 
100. For homogenisation the Microfl uidizer was operated 
at 1200 bar for 3 passages.  Pre-emulsion and reagents 
mixture were mixed in equal parts (fi nal emulsion). 
URT-measurements were carried out with 180 μl of fi nal 
emulsion and 4 μl of working standard solution (0.3 %) at 
37 °C. Left axis (grey) shows the inital slopes (URT): mean 
+/- stdev, n =2 (2 rep). Dashed lines are limits of +/- 3 s (s 
= 3.08%). Right axis (black) shows the modal droplet size 
(n = 1 (3 rep)).
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Concentration of TRIS in emulsion
TRIS concentration was varied from 20 to 160 mM in the pre-emulsion before addition of bile 
salts solution. Further TRIS added via bile salts solution was not considered. At concentrations 
above 80 mM TRIS in the pre-emulsion, the initial slopes reached a plateau. An infl uence on 
the droplet size was not observed (Appendix A III).
Stability of emulsion 
The pre-emulsion was stored over 10 days at 5 ± 3°C both after and before addition of the 
bile salts solution. In the latter case the bile salts solution was added freshly on the day of 
measuring. In the emulsion stored with bile salts, the activity was only minimally reduced after 
ten days (Appendix A III).
In order to optimize the buffering system, several emulsions were prepared with different buffers 
containing different concentrations of TRIS and calcium chloride (emulsifi cation method V). 
Each emulsion was used for ultrasonic determination of lipase activity (URT). A second mixture 
was used to control the pH during enzyme reaction (Equipment as used for determination of 
lipase activity according to Ph.Eur./ USP). Results of ultrasonic and pH measurements are 
presented in Appendix A IV. Applying a total TRIS concentration of 50 mM, the change of 
ultrasonic velocity over time during lipase reaction was comparable to the course of the curve 
in a gum acacia-stabilized emulsion (Figure 14). Higher TRIS concentrations of 100 mM or 200 
mM did not show such behavior. In the emulsion containing 50 mM TRIS, a decrease of pH of 
approx. 0.2 units within 15 min during lipase reaction was observed, whereas in the emulsions 
with higher TRIS content the pH decreased only minimally over time. 
Feasibility study to determine pancreatic enzyme activity in drug substance 3.2 
by using ultrasonic velocity measurements
Specificity 3.2.1 
As specifi city is one important criterion for the evaluation of an analytical procedure, the 
specifi city of enzyme activity measurements by ultrasonic methods was investigated for 
amylase, lipase, protease and trypsin (2.2.1.2 - 2.2.1.3, 2.2.1.5). In order to determine specifi city, 
ultrasonic velocity change was measured in systems to which either substrate or enzym had 
not been added as well as in complete systems (positive control). For all enzymes ultrasonic 
velocity only changed in complete systems, but not in those that lacked substrate or enzyme. 
Thus, the methods were specifi c for enzyme activity detection. As an example, results of lipase 
determination are shown in Figure 18. Specifi city tests for the other enzymes are accommodated 
in Appendix A V.
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Additionally, specifi city was tested after adding substances to the working standard solutions, 
which were expected to be present in in-process samples (worst case). 
The infl uence of sodium chloride was tested by adding sodium chloride to the sample solvents 
used for the determination of lipase and amylase activity. Sodium chloride added to the sample 
solvent showed no infl uence on lipase activity (Table 14, Appendix A VI), although sodium 
chloride is absolutely necessary for pancreatic lipolysis (Ruyssen & Lauwers, 1978). Thus, 
maleate buffer pH 7.0, which contains 40 mM sodium chloride, is used according to Ph.Eur 
method. In order to ensure a low salts concentration (Born et al., 2009), the same buffer was 
used for the ultrasonic method, although the concentration of lipase solution (URT/ HR-US) 
was considerably higher as that according to Ph.Eur. According to Benzonana & Desnuelle 
(1968), sodium chloride supports the ionization of the fatty acids at pH 9. However, at a pH 
of 7.2 used for ultrasonic measurements ionization of fatty acids is less important. Higher 
concentrations of sodium lead to inhibition of lipase activity (Borgström & Erlanson, 1973, 
Ruyssen & Lauwers, 1978). Both activation and inhibition were not observed within the tests 
performed in the present thesis, so the method is evaluated as robust concerning sodium in 
the sample matrix. Concerning amylase, no activating effect of sodium has been reported in 
the literature, but Wakim et al. (1969) found an intense enhancement of amylase stability and 
activity caused by chloride ions. Starch solution (URT/ HR-US) contains 6.7 mM sodium 
chloride (Bernfeld, 1955). Although chloride is not directly added to the proteolysis make-up, it 
is likely to be introduced to the proteolysis make-up via glands. No infl uence of chloride in the 
sample matrix was observed (Table 14, Appendix A VI), so the method is evaluated as robust 
concerning chloride in the sample matrix.
Specifi city test for lipase activity measurement by ultrasonic method (HR-US). Figure 18. 
Measuring ultrasonic velocity change in the complete system (addition of  20 μl of Lipase 
solution (URT/ HR-US) to 1050 μl of fi nal olive oil emulsion (URT/ HR-US)) a clear change 
of ultrasonic velocity  was observed. On the left, only 20 μl of Maleate buffer solution pH 
7.0 (HR-US/ URT) were injected, on the right, a bile salts/ TRIS/ Triton X 100 mixture was 
used as “substrate”. In both cases ultrasonic velocity did not change signifi cantly. Shown are 
means +/- stdev (n = 2 (2 replicates)) to improve clarity of the fi gure.
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Infl uence of NaCl concentration in sample matrix on ultrasonic determination of amylase and lipase. Working Table 14. 
standard solutions were prepared in the respective sample solvents with different NaCl content. Ultrasonic measurements were 
performed after adding the working standard solution to the respective substrate preparation at 37°C.
Calcium is added to the proteolysis make-up in very low amounts. However, since calcium has 
an important function in the stabilization and activation of pancreatic enzymes, the effect of 
calcium in the sample matrix had to be tested. Adding calcium chloride to the solvents in higher 
amounts than expected in in-process samples showed no infl uence on the change of ultrasonic 
velocity during amylase, lipase,  protease or trypsin reaction (Table 15, Appendix A VI). 
In agreement with the ultrasonic method, the pharmacopoeias do not specify the addition 
of calcium to the amylase assay.  In the literature, calcium is only considered to have a 
protective effect towards proteolytic attacks (Stein & Fischer, 1958) and a stabilizing effect 
(Vallee et al., 1959; Buisson et al.,1987), but no infl uence on amylase activity. During emulsion 
development it was shown that lipase activity (change of ultrasonic velocity over time) did 
not increase further at calcium concentrations above 50 mM calcium in the olive oil emulsion 
(Figure 17). Calcium (60 mM) was used in the ultrasonic lipase method in order to avoid lag 
times between enzyme addition and maximum lipolysis rate, as described by Brown et al. 
(1977). Thus, analysis times could be reduced. Several authors (Schønheyder & Volqvartz, 
1945; Scow, 1988) suggested a removal of free fatty acids by accumulation of calcium soaps to 
be responsible for the activation of lipase. 
Infl uence of CaClTable 15. 2 concentration in sample matrix on ultrasonic determination of pancreatic enzyme activities 
(amylase, lipase, total protease, trypsin). Working standard solutions in the respective sample solvents with different CaCl2 
content were prepared. Ultrasonic measurements were performed after adding the working standard solution to the respective 
substrate preparation at 37°C.
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Infl uence of isopropanol concentration (30 % (v/v), 25 % (w/w)) in sample matrix on ultrasonic determination of Table 16. 
pancreatic enzyme activities (amylase, lipase, protease, trypsin). Working standard solutions in the respective sample solvents 
with different isopropanol content were prepared. Ultrasonic measurements were performed after adding the working standard 
solution to the respective substrate preparation at 37°C. (CV = Coeffi cent of variation).
In the pharmacopoeia methods, the addition of calcium to the assay is not required. However, 
considering the calcium which is introduced passively via gum acacia, bile salts and pancreas 
powder a calcium concentration of approx. 5 mM in the pharmacopoeia assay can be assumed. 
As free fatty acids are titrated with sodium chloride, higher concentrations of calcium are 
not necessarily required in the pharmaocpoeiea assays. For ultrasonic measurements of 
proteases, calcium was added to the system via substrate (trypsin) or enzyme solution (total 
protease) in agreement with the pharmacopoeias. In the literature, calcium ions are described 
as essential for complete activation of trypsin and having furthermore stabilizing effects 
(Ruyssen & Lauwers, 1978). For the determination of free protease activity, calcium is not 
considered in the USP and was therefore omitted from the ultrasonic method. Taken together, 
the methods are evaluated as robust concerning calcium in the sample matrix. 
Isopropanol content in the sample solvents up to 30 % (v/v) and 25 % (m/m), respectively, was 
tested. In-process samples of early process steps (API process) contain varying amounts of 
isopropanol. Pancreatic enzymes start to precipitate at isopropanol concentrations of  approx. 
30 % (w/w). During lipase, protease and amylase reaction, the change of ultrasonic velocity over 
time was not infl uenced by the presence of isopropanol concentrations up to 25 % (w/w) in the 
sample solvent (Table 16, Appendix A VII). Trypsin showed a slight increase of initial slopes 
accompanied by high CVs of up to 17 % at isopropanol concentrations above 16  % (w/w). 
In-process material also harbors diverse proteins introduced via glands. In order to check the 
infl uence of the present proteins, casein, a mixture of several proteins, was utilized for simulation. 
Whereas porcine pancreas glands contain up to 20 % of proteins and solid components, for
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Infl uence of protein (casein) concentration in sample matrix on ultrasonic determination of amylase, lipase and Table 17. 
trypsin. Working standard solutions in the respective sample solvents with different casein content were prepared. Ultrasonic 
measurements were performed after adding the working standard solution to the respective substrate preparation at 37°C. 
early in-process samples, approx. one half can be assumed. In the course of proteolysis process, 
the content decreases steadily. Considering the presence of high-weighed fi bers and sample 
dilution, the tested range from 0 to 2.5 % (w/v) casein should be suffi cient. For the determination 
of amylase activity, a slight increase of ultrasonic velocity change over time was observed using 
Phosphate buffer (URT/ HR-US) when casein was present. This increase of ultrasonic signal 
could theoretically be caused by simultaneous monitoring of protease reaction as protein was 
available as substrate. However, the effect was eliminated by changing the phosphate buffer 
concentration in the enzyme solvent from 0.02 M to 0.2 M (Table 17, Appendix A VIII). Using 
starch solution also prepared in Phosphate buffer 0.2 M (URT/ HR-US), inadequate standard 
deviations were obtained during ultrasonic measurements of amylase activity, supposably 
caused by instability of the starch solution. Thus, the less concentrated Phosphate buffer (URT/ 
HR-US) was used to prepare the starch solution allowing reliable ultrasonic measurements. 
Lipase and trypsin activities were not infl uenced by the protein concentrations tested (Table 17, 
Appendix A VIII). For the tested range, a disturbance by proteins in the matrix (model casein) 
can be excluded for the ultrasonic determination of amylase (using Phosphate buffer 0.2 M 
(URT/ HR-US) as sample solvent), lipase and trypsin activity.
Process material contains a complex mixture from mono-, di- and triglycerides introduced 
via glands. Olive oil, a mixture of diverse glycerides, was used to simulate fat in the matrix. 
Whereas porcine pancreas glands contain approx. 15 % of lipids, for early in-process samples, 
approx. one half can be assumed. In the course of proteolysis process, the content decreases 
steadily. Olive oil concentrations in the range of 0 to 7.5 % were tested. The addition of olive 
oil in different concentrations had no or only a small infl uence on ultrasonic velocity change as 
a measure of lipase and protease activity (Table 18, Appendix A IX). 
Regarding the determination of amylase and trypsin activity, a strong infl uence of  the 
addition of fat on the ultrasonic velocity changes was found. Using 0.02 M phosphate buffer 
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for the determination of amylase activity, a clear decrease of initial slopes was observed with 
ascending olive oil content. At olive oil concentrations higher than 2 % (v/v), high standard 
deviations occurred (Figure 19).  Furthermore, blanks were determined by repeating the 
experiment, but only Phosphate buffer solution (URT/ HR-US) served as ‘substrate’. The blanks 
showed an opposite behavior. In another experiment an increased phosphate buffer concentration 
(0.2 M) was introduced for the preparation of starch and amylase solution on the one hand and 
only for the preparation of amylase solution on the other hand. Ultrasonic measurements with 
starch solution prepared in the Phosphate buffer solution 0.2 M (URT/ HR-US) were unreliable 
due to high CVs. Preparing only the amylase solution in 0.2 M Phosphate buffer 0.2 M (URT/ 
HR-US) eliminated the infl uence of fat on the ultrasonic veloctiy change as a measure of amylase 
activtiy. But the dispersion was  insuffi cient, as oil agglutinations were found at the mixer wall 
and the solvent emulsion showed only a slight turbidity (Table 12, Appendix A IX). 
Due to the instability of the sample solvent emulsions, 0.2 % (v/v) of Triton X 100 was added 
in an additional experiment to the sample solvents for the determination of amylase (optimized) 
and total protease activity. The addition of Triton X 100 did not lead to a recurrence of fat 
disturbances regarding amylase and to an occurance of fat disturbances regarding total protease, 
respectively.
Using Triton X 100 solution (URT/ HR-US), for the determination of trypsin activity an extreme 
increase of initial slopes was observed (Figure 20, Appendix A IX). The results were confi rmed 
by using offi cial FIP reference standard solutions (grey triangles) instead of working standard 
solutions (Figure 20, Appendix A IX).
Blanks were determined by repeating the experiment, but only TRIS buffer (URT/ HR-US) for 
the determination of Trypsin activity served as ‘substrate’. Blanks showed the same behavior 
towards fat, i.e. an increase of ultrasonic velocity change with ascending olive oil content. In 
a third experiment, Triton X 100 was omitted leading to an elimination of fat disturbances. 
Infl uence of fat (olive oil) on amylase activity measurement by ultrasonic method Figure 19. 
(URT). Working standard solutions (0.05 %) with different olive oil content were prepared 
by mixing in a household blender for 10 min. Ultrasonic measurements were performed after 
adding 4 μl of working standard solution (0.05 %) to 180 μl of starch solution 6 % (URT/ HR-
US) at 37°C. Shown are means +/- stdev (n = 2 (2 replicates)) to improve clarity of the fi gure. 
Dashed lines represent limits of +/- 3s (s = 1.86 %). 
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Additionally, other solvents were tested concerning applicability of oil-containing samples 
(Figure 21, Table 18). The use of  borate buffer, phosphate buffer and calcium chloride solution 
showed no benefi t compared to the use of Hydrochloric acid 1 mM (URT/ HR-US). 
Infl uence of fat (olive oil) on trypsin activity measurement by ultrasonic method Figure 20. 
(URT). Working standard solutions (1.0 %, black squares) and offi cial FIP trypsin reference 
standard solutions (0.03 %, grey triangles) with different olive oil content were prepared by 
mixing in a household blender for 10 min. Ultrasonic measurements were performed after 
adding 8 μl of  the working/ FIP standard solution to 180 μl of BAEE solution (URT/ HR-US) at 
37°C. Shown are means +/- stdev (n = 2 (2 replicates)) to improve clarity of the fi gure. Dashed 
lines represent limits of +/- 3s (s = 1.73 %). 
Test of several sample solvents (Borate buffer (BB), Phosphate buffer (PP) and Figure 21. 
CaCl2 as alternative to HCl to avoid fat disturbances during ultrasonic determination of trypsin 
activity (URT). Working standard solutions (0.1 %) in different solvents with different olive oil 
content were prepared by mixing in a household blender for 10 min. Ultrasonic measurements 
were performed after adding 8 μl of working standard solution (0.1 %) to 180 μl of BAEE 
solution (URT/ HR-US) at 37°C. White columnes show the change of ultrasonic velocity 
without addition of olive oil, grey colmunes show the change of ultrasonic velocity in the 
presence of 0.5 % (v/v) olive oil in the sample solvent. Shown are means +/- stdev (n = 2 
(2 replicates)) to improve clarity of the fi gure.
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Table 18. Infl uence of fat concentration in sample matrix on ultrasonic determination of pancreatic enzymes. Working 
standard solutions in the respective sample solvents with different olive oil content were prepared by mixing in a household 
blender for 10 min. Ultrasonic measurements were performed after adding the working standard solution to the respective 
substrate preparation at 37°C.
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Precision3.2.2 
As precision is another important criterion for the evaluation of an analytical procedure, the 
repeatability of enzyme activity measurements by ultrasonic methods was investigated for 
amylase, lipase, protease and trypsin (Table 19). Two different methods were used of how to add 
the enzyme solution: On the one hand, the measurement cell was opened after baseline check 
again to inject the enzyme solution by using one pipette for injection and another for mixing 
(Cell injection method), on the other hand, the measurement cell was  fi lled with substrate and 
enzyme solution simultanously using a pre-mix of both solutions (Pre-mixing method). For 
HR-US, the cell injection was also done by using a syringe and injecting the enzyme solution 
through a septum without opening the cell again after baseline check. Mostly, the use of the 
Pre-mixing method led to improved repeatabilites compared to the cell injection method. Using 
the FTS and the Pre-mixing method, best repeatabilities were observed (Working with the FTS, 
the Cell injection method was non-applicable due to the closed system of the FTS). 
In-process material of the API process generally shows high amylase activities. As PAT 
methods should be fast and easy, sample preparation should be avoided (e.g. dilution prior 
to measurement). In order to investigate the precision when a highly concentrated sample 
was injected, 37.5 μl (typically 300 μl) of a 0.4 % (w/v) amylase working standard solution 
(eight-fold higher concentration than typically used) were injected. The repeatability was 
0.89 % using HR-US FTS.
In order to evaluate the infl uence of fi bers on the ultrasonic measurement, the repeatability for 
the ultrasonic measurements of free protease activity in pancreas (dispersed in water) and a 
suspension (after separation of fi bers) was determined using HR-US FTS. 
Repeatability of enzyme activity measurements by ultrasonic methods using URT, HR-US and HR-US FTS. Table 19. 
Ultrasonic measurements were performed after adding the working standard solution to the respective substrate preparation at 
37°C. Two basically different methods were used of how to add the enzyme solution (Cell injection method via pipette/ syringe 
and Pre-mixing method). Working with the FTS, the Cell injection method was non-applicable. Measurements not performed 
are marked with a dash.
    *  Using a syringe and injection through a septum the repeatability obtained was 1.99 % for amylase, 2.13 % for free  
 protease  and 1.95 % for trypsin
  **  Determination in starch 3 % (w/v), other results in starch 6 % (w/v)
*** Determination in casein 0.63 % (w/v), other results in casein 1.25 % (w/v)
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The samples were either fi ltered before measurement or directly used. The samples were 
injected into the casein solution without previous sample dilution. For comparison the masses 
of the injected volumes were determined (Table 20). 
For the replications of the sample without previous fi ber separation, high variations were 
observed. Following fi ltration repeatability was reassessed. Evaluation referring to the mass 
showed improved repeatability compared to the evaluation referring to the volume. Measuring 
the suspension after fi ber separation the repeatability was improved compared to the pancreas 
dispersed in water. 
In order to determine internal laboratory variations such as the performance by different 
operators and on different days or the use of different reagent batches, the intermediate precision 
of enzyme activity measurements by ultrasonic methods was investigated for amylase lipase, 
protease and trypsin (Table 21). Except for lipase method (HR-US), intermediate precisions 
were improved by using the Pre-mixing method.
Repeatability for the determination of free protease in pancreas dispersed in water and a suspension after fi ber Table 20. 
separation using HR-US FTS. Ultrasonic measurements were performed after adding the sample to casein solution (URT/ 
HR-US) at 37°C. Pancreas dispersed in water was used for measurement before and after fi ltration.
Intermediate precision of enzyme activity measurements by ultrasonic methods using URT and HR-US. Ultrasonic Table 21. 
measurements were performed after adding the working standard solution to the respective substrate preparation at 37°C. 
Two basically different methods were used of how to add the enzyme solution (Cell injection method via pipette/ syringe and 
Pre-mixing method). Measurements not performed are marked with a dash.
 
**  Determination in starch 3 % (w/v), other amylase results in starch 6 % (w/v)
***  Determination in casein 0.63 % (w/v), other free protease results in casein 1.25 % (w/v) 
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Linearity3.2.3 
As linearity is one important criterion for the evaluation of an analytical procedure, the linearity 
of enzyme activity measurements by ultrasonic methods was investigated for amylase, lipase, 
protease and trypsin (2.2.1.2 - 2.2.1.3, 2.2.1.5). In order to determine linearity, ultrasonic 
velocity change was measured by injecting different concentrations of working standard 
solution. Depending on the concentration of enzyme typically used, different ranges of enzyme 
concentration were investigated for amylase, lipase, protease and trypsin. Although a broad 
linear range was observed for all enzymes, no proportionality was found (no line through 
orign). As an example, results of lipase determination are shown in Figure 22. Linearity was 
confi rmed in the range between 0.2 and 0.5 % (w/v) concentrated working standard solution. 
Concentrations of 0.1 and 0.6 % (w/v) were not within the linear range. Tested ranges and linear 
ranges for amylase, protease and trypsin are presented in Table 22 and Appendix A X. 
 
Linearity experiments of amylase, protease and trypsin activity measurement by ultrasonic method (HR-US, FTS Table 22. 
or URT). Ultrasonic measurements were performed after adding the sample solution to the respective substrate preparation 
at 37°C. Work Std means working standard solution prepared in Phosphate buffer solution (URT/ HR-US) or Borate buffer 
solution pH 7.5 (URT/ HR-US) and Triton X 100 solution (URT/ HR-US), respectively; Drug product I stands for Drug 
product I solution prepared in Calcium chloride 0.02 M (URT/ HR-US). FIP Std means Trypsin FIP reference standard solution 
prepared in Triton X 100 solution (URT/ HR-US). 
Test of linearity of lipase Figure 22. 
activity measurement by ultrasonic 
method (HR-US). Lipase working 
standard solutions (20 μl) with different 
concentrations in the range 0.1 to 
0.6 % (w/v) were injected into 1050 μl of 
fi nal olive oil emulsion (URT/ HR-US). 
Ultrasonic measurements were carried 
out at 37°C. Linearity was observed in 
the range between 0.2 and 0.5 % (w/v) 
working standard solution. Shown are 
means +/- stdev (n = 2 (2 replicates)) to 
improve clarity of the fi gure.
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Robustness3.2.4 
Influence of temperature3.2.4.1 
As ultrasonic velocity shows a strong dependency on temperature, the infl uence of small 
temperature differences (36.8 - 37.2°C) was investigated to estimate the impact of temperature 
decreases caused by enzyme injection. Due to the differences in system tempering, the test 
was performed for URT as well as HR-US. No infl uences were observed for all enzymes 
(Appendix A XI).
Additionally, wide temperature ranges (25 - 37°C) were tested to reproduce information about 
properties of pancreatic enzymes from the literature. Comparable behavior of the pancreatic 
enzymes towards temperature between ultrasonic analysis and literature indicate the monitoring 
of enzyme activity. No increase of amylase activity was observed from 25 to 30°C, using 
1 % (w/v) starch solution and 0.1 % (w/v) working standard solution. Using a 6 % (w/v) starch 
solution, amylase activity increased with ascendig temperature over the whole temperature range 
tested, in agreement with the literature (Ruyssen & Lauwers, 1978). Lipase, protease and trypsin 
activity also increased with ascending temperature in the tested range (Appendix A XII). 
Influence of substrate concentration3.2.4.2 
Since a suitable substrate concentration is mandatory to reach a linear dependency between 
ultrasonic signal and  enzyme concentration, different concentrations of substrate (starch, olive 
oil, casein and BAEE) were introduced for the ultrasonic determination of amylase, lipase, 
protease and trypsin activity.  
The change of ultrasonic velocity decreased with ascending casein or BAEE solution regarding 
the determination of protease and trypsin activity (Table 23, Appendix A XIII).
Infl uence of substrate concentration on ultrasonic determination of pancreatic enzymes. Solutions/ Emulsions with Table 23. 
different conent of substrates were prepared. Ultrasonic measurements were performed after adding the working standard 
solution to the respective substrate preparation at 37°C.
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Stability of substrate preparation over time3.2.4.3 
According to pharmacopoeias, fresh substrate preparations need to be prepared on the day of 
analysis. As preparation of substrate solutions is time-consuming and only very small amounts 
of substrate solutions are used for one ultrasonic analysis, stability of substrate preparations 
was tested over several days. Therefore,  enzyme activity in freshly prepared substrate solution 
and emulsion, respectively, was determined. Defi ned time intervals later the measurements 
were repeated using the same substrate preparation. The olive oil preparation was stored at 
2 - 8 °C. Other substrate solutions were stored at room temperature. Starch and casein solutions 
showed turbidity after 48 hours and the ultrasonic measurements showed high CVs. The BAEE 
solution and the olive oil emulsion were stable within the tested ranges of 48 hours and 21 days, 
respectively (Table 24, Appendix A XIV).
Test of substrate stability over time evaluated to test applicability to ultrasonic velocity measurements for Table 24. 
determination of pancreatic enzyme activities. Amylase, lipase, protease and trypsin activities in freshly prepared substrate 
solution and emulsion, respectively, were determined. Defi ned time intervals later the measurements were repeated using the 
same substrate preparation (olive oil preparation was stored at 2 - 8 °C, other preparations were stored at room temperature). 
Influence of extraction (dissolution) time3.2.4.4 
For extraction (dissolution) of pancreas powder in the sample solvent, 15 to 20 min are needed. 
Longer extraction times were tested in case of disturbances during routine measurements. The 
enzymatic activities were not infl uenced by extraction (dissolution) times between 10 and 
85 min (Appendix A XV). 
Stability of enzyme in titration equipment3.2.4.5 
In order to test the applicability of the titration system, enzyme stability in the titration equipment 
was tested for the determination of amylase activity (Figure 23 A, Appendix A XVIII) and 
free protease activity  (Figure 23 B, Appendix A XVIII) according to 2.2.1.5 and 2.2.1.6. In 
particular, this equipment was conceivable to accelerate linearity experiments (3.2.3). After 
the enzyme solutions had been kept for a long time interval (more than 20 min) in the dosing 
system, losses of amylase and protease activity were observed using the titration equipment. 
Thus, the titration equipment was not applicable to test linearity.
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Lipase: Potential influencing factors of lipase activity depending on substrate 3.2.4.6 
emulsion
Influence of bile salts in emulsion
Bile salts enhance the rate of lipolysis due to assistance in removing and solubilizing fatty acids. 
Based on the pharmacopoeias, an emulsion containing 6 % (w/v) bile salts (Lipase Activating 
Mixture Ph.Eur.) was defi ned. The dependency of lipase activity on the bile salts concentration 
was investigated. Testing a range from 0.11 to 1.05 % (w/v), concentrations above 0.4 % (w/v) 
showed no infl uence on lipase activity (Appendix A XVI).
Influence of pH in emulsion
As lipase activity depends on pH, the pH of the TRIS buffer was varied between 7.2 and 9.5. 
An increase of ultrasonic velocity change was observed between pH 7.2 to 8.4. Between pH 8.4 
and 9.5 ultrasonic velocity change declined slightly (Figure 24, Appendix A XVI).
Test on exposure times of working standard in the titration equipment at 37 °C Figure 23. 
(HR-US). Data series marked with triangles and rhombs (∆/ ◊) show the ultrasonic velocity 
changes over time after periodic injection of amylase (A) or free protease (B) solution into 
the cell fi lled with starch solution 6 % (URT/ HR-US) (A) or casein solution (URT/ HR-US) 
(B). The circles (○) mark data points obtained in measurements when the enzyme solution 
was added once after staying in the syringe for a short time interval (amylase: 20 and 30 μl, 
protease: 20 and 40 μl). The square (□) refers to the signal obtained when the amylase solution 
was added once after staying in the syringe for a long time interval (A) (n = 1 (1 replicate)).
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Influence of operating time of Microfluidizer® before processing the emulsion
Since the product stream is exposed to high temperatures during processing in the Microfl uidizer® 
increasing with growing operating times of the homogenizer, the infl uence of operating time 
before processing the emulsion was tested. The homogenizer was run over 0, 30 and 60 min 
before the emulsion was processed. The experiment was replicated a second day (2. trial). The 
operating time showed no infl uence on lipase activity (Appendix A XVI).
Total protease: Activation parameters3.2.4.7 
In order to determine total protease activity, inactive zymogens in the sample need to be activated 
by adding enterokinase. Stability of the enterokinase solution (storage at 5 ± 3 °C) and the infl uence 
of enterokinase concentration, activation time and activation temperature were investigated. 
Change of ultrasonic velocity over time increased with ascending enterokinase concentration. 
This effect was eliminated by subtraction of a blank value observed by using Calcium chloride 
solution 0.02 M (URT/ HR-US) instead of pancreatic enzyme solution. Activation temperatures 
between 25 and 45 °C, activation times between 5 and 20 min and storage times up to 6 days 
did not infl uence the change of ultrasonic velocity (Table 25, Appendix A XVII).
Infl uence of enterokinase concentration, storage (5 Table 25. ± 3 °C) time of enterokinase solution and activation temperature/ 
time on ultrasonic determination of pancreatic enzymes. Ultrasonic measurements were performed after adding the total 
protease solution (URT/ HR-US) prepared under varied conditions to the casein solution (URT/ HR-US) at 37°C.
Infl uence of pH in the fi nal olive oil emulsion Figure 24. 
on lipase activity measurement by ultrasonic method 
(HR-US). Olive oil emulsions and bile salts solutions 
were prepared with buffers of different pH values between 
7.2 and 9.5. For ultrasonic measurements 20 μl of lipase 
solution (URT/ HR-US) were injected to 1050 μl of the 
fi nal olive oil emulsions. Shown are means +/- stdev (n = 2 
(2 replicates)) to improve clarity of the fi gure. Dashed lines 
represent limits of +/- 3s (s = 1.43 %).
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Amylase: Dextrins as alternative substrates3.3 
Highly concentrated starch preaparations are often unstable. In contrast to starch, an advantage 
of most dextrins is their ready solubility. Thus, different dextrin preparations were tested as 
alternative substrates to starch solution. The used dextrins differ in the content of reducing 
matters (Dextrin 5, 10 and 20).
The preparation of substrate solution had to be performed differently depending on the reducing 
matters of the dextrins. Dextrin 5 needed to be prepared following the preparation of soluble 
starch, whereas Dextrin 10 and 20 were readily soluble in Phosphate buffer solution (URT/ 
HR-US) at room temperature. The solution of Dextrin 10 and 20 were clear, the solution of 
Dextrin 5 showed a slight turbidity similar to starch solution. 
Different dextrin concentrations were applied (5, 10, 20 % (w/v)) to ultrasonic measurements. 
The preparation of a 20 % (w/v) solution of Dextrin 5 was not possible. Ultrasonic velocity 
changes over time decreased with increasing content of reducing matters of the dextrins from 
Dextrin 5 to Dextrin 20. Comparing the signals obtained with Dextrin 10 and starch, same 
signal strengths were observed. For all investigated dextrins, the initial slopes decreased with 
ascending concentrations (Figure 25, Appendix A XIX). 
Ultrasonic determination of pancreatic enzyme activities in porcine pancreas 3.4 
or porcine pancreas powder-containing material
General3.4.1 
Based on feasibility tests, different ultrasonic methods for the determination of amylase, lipase, 
protease and trypsin were designed. In order to determine enzyme activity in porcine pancreas 
or porcine pancreas powder-containing samples, the change of ultrasonic velocity over time was 
determined in sample as well as working standard solution. The relative activity was calculated 
using the activity label claim of the working standard (based on pharmacopoeia). Calibration 
was done with working standard according to 2.2.1.8. In order to verify the ultrasonic methods 
as alternative, comparative data were generated by determination of enzyme activity according 
Suitability test of dextrins as altenative Figure 25. 
substrates for amylase activity measurement by ultrasonic 
method (URT). Three different concentrations (5, 10 and 
20 % (w/v)) of three dextrins (striped: Dextrin 5, checkered: 
Dextrin 10, dotted: Dextrin 20) were tested (Preparation of 
a 20 % (w/v) solution of  Dextrin 5 was not possible). The 
measurements were carried out at 37°C after injecting 4 μl 
of amylase solution (URT/ HR-US) into 180 μl of the dextrin 
solution. Shown are means +/- stdev (n = 2 (2 replicates)) to 
improve clarity of the fi gure.
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to pharmacopoeia (2.2.2) and ultrasonic methods (2.2.1). The use of ultrasonic methods as PAT 
is based on the ability to determine samples of  the manufacturing process. Therefore, enzyme 
activities were obtained for IPC material, API and drug product (pellets).
Relative amylase activities (FIP/ Ph.Eur.-u/g) in three batches of proteolysis-like Figure 26. 
material (striped: batch a, dotted: batch b, checkered: batch c) with four samples each were 
determined using URT method. The frozen samples were unfrozen and separated from  fi bers 
before measurement. 4 μl of Amylase solution (URT/ HR-US) (sample or working standard) 
were injected into the measurement cell, fi lled with 6 % starch solution (URT/ HR-US). The 
measurements were carried out at 37°C. Shown are means +/- stdev (n = 2 (amylase solutions 
with 1 replicate each) to improve clarity of the fi gure.
Relative free protease activities (FIP/ Ph.Eur.-u/g) in three batches of proteolysis-Figure 27. 
like material (striped: batch a, dotted: batch b, checkered: batch c) with four samples each were 
determined using URT method. The frozen samples were unfrozen and separated from  fi bers 
before measurement. 4 μl of Free protease solution (URT/ HR-US) (sample/ working standard) 
were injected into the measurement cell, fi lled with Casein solution 1.25 % (URT/ HR-US). 
The measurements were carried out at 37°C. Shown are means +/- stdev (n = 2 (free protease 
solutions with 1 replicate each) to improve clarity of the fi gure.
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IPC material 3.4.2 
Proteolysis-like material 3.4.2.1 
Relative activities of amylase, free protease and free trypsin were determined in three batches of 
proteolysis-like material. For trypsin, comparative data using the pharmacopoeia method were 
generated. Prior to ultrasonic measurements, the free trypsin activity of the working standard 
was determined as 1298 U/ g using the offi cial FIP standard (n = 5, CV = 3.1 %).
Higher values of free protease (Figure 27) and free trypsin (Figure 28) activity were observed 
for batch 1 compared to batches 2 - 4, whereas amylase activity was constant for all batches 
(Figure 26). Regarding trypsin, results of the titration method showed the same tendencies as 
the ultrasonic results. Mostly, lower activities were found using the ultrasonic measurement 
(average percentage deviation of 9 % of ultrasonic results in relation to results based on 
pharmacopoeia). Details are shown in Appendix A XX. 
Proteolysis material3.4.2.2 
Proteolysis material I
Relative amylase, free protease and free trypsin activities were determined in three batches of 
proteolysis material (laboratory scale) using URT. Depending on the batch, amylase activities 
ranged from 5,000 to 11,000 FIP/ Ph.Eur.-u/ g (Figure 29, Appendix A XXI). 
Relative free trypsin activities (FIP/ Ph.Eur.-u/ g) in three batches of proteolysis-Figure 28. 
like material (A, B, C) with four samples each were determined using URT method (dotted) 
and Ph.Eur. method (striped). For ultrasonic measurements, the frozen samples were unfrozen 
and separated from  fi bers before measurement. 4 μl of Free Trypsin solution (URT/ HR-US) 
(sample/ working standard) were injected into the measurement cell, fi lled with BAEE solution 
(URT/ HR-US). The measurements were carried out at 37°C.Shown are means +/- stdev (n = 2 
(trypsin solutions with 1 replicate each) to improve clarity of the fi gure. Fresh samples were 
used for the Ph.Eur. method.
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Relative amylase activities (FIP/ Ph.Eur.-u/g) in three batches of Proteolysis Figure 29. 
material I were determined over proteolysis time using URT method. Black/ white symboles 
indicate results obtained by measuring fresh samples of two batches (stored on ice for transport), 
grey symboles indicate results obtained by measuring frozen samples of a third batch determined 
two days after sampling. The samples were separated from  fi bers before measurement. 4 μl 
of Amylase solution (URT/ HR-US) (sample or working standard) were injected into the 
measurement cell, fi lled with 6 % starch solution (URT/ HR-US). The measurements were 
carried out at 37°C. In order to improve clarity of the fi gure, means +/- stdev (n = 2 (amylase 
solutions with 1 replicate each) are shown.
Relative free protease activities (FIP/ Ph.Eur.-u/g) in three batches of Proteolysis Figure 30. 
material I were determined over proteolysis time using URT method. Black/ white symboles 
indicate results obtained by measuring fresh samples (stored on ice for transport) of two batches, 
grey symboles indicate results obtained by measuring frozen samples of a third batch determined 
two days after sampling. The samples were separated from  fi bers before measurement. 4 μl 
of Free protease solution (URT/ HR-US) (sample or working standard) were injected into the 
measurement cell, fi lled with Casein 1.25 % solution (URT/ HR-US). The measurements were 
carried out at 37°C. In order to improve clarity of the fi gure, means +/- stdev (n = 2 (free 
protease solutions with 1 replicate each) are shown. [Due to instrumental disturbances the 
sample of the black data series was not analyzed for time 5h].
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Within a batch, constant amylase activities were observed during hydrolysis. Free protease 
activities increased over hydrolysis time. Free protease activities observed ranged between 
100 and 400 Ph.Eur.-u/ mg (Figure 30, Appendix A XXI). For the determination of free 
trypsin activity, 8 μl of the sample were directly injected into the measurement cell, fi lled with 
BAEE solution (without previous dilution). Trypsin activity increased over hydrolysis time 
(Figure 31).
Proteolysis material II
Additional proteolysis samples were determined after optimizing the amylase and trypsin 
assays concerning fat infl uences on the measurement results using Phosphate buffer 0.2 M 
(URT/ HR-US)  for the preparation of Amylase solution (URT/ HR-US) and Hydrochloric 
acid 1 mM for the preparation of Free trypsin solution (URT/ HR-US). Previously, free trypsin 
activity of the working standard was determined as 1387 U/ g (n = 3, CV = 1.0 %) using the 
offi cial FIP standard and Ph.Eur. method. Furthermore, the solid content was determined for the 
whole hydrolysis time according to 2.2.4.
Relative amylase and lipase activities were stable (Figure 32,  Figure 35), whereas relative free 
protease (Figure 33) and free trypsin (Figure 36) activities increased in the course of proteolysis, 
and total protease activity (Figure 34) decreased over time (Appendix A XXII). The enzyme 
activities showed no dependencies on the solid content (Table 26). 
Relative free trypsin activities (FIP/ Ph.Eur.-u/g) in two batches of Proteolysis Figure 31. 
material I were determined over proteolysis time using URT method. The frozen samples 
were unfrozen and separated from  fi bers before measurement. 8 μl of the samples and Trypsin 
solution (URT/ HR-US) (FIP reference standard 42.4 u/ mg) were injected into the measurement 
cell, fi lled with BAEE solution (URT/ HR-US). The measurements were carried out at 37°C. In 
order to improve clarity of the fi gure, means +/- stdev (n = 2 (trypsin solutions with 1 replicate 
each) are shown.
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Relative amylase activities (FIP/ Ph.Eur.-u/g) in three batches of Proteolysis material II (batch a: rhomb, batch b: Figure 32. 
square, batch c: triangle) were determined using URT method. One batch (grey symboles) was analyzed by measuring fresh 
samples (stored on ice for transport) and two batches  (black symboles) were analyzed by measuring unfrozen samples. Fibers 
were not separated. The measurement cell was fi lled with a pre-mix of 1800 μl Starch solution 3 % (URT/ HR-US) and 40 μl 
of Amylase solution (prepared in Phophate buffer solution 0.2 M). The measurements were carried out at 37°C. In order to 
improve clarity of the fi gure, means +/- stdev (n = 2 (amylase solutions with 2 replicates each) are shown.
 
Relative free protease activities (FIP/ Ph.Eur.-u/g) in three batches of Proteolysis material II (batch a: rhomb, Figure 33. 
batch b: square, batch c: triangle) were determined using URT method. One batch (grey symboles) was analyzed by measuring 
fresh samples (stored on ice for transport) and two batches  (black symboles) were analyzed by measuring unfrozen samples. 
Fibers were not separated. The measurement cell was fi lled with a pre-mix of 1800 μl Casein solution 1.25 % (URT/ HR-US) 
and 40 μl of Free protease solution (URT/ HR-US). The measurements were carried out at 37°C. In order to improve clarity of 
the fi gure, means +/- stdev (n = 2 (free protease solutions with 2 replicates each) are shown.
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Relative total protease activities (FIP/ Ph.Eur.-u/g) in three batches of Proteolysis material II (batch a: rhomb, Figure 34. 
batch b: square, batch c: triangle) were determined using URT method. One batch (grey symboles) was analyzed by measuring 
fresh samples (stored on ice for transport) and two batches  (black symboles) were analyzed by measuring unfrozen samples. 
Fibers were not separated. The measurement cell was fi lled with a pre-mix of 1800 μl Casein solution 1.25 % (URT/ HR-US) 
and 80 μl of activated Total protease solution (URT/ HR-US). Sample incubation was performed at 35 °C for 15 min. The 
ultrasonic measurements were carried out at 37°C. In order to improve clarity of the fi gure, means +/- stdev (n = 2 (total 
protease solutions with 2 replicates each) are shown.
Relative lipase activities (FIP/ Ph.Eur.-u/g) in three batches of Proteolysis material II (batch a: rhomb, batch b: Figure 35. 
square, batch c: triangle) were determined using URT method. One batch (grey symboles) was analyzed by measuring fresh 
samples (stored on ice for transport) and two batches  (black symboles) were analyzed by measuring unfrozen samples. Fibers 
were not separated. The measurement cell was fi lled with a pre-mix of 1800 μl Olive oil emulsion (URT/ HR-US) (fi nal) and 
33 μl of lipase solution (URT/ HR-US). The measurements were carried out at 37°C. In order to improve clarity of the fi gure, 
means +/- stdev (n = 2 (lipase solutions with 2 replicates each) are shown.
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Relative free trypsin activities (FIP/ Ph.Eur.-u/g) in three batches of Proteolysis material II (batch a: rhomb, batch b: Figure 36. 
square, batch c: triangle) were determined using URT method. One batch (grey symboles) was analyzed by measuring fresh 
samples (stored on ice for transport) and two batches  (black symboles) were analyzed by measuring unfrozen samples. Fibers 
were not separated. The measurement cell was fi lled with a pre-mix of 1800 μl BAEE solution (URT/ HR-US) and 80 μl of 
Trypsin solution (prepared in HCl 1 mM). The measurements were carried out at 37°C. The samples were also analyzed by 
using Pharmacopoeia method (dashed): Titrations were carried out at pH 8 and 25°C using 0.02 M NaOH as titration solution. 
In order to improve clarity of the fi gure, means +/- stdev (n = 2 (free trypsin solutions with 2 replicates each) are shown.
Table 26.  Solid contents of proteolysis material (n=2)
Concerning amylase, protease and lipase, reference values with the pharmacopoeia methods 
were determined several weeks later for selected frozen samples (proteolysis time of 3 h and 
7 h) (Table 27). Lower amylase activities were observed, with  up to 50 % percentage deviations 
of URT method results in relation to Ph.Eur. method results. Lipase activities were comparable 
to the results obtained with URT method. Based on measurements according to Ph.Eur., free 
protease activity decreased during hydrolysis whereas ultrasonic measurements showed an 
increase of free protease activity over time. Concerning total protease activity, both methods 
led to results with same tendencies, i.e. a decrease of total protease activity during hydrolysis 
was observed. However, the extent of decrease was different depending on the method used 
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(Table 27). Free trypsin activity was determined in  all samples using both methods. Although 
the same tendencies were observed, up to 60 % percentage deviations of the URT method in 
relation to the Ph.Eur. method were found (Figure 36).
Amylase, lipase, free and total protease activity were determined in selected samples of Proteolysis material II Table 27. 
(Proteolysis 3 h, 7 h) using Ph.Eur. methods (n = 2 (1 replicate each)). Frozen samples were used for measurements which were 
carried out several weeks after ultrasonic measurements. Percentage deviations D (%) of URT in relation to Ph.Eur. are shown 
in brackets.
Active Pharmaceutical Ingredient3.4.3 
Relative activities of amylase, protease and lipase were determined in several API samples 
doing calibration by using one-point and three-point method (2.2.1.7). The results calculated 
using three-point calibration showed lower percentage deviations of URT in relation to Ph.Eur. 
(= 100 %) as compared to the results calculated using one-point calibration. Furthermore, one-
point calibration often resulted in lower values determined by ultrasonic methods compared to 
the pharmacopoeia methods, whereas no tendency was observed for the three-point calibration 
(Table 28, Table 29, Appendix A XXIII). Concerning amylase activity, a high percentage 
deviation of URT in relation to Ph.Eur. was observed for Sample a. The value was confi rmed 
measuring the sample again.
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Amylase, Lipase and free and total Protease activity were determined in API using ultrasonic methods (URT  or Table 28. 
HR-US) and three-point calibration. Ultrasonic measurements concerning lipase and free protease were carried out by using 
the cell-injection method, whereas the pre-mix method was performed concerning the determination of amylase and total 
protease activities (n = 2 (2 replicates each)). The measurements were carried out at 37°C. The samples were also analyzed 
by using Ph.Eur. methods (n = 2 (2 replicates each)). Percentage deviations D (%) of URT in relation to Ph.Eur. are shown in 
parentheses.
Amylase, Lipase, free and total Protease activity were determined in API using ultrasonic methods (URT  or Table 29. 
HR-US) and one-point calibration. Ultrasonic measurements concerning lipase and free protease were carried out by using 
the cell-injection method, whereas the pre-mix method was performed concerning the determination of amylase and total 
protease activities (n = 2 (2 replicates each)). The measurements were carried out at 37°C. The samples were also analyzed 
by using Ph.Eur. methods (n = 2 (2 replicates each)). Percentage deviations D (%) of URT in relation to Ph.Eur. are shown in 
parentheses.
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Drug product3.4.4 
Drug product II3.4.4.1 
An inter-laboratory comparison was performed between fi ve laboratories adopting the USP 
method for determination of relative amylase, free protease and lipase activities in Drug 
product II. For comparison, ultrasonic measurements of amylase and free protease activity were 
done in one laboratory. For practical reasons, lipase activity measurements using ultrasonic 
method could not be included at the same time. They were accomplished later in one laboratory, 
independently of the inter-laboratory comparison. Since URT measurements were carried out 
by one operator, only activities determined by the fi rst operator within the inter-laboratory trial 
are shown concerning the determination of amylase and free protease activity. The results were 
highly comparable with the USP methods (Table 30 - 32). 
Amylase activity in Drug product II was determined within an inter-laboratory trial according to USP. For comparison Table 30. 
with URT method,  only activities obtained by the fi rst operator were included. For URT method, Starch and Dextrin 10 were 
used as substrate. 4 μl of Amylase solution (URT/ HR-US) were injected into the measurement cell, fi lled with Starch solution 
6 % (URT/ HR-US) or Dextrin 10 solution 10 %. The measurements were carried out at 37°C. Shown are average, standard 
deviation (stdev) and coeffi cient of variation (CV) (n = 6, 2 replicates each for USP and URT method).
Free protease activity in Drug product II was determined within a inter-laboratory trial according to USP. For Table 31. 
comparison with URT method,  only activities obtained by the fi rst operator were included. For URT method, 4 μl of Free 
protease solution (URT/ HR-US) were injected into the measurement cell, fi lled with Casein solution 1.25 % (URT/ HR-US). 
The measurements were carried out at 37°C. Shown are average, standard deviation (stdev) and coeffi cient of variation (CV) 
(n = 6, 2 replicates each for USP and URT method).
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Drug product III - VIII3.4.4.2 
Relative enzyme activities were determined in additional pancreas powder-containing products 
(Products III - VIII) with ultrasonic methods and according to Ph.Eur. (Appendix A XXIV). 
The results using URT, HR-US or FTS were highly comparable to the pharmacopoeia methods 
(median of percentage deviation D: 2.3 % (amylase), 1.6 - 1.8 % (lipase), 2.9 - 3.1 % (free 
protease), 2.7 % (total protease); Table 33 - 36), except for sample VII concerning amylase 
activity.  In order to determine total protease activity by HR-US FTS, a 2.5 % (w/v) enterokinase 
solution was used for ultrasonic measurements. They were repeated introducing 1.65 % 
enterokinase solution (URT), based on feasibility studies. Higher percentage deviations of URT 
results in relation to Ph.Eur. method results were observed in comparison to the initial FTS 
experiment using the 2.5 % (w/v) enterokinase solution (Table 36). 
Relative amylase activities in Drug product III - VIII were determined according to Ph.Eur. and HR-US/ FTS Table 33. 
method. For HR-US measurement, 20 μl of Amylase solution (URT/ HR-US) were injected into the measurement cell fi lled 
with 1050 μl of Starch solution 6 % (URT/ HR-US). For FTS measurement, the fl ow-through cell was fi lled with a pre-mix 
of 300 μl of Amylase solution (URT/ HR-US) and 15.75 μl of Starch solution 3 % (URT/ HR-US). The measurements were 
carried out at 37°C (n = 2 (2 replicates each)). D (%) indicates the percentage deviation of URT results in relation to results 
obtained with Ph.Eur. method.
Lipase activity in Drug Table 32. 
product II was determined according to 
USP and URT method. For ultrasonic 
measurements, a premix of  33 μl of 
Lipase solution (URT/ HR-US) and 
1800 μl of fi nal olive oil emulsion 
(URT/ HR-US) were injected into the 
measurement cell. The measurements 
were carried out at 37°C. Shown are 
average, standard deviation (stdev) and 
coeffi cient of variation (CV) (n = 6, 
2 replicates each for USP and URT 
method).
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Relative lipase activities in Drug product III - VIII were determined according to Ph.Eur. and HR-US method. For Table 34. 
HR-US measurement, 20 μl of Lipase solution (URT/ HR-US) were injected into the measurement cell fi lled with 1050 μl of 
fi nal olive oil emulsion (URT/ HR-US). The measurements were carried out at 37°C (n = 2 (2 replicates each)). D (%) indicates 
the percentage deviation of URT results in relation to results obtained with Ph.Eur. method. FTS measurements were not 
performed. 
Table 35. Relative free protease activities in Drug product III - VIII were determined according to Ph.Eur. and HR-US/ FTS 
method. For HR-US measurement, 20 μl of Free protease solution (URT/ HR-US) were injected into the measurement cell 
fi lled with 1050 μl of Casein solution 1.25 % (URT/ HR-US). For FTS measurement, the fl ow-through cell was fi lled with a 
pre-mix of 300 μl of Free protease solution (URT/ HR-US) and 15.75 μl of Casein solution 1.25 % (URT/ HR-US). The 
measurements were carried out at 37°C (n = 2 (2 replicates each)). D (%) indicates the percentage deviation of URT results in 
relation to results obtained with Ph.Eur. method.
Relative total protease activities in Drug product III - VIII were determined according to Ph.Eur. and URT/ Table 36. 
HR-US FTS method. For FTS measurement, the fl ow-through cell was fi lled with a pre-mix of 600 μl of Total protease solution 
(URT/ HR-US) activated with Enterokinase solution 2.5 % and 15.75 ml of Casein solution 1.25 % (URT/ HR-US). For HR-US 
measurement, the fl ow-through cell was fi lled with a pre-mix of 80 μl of Total protease solution (URT/ HR-US) activated with 
Enterokinase solution 1.65 % and 1800 μl of Casein solution 1.25 % (URT/ HR-US). The measurements were carried out at 
37°C (n = 2 (2 replicates each)). D (%) indicates the percentage deviation of URT results in relation to results obtained with 
Ph.Eur. method. 
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DISCUSSION4. 
Ultrasonic velocity measurements are applicable to determine relative enzyme 4.1 
activities using the pharmacopoeia declaration of the reference standard
Absolute enzyme activity describes the converted amount of substrate per time and is given in 
μmol/ min. This enzyme activity strongly depends on the assay design and condition. Therefore, 
pharmacopoeias defi ne Ph.Eur.-units and USP-units in relation to the conditions which are 
described in the corresponding monographs. In addition, the pharmacopoeias stipulate the use 
of offi cial USP or FIP standards with defi ned activities (given in FIP/ Ph.Eur.-u/ g or USP-u/ g) 
to calculate relative enzyme activities. While absolute enzyme activities can vary depending on 
substrate batch, operator or laboratory, the determination of relative activities eliminates intra- 
and inter-laboratory variations making measurements comparable. After developing and 
validating ultrasonic methods to determine pancreatic enzyme activity in the present thesis, 
they were compared to the pharmacopoeia methods by measuring pancreas powder-containing 
samples and reference standard and calculating relative enzyme activities in the samples with 
the declared activity of the reference standard based on pharmacopoeia method (Figure 37).
In order to determine absolute enzyme activities with ultrasonic methods, a correlation 
between substrate conversion and ultrasonic velocity would be required. According to 
Resa & Buckin (2011), calculations of the specifi c concentration increments of ultrasonic velocity 
ai  of substrate, product and solvent correlate ultrasonic signals and enzyme activity (1.4.4). 
The reported correlation model was applicable to the degradation of cellobiose to two glucose 
Evaluation of ultrasonic Figure 37. 
measurements. Relative pancreatic 
enzyme activity according to 
pharmacopoeia is calculated by relating 
the sample signal to the signal and the 
declaration (pharmacopoeia) of the 
reference standard. The pharmacopoeia 
declaration of the reference standard 
was also used to evaluate ultrasonic 
measurements after the ultrasonic 
velocity change of sample and reference 
standard had been monitored.
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molecules by β-glucosidase (Resa & Buckin, 2011). For this simple hydrolysis reaction, 
ultrasonic velocity was infl uenced only by one substrate (cellobiose), one product (glucose) and 
the solvent (water). In the case of complex substrates according to pharmacopoeias (starch, olive 
oil and casein), the stoichiometric relations cannot be comprehended since an endless number of 
intermediate substrates and products are conceivable. The unspecifi c ultrasonic signal of these 
enzyme reactions are a complex interplay of different concurrent operations such as substrate 
degradation to various intermediates, generation of diverse products or matrix effects of the 
sample. Thus, ultrasonic amylase, lipase and protease methods developed in the present thesis 
allow only the determination of relative enzyme activities using a reference standard. In contrast, 
the correlation model according to Resa & Buckin (2011) may be applicable for the degradation 
of trypsin as BAEE is simply cleaved to ethanol and benzoylarginine (Sacks et al., 1971). 
However, the infl uence of the sample matrix on ultrasonic measurement results could be relevant, 
especially for the ultrasonic trypsin method as high sample concentrations are required. 
Even though ultrasonic and pharmacopoeia methods are not identical, the declaration of the 
reference standard according to pharmacopoeias was used in the context of ultrasonic methods 
(see 4.2). Thus, in spite of keeping the substrates the same, the conversion of results obtained 
with the ultrasonic methods to pharmacopoeia units may be questioned. However, this problem 
is not of scientifi cal nature, but a formal or legal problem which could be solved by defi nition 
of a new unit (e.g. URT-unit) and the remark that one pharmacopoeia unit complies with one 
unit newly introduced.
Do the substrates and their preparations conform with the demands of  the 4.2 
pharmacopoeia?
Concerning pancreas powder, several monographs exist in the pharmacopoeias. Ph.Eur. and USP 
give different defi nitions of one enzyme activity unit (USP-unit, Ph.Eur.-unit) and variations 
in the analysis methods for the three categories of enzymes (Creon International Scientifi c 
Brochure, 2007). Thus, the enzyme activity units are closely related to the analysis method and 
the conditions described in the pharmacopoeia monographs. If all conditions which infl uence 
pancreatic enzyme activities, such as substrate preparations, ionic environment, concentration 
ratios between substrate and enzyme, analysis time, temperature or product removal had been 
kept as in the pharmacopoeia monographs, identical enzyme activities would have been expected 
in the ultrasonic measurement cell. However, the use of ultrasonic spectroscopy required certain 
changes to the methods to be introduced which led to deviations from the pharmacopoeia 
conditions. Table 37 shows the fi nal ultrasonic methods in comparison to the pharmacopoeia 
methods regarding substrate preparation, enzyme solvent, pH, temperature and additional 
reagents. For all enzymes, the pharmacopoeia substrate was kept, and only the preparation was 
optimized in case this was necessary to obtain reliable results with ultrasonic methods. For 
instance, higher concentrations of enzyme solutions compared to pharmacopoeias had to be 
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applied in order to initiate a signifi cant change of ultrasonic velocity during enzyme reaction. 
This requirement was inline with one aim of the present thesis which is to analyze in-process 
material without sample preparation. The addition of co-factors also supported an increase in 
ultrasonic signals by activating the enzymatic reaction. The limited solubility of substrates 
and instability of substrate preparations did not allow the pharmacopoeia concentration ratios 
between substrate and enzyme to be maintained involving supposably the loss of substrate 
saturation which had to be considered within feasibility tests (e.g. linearity). As another 
instance, pharmacopoeia methods apply pH STAT conditions for determination of lipase or 
trypsin activity allowing a continuous removal of the reaction products leading to an increased 
enzyme activity. pH STAT conditions cannot be realized for ultrasonic measurements.
Concerning protease, the 1.25 % casein solution was adopted without modifi cation, but the 
substrate-enzyme-ratio was reduced but linearity was ensured (Table 22). Considering the 
increased enzyme concentration, conditions of zymogen activation were adjusted (Table 25). 
Robustness measurements concerning activation showed no infl uences of varied activation 
times (5 to 20 min) and diverse temperatures (25 to 45°C) on protease activity.
Concerning amylase, the starch concentration and the solvent were optimized. In pre-tests using 
the starch solution as described in the pharmacopoeias (1 %), a dependency of amylase activity 
on the starch concentration was observed. The activity initially increased with ascending 
temperature but reached a plateau at 30°C (Appendix A XI), although the activity optimum 
is at approx. 40°C (Ruyssen & Lauwers, 1978). Both experiments indicated that substrate 
saturation was not achieved. Consequently, higher starch concentrations were used (Table 37). 
Dependencies of amylase activity on the pH or the chloride content in the sample were eliminated 
by preparing the substrate solution in sodium chloride-containing phosphate buffer. In addition, 
the temperature was increased as compared to the pharmacopoeia method. A temperature of 
37 °C was chosen for all enzymes and proved to be more time effi cient, because chilling the 
system is time-consuming. Although amylase activity is temperature-dependent, the calibration 
with working standard eliminates this infl uence (relative determination). Taken together, the 
ultrasonic amylase assay can be considered to resemble the pharmacopoeia method closely.
A radical change has been introduced to the lipase substrate preparation. The substrate olive oil, 
the bile salts as well as their ratio were kept, but the substrate-enzyme-ratio was reduced. Gum 
acacia had to be replaced by Triton X 100 (chapter 3.1). Calcium is an ion naturally associated 
with gum acacia that infl uences lipase activity. It was added to the substrate emulsion as calcium 
chloride. Differences in droplet size and different interface areas, respectively, infl uenced the 
lipase activity considerably, but the calibration with working standard eliminates this infl uence 
(relative determination). The concentration of 60 mM calcium was a compromise between lack 
of infl uence on lipase activity (Figure 17) and stability of the emulsion. TRIS (300 mM) was 
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introduced in higher concentrations than required for lipase activity saturation (see 3.1.2) to 
ensure a stable pH during lipase reaction. This decision was based on pH measurements over 
time during lipase reaction (Appendix IV). Furthermore, the pH was lowered from pH 9.0 
(according to Ph.Eur.) to pH 7.2 for ultrasonic measurements. This led to more stable baselines 
during ultrasonic measurements which was attributed to a more stable emulsion. In emulsions 
with pH 8 to 9, creaming effects were observed, while this was not the case for emulsions with 
a pH of approx. 7. This effect was only found after long storage times. Via particle size or 
particle size distribution measurements, an improved stability could not be verifi ed. The use of 
an emulsion with pH 7.2 also led to an improved repeatability for the ultrasonic determination 
of lipase activity. Nevertheless, the pH optimum of lipase was  at pH 8.4 under these conditions 
(Figure 24). As a working standard was used for relative determination, a pH of 7.2 was 
acceptable and ensured reliable measurements. Consequently, results observed with Ph.Eur. 
and ultrasonic methods are comparable as shown for the determination of liquid IPC samples 
(Figure 35) , API (Tables 28 + 29) and drug product (Tables 32 + 34). However, choosing the 
suboptimal pH led to lower sensitivity as compared to pH 9 according to pharmacopoeias, 
which is also indicated by a low slope of the calibration curve observed within linearity tests 
(Figure 22). Taken together, the analysis of  diverse samples have shown, that results obtained 
with pharmacopoeia and ultrasonic methods are comparable due to calibration with reference 
standard (relative determination).
Comparison of  ultrasonic methods and pharmacopoeia methods [MF = Microfl uidizer, BAEE = N-Benzoyl-L-Table 37. 
arginine ethyl ester hydrochloride, TRIS = Tris(hydroxymethyl) aminomethane, Mal = Maleic anhydride, TCA = Trichloroacetic 
acid].
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Special requirements of ultrasonic spectroscopy on substrate preparations 4.3 
led to the investigation of alternative excipients and substrates
The use of ultrasonic spectroscopy for the determination of pancreatic enzyme activities 
makes high demands on the substrate preparations as the technique is very sensitive to 
instabilities of  the preparations, especially of emulsions (1.4.5). Since lipases are enzymes 
that act on non-wate-soluble substrates in an aqueous environment, the substrate used for 
lipase determination has to be processed into an emulsion. To obtain oil-in-water emulsions, a 
range of surfactants can be used and processed together with the lipid and water phases with a 
number of different devices. In the present thesis the aim was to measure lipase activity under 
conditions as close as possible to the pharmacopoeia methods. Therefore, the emulsion initially 
used consisted of olive oil, TRIS buffer, bile salts and gum acacia. The gum acacia-containing 
emulsions prepared in a household blender (Ph.Eur., USP) emerged as inapplicable since 
baselines measured in the ultrasonic spectrometer were unstable. The adoption of a high-pressure 
homogenizer (Microfl uidizer®) led to smaller droplet sizes and tight droplet size distributions. 
But adding the Reagents mixture (Ph.Eur./ USP) after high-pressure homogenization of the 
Olive oil stock emulsion (Ph.Eur./ USP) led to an enlargement of particle size with increasing 
number of passages and pressure (Figures 11 + 12). The emulsions were “over-processed” 
due to high energy density, a phenomenon frequently discussed in the literature. This effect 
was eliminated by adding Reagents mixture (Ph.Eur./ USP) before homogenization where a 
reduction of droplet size was observed with increasing numbers of passages (Figure 13). But 
addition of the lipase co-factor calcium via calcium chloride again led to emulsion instabilities 
(Appendix A II). Jafari et al. (2007) also observed the phenomenon of “over-processing” 
expressed in re-coalescence during microfl uidization at pressures above 600 bar and more than 
two passages and suggested inter alia the use of suffi cient surfactant which stabilizes the new 
interfaces rapidly. Occupation of interfaces depends on diffusion. Polysaccharides and proteins 
diffuse very slowly due to their high molecular weights. They are slightly surface active, but 
affect the formation of the interfacial fi lm very slowly. Gum acacia needs three or four days to 
occupy the interfaces (Shotton & White, 1963). The elimination of “over-processing” by adding 
Reagents mixture (Ph.Eur./ USP) before homogenization can be attributed to glycholic acid, 
taurocholic acid and their derivates contained in bile salts which show emulsifying behavior 
due to their amphiphilic structure. In contrast to gum acacia, they occupy the interfaces quickly 
which leads to an optimized stabilization during processing. Furthermore, the addition of 
Reagents mixture (Ph.Eur./ USP) reduced the percentage of olive oil and the viscosity of the 
aqueous phase. Consequently, the turbulent fl ow within the chambers, which is essential for 
droplet degradation in Microfl uidizers® (Schubert, 2005), was supposably formed more easily 
than in the Olive oil stock emulsion (Ph.Eur./ USP) with higher viscosity. 
Although the baselines of these emulsions were stable, the lipase reaction curve did not follow 
a general enzyme reaction curve over time after adding the lipase solution (Figure 14). An 
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extreme decrease of ultrasonic velocity after approx. 18 minutes was observed, accompanied 
by a fast droplet growth. One reason for the emulsion breaking could be the degradation 
of the emulsifi er. Gum acacia is a complex polysaccharide which consists of a mixture of 
highly branched arabinogalactan heteropolymers and approx. 2 % proteins (Idris et al., 1998, 
Al-Assaf et al., 2005). Proteolytic measurements showed an increase in change of ultrasonic 
velocity of approx. 15 % in the gum acacia-containing casein solution as compared to pure 
casein solution (Figure 15) which indicate the degradation of the protein fraction in gum 
acacia. In the literature, the proteolytic hydrolysis of gum acacia is described as incomplete 
(Osman et al., 1993, Mahendran et al., 2008). Sabah El-Kheir et al. (2008) described the 
stabilization of gum acacia as follows: Preferentially, the protein-rich high molecular mass 
component adsorbs on the droplet surface. The hydrophobic polypeptide chains adsorb to the 
surface, whereas the carbohydrate blocks repulse each other (electrostatic and steric repulsion). 
Consequently, the degradation of the proteins by the pancreatic proteases is considered to lead 
to less adsorption of the gum acacia on the surface and therefore to low stabilization of the 
emulsion and increasing coalescence. Another reason for the deviating lipase reaction curve 
over time is seen in buffering the system. The emulsion (Ph.Eur., USP) is used in a pH STAT 
method according to pharmacopoeia methods. In order to keep the pH stable sodium hydroxyde 
is continuously added. Consequently, a high percentage of buffering components is not essential 
in the pharmacopoeia method (approx. 1 mM TRIS in fi nal emulsion), whereas during ultrasonic 
measurements released fatty acids lead to a permanent decrease of pH which can cause the 
breaking of the emulsion, unless suffi cient buffer capacity is present. The instability towards 
the addition of calcium chloride (Appendix A II) resulting in a decrease of pH might be also 
attributed to an insuffi cient buffering system. As calcium is contained in process samples it had 
to be included in the emulsion. The absence of calcium in the substrate emulsion would make 
the results dependent on the calcium content in the analyzed samples. Calcium also minimizes 
the lag phase at the beginning of the lipase reaction (Brown et al., 1977). Consequently, analysis 
times can be reduced in the presence of calcium, which is essential for the use of ultrasonic 
spectroscopy as PAT method.
Taken together, emulsion composition according to pharmacopoeias was not suitable for the 
ultrasonic determination of lipase activity. Gum acacia was shown to be unsuitable as emulsifi er 
since the protein content, which can interfere with pancreatic proteases, led to increased changes 
of ultrasonic velocity and supposably to emulsion destabilization. The deviating course of the 
reaction curve over time and the instability towards calcium chloride might be also eliminated 
by further optimization of the buffering system. 
As an alternative, the nonionic emulsifi er Triton X 100 was tested. Triton X 100 is an octylphenol 
ethoxlate that is commonly used as detergent, wetting agent or emulsifi er in oil-in-water emulsions 
due to an Hydrophilic-lipohilic balance (HLB) of 13.4. Owed to its non-denaturing properties, 
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it is often used as solubilizer for proteins. In contrast to the gum acacia-stabilized emulsions, 
measurements of lipase activity in Triton X 100-stabilized emulsions showed a regular course 
over time. In order to test quality and suitability of the emulsions to determine lipase activity via 
ultrasonic spectroscopy, several parameters were varied. Lipase activities as well as droplet sizes 
were determined for the prepared emulsions (3.1.2). Modal droplet sizes were only infl uenced 
at very low numbers of passages or emulsifi er concentrations. Dependencies of  lipase activity 
on droplet sizes were not observed. Varying the olive oil concentration, lipase activity showed 
the typical course described by Brown (1902) (Figure 16). Opposite effects measuring higher 
slopes at lower substrate concentrations were previously found for the gum acacia-containing 
emulsions (Figure 13). Furthermore, varying concentrations of calcium chloride (Figure 17) 
and TRIS (Appendix A III) did not cause destabilization of the emulsion, as the modal droplet 
size was unaffected. A plateau of lipase activity was observed above concentrations of 50 mM 
calcium chloride (Figure 17) and 40 mM TRIS (Appendix A III). Calcium chloride and TRIS 
had to be used at least at these concentrations to avoid infl uences of the sample matrix. 
Caused by its low molecular weight, Triton X 100 is likely to occupy the interfaces faster than 
the proteins contained in gum acacia. As Triton X 100 has only a small effect on the viscosity 
in comparison to gum acacia, the turbulent fl ow stream in the Microfl uidizer® was enhanced. 
Both effects apparently led to the elimination of the disadvantages of the gum acacia-containing 
emulsion. The addition of bile salts solution before high-pressure homogenization was no longer 
necessary saving energy costs due to lower volume and consequently lower processing times in 
the Microfl uidizer® (50 % time saving). 
Alternative substrates were considered, especially concerning the determination of amylase 
activity. In order to measure amylase activities in highly concentrated samples, an increase 
of starch concentration from 1 % (w/v) to higher concentrations was necessary for ultrasonic 
method. When starch concentration was increased, stability of substrate preparations decreased 
as indicated by growing turbidity and swelling. The solutions could not be used for more than 
24 h (Table 24).The instabilities were supposably boosted by the need to dissolve starch in 
phosphate buffer instead of water. According to pharmacopoeias, fresh starch solution prepared 
on the day of analysis has to be used, although preparation of the starch solution is very time-
consuming  and instabilities are generally observed only after several days. In order to measure 
amylase activities continuously within PAT, substrate stability over several days and a fast 
preparation would be preferable. 
As most dextrins are readily soluble in water in contrast to starch, several dextrins (5, 10, 20 % 
of reducing matters) were tested as alternative substrates. Dextrin 5 needed to be prepared 
following the preparation of soluble starch solution, whereas Dextrin 10 and 20 were readily 
soluble in Phosphate buffer (Ph.Eur./ USP) at room temperature. The solutions of Dextrin 10 
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and 20 were clear, the solution of Dextrin 5 showed a slight turbidity similar to starch solution.
Based on the solubility and the strength of the ultrasonic signal, Dextrin 10 is conceivable as 
alternative substrate (Figure 25). Differences in ultrasonic velocity occur when the hydration 
shells of the molecules change. Thus, major differences in ultrasonic velocity should be monitored 
during degradation of a substrate with high molecular weight to small single components. Thus, 
substrates with low molecular weight, e.g. p-nitrophenyl-maltotrioside or derivates (Wallenfels 
et al., 1980; Winn-Deen et al., 1988), seem rather inapplicable for ultrasonic measurements. 
Only for starch (Mörman et al., 1982), amylose (Ishikawa et al., 1990), γ-cyclodextrin (Kondo 
et al. (1989), Ishikawa et al., 1990) and dextrins (Hreczuk-Hirst et al., 2001), a rapid degradation 
by porcine pancreatic amylase via multi-chain or multiple-attack mechanism mainly to maltose 
is described in the literature. Thus, the choice of dextrins was basically right, but standard 
deviations were higher than those observed with starch solution (Table 30, Appendix A XIX). 
Furthermore, a dependency of amylase activity on the substrate concentration was found 
(Figure 25). An explanation for the higher variability compared to the use of starch might be the 
fact that the ‘p.a.’ grade, which is rarely available, was not introduced. Due to multiple attack 
mechanism, γ-cyclodextrin might be another alternative substrate. The reagent grade ‘p.a.’ is 
available, still γ-cyclodextrin is an expensive alternative to soluble starch.
Sample preparation was simplified compared to pharmacopoeia methods4.4 
Within PAT, measurements need to be simple and quick. Thus, the capability of ultrasonic 
spectroscopy to determine enzyme activity in real-time provides a basis for PAT. In contrast, 
the determination of amylase or protease activities according to pharmacopoeias in one sample 
requires approx. 40 min since long incubation times and several numbers of dilution steps 
are involved. The necessary times are reduced by determining several samples simultaneously 
as dead times (e.g. incubation) can be utilized. However, PAT samples need to be analyzed 
successively, so that interlacing of several steps is not possible. For lipase and trypsin activity 
measurements according to pharmacopoeia (titration methods), approx. 7 min per sample 
are needed. Comparable to ultrasonic methods, the required assay times do not change with 
increasing number of samples. In order to minimize analysis times for all enzyme classes, 
sample preparation should be quick and automatable. 
According to pharmacopoeias, the samples have to be grinded with sea sand and a few droplets 
of the sample solvent before the total volume of sample solvent is fi lled up in order to ensure 
complete moistening. This preparation step was omitted for ultrasonic application to avoid 
resonator damages and disturbances of the ultrasonic signal caused by the sand particles. Due 
to up to fourty-fold smaller sample volumes used for ultrasonic methods as compared to those 
used in pharmacopoeia methods, incomplete moistening was rarely observed. If dissolution 
is not  complete after 10 min, the extraction time can be extended based on feasibility tests 
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(3.2.4.4, Appendix A XV). As the grinding step is omitted in ultrasonic methods, an automatic 
sample dilution within PAT is easily conceivable.
Based on pharmacopoeias, extraction times of 15 min are necessary to prepare the solution of 
pancreas powder-containing product. Therefore, 10 to 15 min were also applied to ultrasonic 
methods (3.2.4.4). Analysis times were still reduced by using ultrasonic methods since only one 
sample solvent and one substrate solution is needed for the real-time-monitoring using ultrasonic 
spectroscopy, in contrast to Ph.Eur. methods which need a multiplicity of further reagents and 
steps (Table 37). However, substrate solutions must be degassed for HR-US measurements to 
avoid air-bubbles which can disturb ultrasonic measurements (4.12). For URT measurements 
degassing was not necessary to obtain realiable measurement results.
In order to obtain an adequate ultrasonic signal, the samples were diluted less than those analyzed 
with the pharmacopoeia methods. As BAEE is readily soluble, the injection of undiluted in-
process samples was possible for the determination of trypsin using a build-in system (URT) in 
combination with the cell injection method (Figure 31). Besides injecting the enzyme solution 
into the cell fi lled with substrate solution, cell fi lling can also be performed by using a pre-mix of 
substrate and enzyme solution such as used for FTS measurements. Since the substrate volume 
can indefi netly be extended, using the pre-mix method theoretically allows the injection of any 
sample concentration and therefore the injection of undiluted samples for all enzyme classes. 
However, the injection of undiluted samples should be considered critical. Compared to the 
ultrasonic determination of lipase, protease or amylase activities, the determination of trypsin 
activity showed more disturbances, particularly concerning the analysis of proteolysis II material 
(Figure 36). This fact is supposably caused by the higher sample concentration and the lower 
content of buffer in the enzyme solution leading to an intense infl uence of the sample matrix. 
Using the example of amylase, it was shown clearly to what extent the sample solvent (Phosphate 
buffer solution (URT/ HR-US) or Phosphate buffer solution 0.2 M (URT/ HR-US)) infl uences 
the ultrasonic measurement results (Table 18). 
Selectivity of ultrasonic methods is suitable for determination of enzyme 4.5 
activity of a single enzyme class in pancreas powder
Pancreas powder is a complex mixture of  several enzymes which are categorized in the 
three main enzyme classes lipases, amylases and proteases. During ultrasonic measurements, 
simultaneous reactions of the three enzyme classes cannot be distinguished. Thus, the use of 
specifi c substrates has to ensure that secondary reactions do not proceed. In chapter 1.5 the 
use of the terms specifi city and selectivity is explained. Tests of specifi city/ selectivity were 
indispensable to evaluate the feasibility of measuring changes of ultrasonic velocity for the 
determination of lipase, amylase or protease activities in pancreas powder. Initial specifi city 
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tests were done with systems to which
enzyme was not added, ▪
substrate was not added and ▪
substrate and enzyme were added (positive control). ▪
The fi rst case was tested to ensure that no effects of temperature, volume addition, substances 
contained in the sample solvent as well as the substrate solution itself disturb the ultrasonic 
velocity measurements. The second case assured that no secondary reaction, caused e.g. by 
another pancreatic enzyme (sample matrix), is simultaneously detected. For all enzymes, 
ultrasonic velocity signifi cantly changed only in the complete systems, but not in those that 
lacked substrate or enzyme (Figure 18, Appendix A V).
The signal strengths (change of ultrasonic velocity over time) of the negative controls were 
mostly far below 1 % of those of the positive controls. Besides the trypsin method, the lipase 
method showed the highest selectivity, supposably due to the fi ve-fold higher signal as compared 
to the other enzyme determinations. The high selectivity of the trypsin method is attributed to 
the stable and clear substrate solution of BAEE. For total protease, approx. 5 % of the ultrasonic 
signal observed for the positive control was monitored by adding the activation mixture without 
working standard to the casein solution. This can be explained by the simultaneous monitoring of 
enterokinase activity. Subtraction of a blank was shown to be suitable to eliminate the superposed 
enterokinase signals (Table 25). Since the Ph.Eur. method, which also detects enterokinase 
activity, does not apply its subtraction, analysis and subtraction of blanks were not included in 
the fi nal ultrasonic method to determine total protease activity. With the amylase method, about 
4 % of the ultrasonic signal observed for the positive control was monitored for the system that 
lacked enzyme. The uncertain stability of the highly concentrated starch solution might be one 
reason for this fact. Within FTS measurements, the 6 % (w/v) starch solution was obviously 
found to be instable (strong turbidity and fl occulation approx. two hours after preparation) since 
higher substrate volumes as compared to the build-in system methods were applied. Thus, the 
concentration was reduced to 3 % (w/v) for later measurements. 
To sum up, the initial tests demonstrated high selectivity of the ultrasonic methods for the 
determination of lipase, free protease and trypsin in pancreas powder, as proven for working 
standard (API). Slightly lower selectivity was observed for the other ultrasonic methods 
(amylase, total protease).
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Reliable determination of pancreatic enzyme activities in drug product 4.6 
and active pharmaceutical ingredient is demonstrated by comparison with 
pharmacopoeia methods
Feasibility tests were performed to fi nd infl uencing factors and sources of error during ultrasonic 
measurements. Based on these tests, methods for the determination of amylase, protease and 
lipase activity were defi ned. In order to evaluate the methods, determinations of pancreatic 
enzyme activities in API and drug product were performed using ultrasonic and pharmacopoeia 
methods (chapter 3.4). Working standard was used for calibration. Furthermore, these tests served 
to check the capability of the ultrasonic methods for release testing and stability control.
In order to compare the results obtained with ultrasonic and pharmacopoeia methods, deviations 
were calculated as percentage of URT results compared to pharmacopoeia results. Preponderately, 
the percentage deviations were between 0 and 4 % (Table 28 - 29, Table 33 - 36). For product VII, 
a high percentage deviation of 8.6 % was observed concerning amylase activity (Table 33), that 
can be attributed to an instable 6 % starch solution (sample was the last one determined on the 
analysis day). Although stability tests pointed at stability over 24 hours (Table 24), in this trial 
the starch solution had already shown slight turbidity 8 h after preparation. Therefore, a 3 % 
starch solution is recommended and the starch preparation needs to be checked for turbidity 
before each measurement. Compared to the determination of amylase and lipase (Table 28 - 29, 
Table 33 + 34), higher  percentage deviations were observed for the determination of free or 
total protease activity (Table 28 + 29, Table 35 + 36). A possible explanation might be the fact 
that the repeatability of the pharmacopoeia assays is relatively high, caused by the complicated 
sample preparation including several dilution steps and fi ltration. 
For all enzyme classes, higher activities were observed in most cases with the pharmacopoeia 
methods. This fact can be attributed to the time point of analysis, as determination according to 
pharmacopoeias had mostly been performed a long time before ultrasonic measurements. As an 
example, there was a delay of approx. one year for the determination of total protease activity 
in Product III-VII (Table 36).
In summary, a comparison between ultrasonic and pharmacopoeia results showed that both 
methods were comparable. The use of ultrasonic spectroscopy to determine enzyme activity in 
drug product is conceivable for PAT, but also for release testing or stability tests.
Is the selectivity of the ultrasonic methods sufficient for the determination of 4.7 
pancreatic enzyme activities in liquid in-process samples?
The high selectivity of ultrasonic methods for the determination of amylase, lipase, protease 
and trypsin activity in API has been demonstrated (4.3). Selectivity refers to the extent to 
which a method can determine particular analytes in a complex mixture without interference 
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from other components (CITAC/ Eurachem, 2002). In order to evaluate possible interferences 
the composition of liquid in-process samples derived from the beginning of the API process 
needed to be considered. In order to obtain pancreas powder, proteolytic cell disruption 
releases pancreatic enzymes from the glands into an aqueous, buffered medium (1.2). Sodium, 
calcium and isopropanol are expected to be found in process samples from the beginning of 
the API process, as these components are added to the proteolysis make-up. Furthermore, fats 
and proteins introduced via glands have to be considered. Thus, the initial specifi city tests 
(Appendix A V) had to be extended concerning these matrix components. Their infl uence 
was tested by determining working standard solutions which contained diverse amounts of the 
substances expected (Table 14 -18).
The ultrasonic methods are robust towards sodium or calcium chloride in the sample matrix, as 
measurements of ultrasonic velocity change over time were independent from varied content 
of both salts in the sample solvent (3.2.1). However, when high concentrations of calcium are 
present during ultrasonic determination of lipase activity two disadvantages arise. An increased 
ionic strength often leads to reduced emulsion stabilities (reduced zeta potential). While an 
adequate stability of the emulsion was obtained using 60 mM CaCl2 (2.1.3.2), the precipitation 
of calcium soaps led to intractable deposits in the measurement cells reducing the amplitude 
of the resonance peaks. Removal of the deposits was time-consuming but possible by gentle 
rubbing with cotton buds and rinsing with surfactant and water. Cleaning of the FTS was more 
problematic as the mechanical step was not applicable. Nevertheless, 60 mM calcium had to 
be added to the system to reduce analysis times. The ultrasonic methods are also very robust 
towards isopropanol and proteins (model casein) in the sample solvent, except for the trypsin 
method in the presence of isopropanol. At this, the tests showed a slight increase of initial slopes 
accompanied by high CVs of up to 17 % at isopropanol concentrations above 16  % (w/w). 
This fact can be one reason for the unreliable results obtained for some proteolysis samples 
(Proteolysis II), discussed elsewhere.
In contrast, the presence of fats (model olive oil) led to several disturbances of ultrasonic 
measurement requiring several additional tests (Table 18). No negative infl uence of fat in the 
sample matrix was observed for lipase. This means, additional, optionally non-emulsifi ed, olive 
oil had no infl uence on the emulsion stability (Table 18). 
Concerning the determination of free protease, a slight increase of ultrasonic velocity change 
over time was obtained, which was signifi cant for concentrations higher than 5 % (v/v) olive 
oil in the solvent (Table 18). Thus, the reaction of lipases was simultaneously detected, as the 
olive oil serves as substrate for lipases. Casein used as protease substrate supposably acted as 
emulsifi er and provided the olive oil in emulsifi ed form to the lipase. However, the effect was 
small and critical for high fat concentrations that are only expected when injecting a sample 
from an early process step straightly without previous dilution in Borate buffer (URT/ HR-US).
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As opposed to the free protease method, the olive oil did not disturb the ultrasonic determination 
of total protease activity (Table 18). This can be explained as follows: 
The dilution of the sample with enterokinase solution minimized the total fat content in  ▪
the sample cell. 
Lipolysis had already proceeded during activation time (35 °C, 15 min) previously to  ▪
ultrasonic measurement.
The emulsifi cation of olive oil in Calcium chloride solution (URT/ HR-US) was inadequate, as 
indicated by slight turbidity, creaming effects and oil agglutinations deposited at the mixer wall. 
In order to ensure better emulsifi cation of the olive oil for better availability of the substrate for 
lipolysis, the experiment was repeated with addition of Triton X 100. Again, no infl uence of 
fat on the protease activity was  found. Thus, the ultrasonic method to determine total protease 
activity is robust towards fat.
For trypsin, a high increase of ultrasonic veloctiy change over time was observed with increasing 
fat content due to simultaneous detection of lipase activity (Figure 20). This effect was eliminated 
using 1 mM hydrochloric acid as enzyme solvent without Triton X 100 (Table 18). However, 
with this solvent the enzyme solution merely showed slight turbidity, creaming effects were 
observed and there were oil agglutinations deposited at the mixer wall indicating incomplete 
emulsifi cation of the olive oil in the sample solvent. As process samples contain several 
emulsifying agents such as proteins, mono- or diglycerides, fats could be made available for 
lipolysis during trypsin determination. Consequently, an enzyme solvent which contains an 
emulsifi er such as Triton X 100, is a more appropriate model to simulate the in-process samples. 
Other enzyme solvents were tested as alternatives for the determination of trypsin activity. 
While calcium chloride showed similar effects as hydrochloric acid in the presence and absence 
of Triton X 100, the use of borate buffer and phosphate buffer without adding an emulsifi er 
resulted in an increase of initial slopes in the presence of olive oil (Figure 21). Concluded, 
ultrasonic velocity change increased when olive oil was available in emulsifi ed form. In the 
next step, blanks were obtained without BAEE. The blanks showed the same behavior as 
complete samples, i.e. the change of ultrasonic velocity increased with ascending olive oil 
content. Indeed, subtracting the blanks minimized the fat infl uence but did not eliminate it 
(Table 18). Therefore, monitoring the blank was not suffi cient to solve the problem. The clear 
effect of fat on the ultrasonic determination of trypsin activity can be another reason for the 
unreliable results obtained for some proteolysis samples (Proteolysis II) (Figure 36), discussed 
elsewhere.
In case of amylase, an opposed behavior towards olive oil was observed (Figure 19, 
Table 18). The initial slopes decreased with increasing olive oil content in the enzyme solvent. 
Consideration of blanks was not suitable since they showed an increase of intial slopes with 
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increasing olive oil content. Using 0.2 M phosphate buffer, which was also adopted to eliminate 
the protein effect, initial slopes remained constant when the olive oil content in the sample 
solvent was varied. As the emulsifi cation of olive oil in Phosphate buffer 0.2 M (URT/ HR-US) 
could not be accomplished, the independency of the ultrasonic measurements on the fat content 
was confi rmed after adding emulsifi er (Triton X 100) to the sample matrix. Thus, the amylase 
method using Phoshpate buffer 0.2 M (URT/ HR-US) is robust towards fat content in the sample 
matrix. Based on the results, straight application of in-process samples without further dilution 
is regarded as critical for amylase determination due to the dependency of emulsifi cation and 
ultrasonic velocity change on the sample solvent.
In summary, the selectivity of the methods seems to be suitable for the determination of amylase, 
protease and lipase activities in in-process material so that no effects of fats are expected. But 
ultrasonic determination of  trypsin activity is supposably not reliable yet in the presence of 
fat.
Is determination of pancreatic enzyme activity sufficiently reliable for in-4.8 
process samples?
Within feasibility tests, the infl uence of different components which are present in in-process 
samples of early API process steps was tested by adding these components to working standard 
solutions. While the fat infl uence was eliminated for the determination of amylase activity in 
the model sample by using a higher concentrated buffer as sample solvent, the determination of 
trypsin was not reliable in the presence of fat and isopropanol. In-process samples differ from 
model samples in texture and content of fi bers. Thus, the developed methods were used for 
determination of pancreatic enzyme activity in proteolysis and proteolysis-like material using 
working standard for calibration. In some cases, reference measurements with pharmacopoeia 
methods were obtained. While lipase determination reliably worked (Figure 35, Table 27), 
determinations of the other pancreatic enzymes differed according to sample material and used 
method. All enzyme activities showed a plausible course of enzyme activity during proteolysis 
but no direct dependency on the solid content. 
Using Phosphate buffer (URT/HR-US) as enzyme solvent for the ultrasonic determination of 
amylase activity, lower relative amylase activities of approx. 7,000 Ph.Eur.-u/ g were measured 
in the proteolysis-like material (Figure 26) as compared to proteolysis samples (Proteolysis I) 
with an average relative amylase activity of approx. 9,000 Ph.Eur.-u/ g (Figure 29). Due to the 
optimized conditions for proteases (trypsin) in the proteolysis-like material, lower amylase 
activities in the proteolysis-like material are plausible. Comparing the fi rst proteolysis experiment 
(Proteolysis I) with the second proteolysis experiment (Proteolysis II), one-tenth higher amylase 
activities (approx. 10,000 FIP/Ph.Eur.-u/g) were observed using the more concentrated buffer 
(Phosphate buffer 0.2 M (URT/ HR-US)) as sample solvent, measuring the samples without 
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previous separation of fi bers, using the Pre-mixing method and applying a 3-point-calibration 
(Figure 32). Furthermore, the CVs within one batch were reduced from averaged 7 % to 1.5 %. 
The variations within the three proteolysis batches were distinctly reduced in Proteolysis II. 
Robustness measurements of the feasibility studies concerning fat content proved a loss of 
40 % amylase activity at high olive oil contents. Thus, the difference of 10 % observed between 
the fi rst and second proteolysis experiment may be caused by the fat content of the in-process 
samples. Additionally, the variability of the porcine glands introduced may lead to differences in 
amylase activity during proteolysis. Reference measurements of selected Proteolysis II samples 
using the Ph.Eur. method showed approx. 20 % reduced activities compared to the ultrasonic 
method results (Table 27). The sample matrix might disturb the Ph.Eur. method. Another reason 
might be the time gap between both measurements, as the measurements according to Ph.Eur. 
were carried out one month later with frozen samples (defrosted before measurement).
As expected, free protease activity increased over time during proteolysis due to activation 
processes (Figure 33). Higher free protease activities of approx. 600 Ph.Eur.-u/ g were determined 
in the proteolysis-like material (Figure 27) as compared to proteolysis samples (Proteolyse I) 
with free protease activities of approx. 350 Ph.Eur.-u/ g (Figure 30). Higher activities in the 
proteolysis-like material are plausible, because activated trypsin is enhanced due to optimized 
conditions for proteases. Comparing the fi rst proteolysis experiment (Proteolysis I) with 
the second proteolysis experiment (Proteolysis II), comparable free protease activities were 
obtained (Figure 30, Figure 33). Implementation of the Pre-mixing method and applying a 
3-point-calibration led to improved CVs, reduced from averaged 4.5 % to 2.5 %. Using the 
Ph.Eur. method, unreliable results were obtained within reference measurements of selected 
Proteolysis II samples. Free protease activity decreased in the course of proteolysis (Table 27) 
indicating the limit of the Ph.Eur. method. Another reason might be the time gap between both 
measurements, since the measurements according to Ph.Eur. were performed one month later 
with frozen samples (defrosted before measurement). The decrease of total protease activity 
over time during proteolysis results from auto-digestion of the activated proteases (Figure 34). 
Reference values obtained with Ph.Eur. method showed same tendencies (Table 27). However, 
percentage deviations of ultrasonic method in relation to the pharmacopoeia method of up to 
20 % were observed, supposably caused by the time gap between ultrasonic and pharmacopoeia 
measurements. 
Trypsin activity increased over time during proteolysis due to activation (Figure 36). Higher 
trypsin activities up to 500 Ph.Eur.-u/ g were determined in the proteolysis-like material 
(Figure 28), since in proteolysis samples (Proteolyse II) free trypsin activities of 100 Ph.Eur.-u/ g 
were observed (Figure 36). Higher activities in the proteolysis-like material are plausible 
as activated trypsin is enhanced due to optimized conditions for proteases. A comparison of 
ultrasonic measurement results with those obtained with Ph.Eur. method showed differences 
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for proteolysis-like (Figure 28) and proteolysis II material (Figure 36). When proteolysis-
like material was analyzed, ultrasonic measurements gave similar results as the Ph.Eur. 
method. Merely lower activities were found using the ultrasonic method. Whereas the Ph.Eur. 
method was performed with freshly sampled material, frozen material was used for ultrasonic 
measurements carried out some weeks later. This fact might be the reason that the fi rst sample 
of each batch showed particularly high percentage deviations of ultrasonic method in relation 
to the pharmacopoeia method. This is supposably caused by the fast change of trypsin activity 
over time due to activation processes. Other percentage deviations ranged within 3 to 5 %. 
In contrast, high percentage deviations of about 30 % were obtained for free trypsin activity 
in proteolysis II material. Whereas the trypsin activities determined by Ph.Eur. method had a 
similar time course, high variations within the three batches and outliers (3 - 4 hours) were 
observed for ultrasonic measurements (Figure 36). This was not expected as proteolysis II 
material was dissolved in 1 mM HCl to reduce fat infl uences by lacking Triton X 100 from 
the sample solvent. Thus, an optimization of the determination of trypsin activity would have 
been expected from proteolysis-like to proteolysis II material. Determining trypsin activity 
of the working standard, ultrasonic and pharamcopoeia methods led to different activities of 
the working standard (URT: 1,296 u/ g, Ph.Eur.: 1,387 u/ g). In order to check this fact as 
reason for the high percentage deviations of ultrasonic method in relation to Ph.Eur. method, 
the trypsin activity based on Ph.Eur. was also used to calculate the relative trypsin activities of 
proteolysis II material. Only slightly improved percentage deviations were obtained. 
The ultrasonic method to determine trypsin activity differs from the other ultrasonic methods 
in sample dilution. Samples are only diluted approx. twofold, which leads to a higher infl uence 
of the sample matrix compared to other ultrasonic methods.  Therefore, more emulsifi ed fat and 
more isopropanol are present in the measurement cell infl uencing the ultrasonic measurement 
result. Disturbances were more intense for the proteolysis II material as compared to the 
proteolysis-like material. Using the Pre-mixing method was one difference between both 
determinations, but since analysis of working standard solutions was not conspicuous this 
difference does not seem to be the reason for the different behavior. Furthermore, Triton X 100 
was not introduced for proteolysis II material. In feasibility test, the lack of Triton X 100 led to 
minimized fat infl uences. Thus, the reasons caused the disturbances in measurement seem to 
be others:  First, fi bers were included, which supposably led to higher variations. For the other 
ultrasonic methods the fi bers were uncritical as samples were diluted strongly. Secondly, the 
different sample composition such as higher fat and isopropanol content in proteolysis material 
compared to proteolysis-like material, might have caused more disturbances.
In conclusion, for lipase, amylase and protease plausible results were obtained in proteolysis 
material. Nevertheless, the tests demonstrated the complex interplay between different matrix 
components. In part, this led to unreliable results with both the ultrasonic (trypsin) and the 
pharmacopoeia methods (amylase, protease). For the determination of trypsin, the disputable 
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measurement results confi rmed the feasibility tests. It was clearly shown that further research is 
needed concerning the ultrasonic trypsin method. 
The pre-mixing method leads to improved precisions4.9 
Precision is one important parameter to judge and ensure quality and reliability of analytical 
results. ICH (1994) distinguishes repeatability, intermediate precision and reproducibility (1.5). 
Repeatability and intermediate precision were determined for ultrasonic methods using working 
standard (API). Repeatability was found between 1 and 2 % for both build-in system devices 
(URT, HR-US) and all ultrasonic methods (Table 19). As a result, the repeatabilities were 
highly comparable with those of the pharmacopoeia methods. Except for lipase determination, 
best repeatability of less than 1 % was observed using the Flow-through System HR-US FTS 
(Table 19). As ultrasonic velocity depends on temperature, reasons for the improved precisions 
are supposably the permanently closed measurement cells and the pre-conditioning of the fl uids 
before reaching the cells (Figure 9). Concerning determination of amylase activtiy, the reduced 
starch concentration might have also infl uenced the result. A 6 % (w/v) starch solution was not 
suitable for FTS measurements since instabilities occured. These instabilities were supposably 
caused by the higher volume in the substrate reservoir bottle as compared to the volumes needed 
for HR-US measurements in the build-in system. Furthermore, the backfl ow into the bottle, 
i.e. alternately tempering to 37 °C and cooling down at room temperature, could have depressed 
the stability of the starch solution. While testing repeatability of the lipase method, a continuous 
decrease of activity over time was observed from the analysis of the fi rst to the analysis of the 
sixth working standard solution  accompanied by deposits of calcium soaps in the system. This 
effect might be the reason for the fact that the repeatability was not improved using the FTS 
compared to the use of the build-in system for lipase determination (Table 19). 
As a result from working with the FTS, the Pre-mixing method was also applied to the URT and 
HR-US spectrometer (build-in systems) (Table 19). The repeatability improved, supposably 
caused by the higher volume of enzyme solution which is pipetted with less variability as smaller 
volumes. Furthermore, mixing of substrate and enzyme solution in the sample cell often induces 
the generation of air bubbles which can initiate disturbances of ultrasonic measurements.
Concerning total protease activity, Born et al. (2009) observed repeatabilities of 5 % and higher 
using URT. Similar to the pharmacopoeia method (2.2.2.3), Born et al. performed several sample 
preparation steps (e.g. incubation of casein with enzyme, stopping the reaction with TCA and 
centrifugation). Afterwards, ultrasonic veloctiy in the supernatant was measured as difference 
to a blank (1.4.4). Since ultrasonic velocity in the samples was measured once after stopping 
the reaction, slight variations in e.g. the incubation time could have infl uenced the measurement 
result. In contrast, for the present thesis ultrasonic spectroscopy was used to monitor protease 
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activity in real-time. This led to improved precisions.
For intermediate precision measurements, no calibration with working standard was done but 
absolute ultrasonic velocity changes were used to calculate intermediate precisions. They  were 
improved using the pre-mixing method and range between 2 and 3 %. Having reached adequate 
intermediate precisions optionally makes calibration on each analysis day unnecessary. 
Tempering systems are sufficient, but influence analysis time4.10 
Linearity is another important parameter to judge  and ensure quality and reliability of analytical 
results. The linearity of an analytical procedure is its ability to obtain results which are directly 
proportional to the concentration or potency of the analyte (ICH Q2 (R1), 1994). Testing 
linearity of the ultrasonic methods, linearity was found in a broad range for all methods. The 
calibration lines were no lines through the origin (Figure 22). For the ultrasonic determination 
of API, one- and three-point calibration were tested (Table 28 + 29). In most cases, the one-
point calibration led to lower results as compared to the pharmacopoeia methods, whereas no 
tendency was observed for the results obtained using the three-point calibration. Furthermore, 
results calculated using the three-point calibration showed smaller percentage deviations of 
ultrasonic method in relation to pharmacopoeia method as compared to the results calculated 
after one-point calibration. Consequently, the performance of one-point calibration led to less 
accurate results than using three-point calibration.
In order to obtain accurate results by one-point calibration, equal changes of ultrasonic velocity 
over time for the analysis of working standard (calibration) and sample are required. In the 
case of non-homogeneous samples, this demand is  diffi cult to meet. In contrast, three-point 
calibration allows a broader range of enzyme solution concentration (within the linear range) 
and leads to more reliable results when the change of ultrasonic velocity (m/s²) of the sample 
over time is not identical to that of the reference standard. 
Methods are robust towards small temperature variations4.11 
Given its relation to density, ultrasonic velocity strongly depends on temperature (1.4.3). 
Coupland (2004) dealed with the inadequate temperature control as a common problem of 
low-intensity ultrasonic devices, which can be excluded by holding a reference cell in close 
thermal proximity to the sample cell. Thus, in order to ensure no infl uence of small temperature 
changes the enzyme activity measurements were always performed by using one cell fi lled 
only with substrate and one cell fi lled with the substrate-enzyme-mix. When enzyme solution 
is added to the sample cell, temperature in the sample cell decreases faster than in the reference 
cell as the sample cell has been opened and ice-cold enzyme solution has been injected into the 
cell. After closing the cells, the difference between both cells is adjusted within a defi ned time 
period, which is characterized by a non-linear course of ultrasonic velocity change. Afterwards, 
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the temperature in both cells increases to the set temperature while a linear course of ultrasonic 
velocity change is observed. In this latter stage, temperatures below 36.8 °C have not been 
observed. Small temperature differences tested in the range from 36.8 °C to 37.2 °C showed no 
infl uence on the enzyme activities (2.2.4.1, Appendix A XI) allowing measurements to start 
immediately after temperature adjustment of the sample cell to that of the reference cell. The 
time which was necessary for adjustment was determined as 40 sec (URT), 200 sec (HR-US) and 
100 sec (FTS), respectively, as proven within specifi city tests when no enzyme was present. 
Short analysis times are essential for the use of analytical methods within PAT. Therefore, the 
pharmacopoeia methods are not applicable as PAT method (4.4). In contrast to pharmacopoeias, 
ultrasonic methods are time-saving as they monitor the enzyme reaction in real-time and need 
only few reagents. 
Due to another tempering system and smaller cell volumes (1.4.3), the URT device allowed 
faster measurements than the HR-US spectrometer (Table 38). Analysis times of the build-in 
system were reduced with HR-US FTS, supposably due to pre-conditioning of the substrate-
enzyme-mixture in the instrument (1.4.3). Tempering the cleaning, substrate or enzyme solutions 
prior to HR-US measurements showed no infl uence on the time consumption. The pre-mixing 
method led to small improvement of analysis times as the beginning of the evaluation area was 
shifted from 250 to 100 sec after enzyme addition. Potentially, analysis times can be improved 
by reducing the evaluation area from current 200 sec to shorter times (e.g. 50 sec).
Times needed for basic steps of URT and HR-US measurement (without negligible times for fi lling and cleaning).Table 38. 
* Using the FTS or fi lling the cells of  the conventional ultrasonic devices via Pre-mixing method the analysis time is  
 reduced due to the omitted baseline check
Summing up, temperature control was adequate for both devices during determination of 
enzyme kinetics, extensively proved in precision and specifi city tests. However, the tempering 
system infl uenced the analysis times leading to 2.5-fold longer analysis times using HR-US in 
comparison to URT measurements. In view of PAT, reduction of analysis times for HR-US is 
necessary.
A Flow-Through System pioneers complete automation4.12 
The feasibility to determine enzyme activity in different kinds of samples using the build-in 
systems of URT/ HR-US devices has been shown (3.4), which would allow an at-line application 
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of both devices for PAT purpose. In order to use the ultrasonic technique as on-line measurement 
as well, an FTS was tested. The use of  the FTS implicated the necessity to pre-mix substrate 
and enzyme solution (Pre-mixing method) and to subsequently rinse the pre-mix through a 
tubing system into the resonator cells. 
Using working standard (API), repeatability and analysis times were improved with FTS in 
comparison to the use of the build-in systems (Table 19). Adopting the Pre-mixing method, 
theoretically enables the application of any sample concentration due to an unlimited substrate 
volume. As an example, a highly concentrated sample was introduced for the ultrasonic 
determination of amylase activity, adding a reduced volume of sample to the starch solution. 
The repeatability was debased but adequate (below 1 %) (3.2.2). Although liquid process 
samples could be applied without previous sample dilution (Table 20, Figure 31), the addition 
of the sample solvent as buffer is adjuvant to avoid matrix effects. As an example, Phosphate 
buffer 0.2 M (URT/ HR-US) eliminated fat disturbances during monitoring amylase activity 
(Figure 19).
Handling and cleaning of the system with water and a low concentration of surfactant solution 
was generally easy and quick, as required for PAT use. However, calcium soaps precipitated 
during lipase reaction led to deposits in the cells, which were hard to remove, since mechanical 
cleaning was not possible. Conveniently, beginning of precipitation appears in reversion of 
attenuation (Figure 38). Initially, ultrasonic attenuation decreases during lipase reaction since 
the droplet size is reduced due to the degradation of olive oil (1.4.5). Then, precipitated calcium 
soaps enhance the wave scattering leading to a decrease of amplitude (and an increase of 
attenuation). Hence, maintaining exposure times in the FTS below 420 sec and subsequently 
rinsing with surfactant and water can avoid deposits of calcium soaps.
Considering the determination of enzyme activity in liquid IPC samples, the effect of fi bers 
in the samples regarding passage through the tubes and consequential cleaning issues needed 
special attention. After injecting pancreas dispersed in water into the FTS without previous 
 Lipase reaction was Figure 38. 
monitored by measuring the change 
of ultrasonic velocity (black) and 
attenuation (grey) over time. Initially, 
ultrasonic attenuation decreased due 
to droplet size reduction. After 450 
sec attenuation reversed caused by the 
precipiation of calcium soaps.
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fi ltration (Table 20), fi bers got caught in the tubing material, especially in the tube adapters. To 
remove the fi bers by rinsing out the system was diffi cult. Thus, the adapters had to be removed, 
cleaned and reattached to the system. It is also expected that fi bers got caught inside the FTS 
as fi bers were still found one day later although the system was rinsed for several hours. When 
the fi bers were separated from the samples, no cleaning problems were observed. Furthermore, 
repeatabilities of the measurement were improved (Table 20). Thus, for the determination of 
highly fi bered IPC samples, previous fi ber separation is recommended. In laboratory scale, fi ber 
separation was done via dissolution basket. Concerning automation, commercialized fi ltering 
systems (Figure 39) are available (e.g. by Flownamics®, Trace Analytics GmbH, Eppendorf  AG), 
generally offered to obtain cell-free or sterile samples from bioprocesses. A replacement of the 
membrane with a tubular sieve may lead to an effective separation of crude fi bers without losses 
of enzyme activities. Alternatively, a set-up avoiding adapter pieces and featuring large tube 
diameters is conceivable to ensure an adequate cleaning. However, enlarged diameters of the 
tubing material would consequently lead to an unacceptable increase of analysis time.
In addition to FTS, automation was tested in another manner. Tests using a dosing apparatus and 
titration equipment showed a loss of enzyme activity (tested for amylase and protease) after 
long holding times (more than 20 min) of the enzyme solution in the dosing system (Figure 23). 
This decrease can be attributed to either slow absorption to tubing or syringe material or to the 
long exposure time to room temperature. Since the tubing material is known as biocompatible, 
the latter case seems to be more likely. This effect of long duration times (more than 20 min) 
has to be considered for planning the use of an autosampler in the laboratory or the sampling 
(branch line) in the process. 
In view of PAT, an adequate stability of substrate solutions is needed to ensure a continuous 
operation. Stability for three weeks was proven for the olive oil emulsion. However, tempering 
the emulsion to 37 °C continuously has a negative infl uence on the stability. As opposed to 
the olive oil emulsion, the stability of starch solution is enhanced when the solution is stored 
in a waterbath at 37 °C. Nevertheless, starch preparations were often stable for only one day 
depending supposably on the water content of the used starch. The pharmacopoeias require 
daily preparation of fresh starch solution. Although the same is specifi ed for casein solution, 
Set-up of sampling device with fi lter element part, which sticks into the Figure 39. 
medium. Special extension modules can be used to elongate it (Scheper et al. (1996). 
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casein solutions are sometimes stable for several days (proven for 96 hours). Incipient turbidity 
and fl occulation of the starch or casein solutions indicate the expiration of use for ultrasonic 
methods. Stability of BAEE solution was tested over 48 hours and longer physical stability is 
expected. Chemical instability during long operation times is estimated to be uncritical as a 
broad range of substrate concentrations was identifi ed with no effect on the change of ultrasonic 
velocity (Table 23) wherat the operating substrate concentrations are in the middle or at the end 
of the tested ranges.
Given the impossibility to determine enzyme activity in-line, the use of an auto-sampling device 
is also part of automation. In this work, autosampling has not been considered in the practical 
section but should be addressed in future studies. Auto-sampling is needed for sampling, dilution 
of the samples, and pre-mixing with substrate solution. Hansen (2004) gave a helpful overview 
about sampling technologies. Flow Injection Analysis (FIA), developed by Ruzicka & Hansen 
(1981), is a sampling technique based on discrete sampling by injection into a continuously 
fl owing carrier stream, which may be merged downstream with reagents, transporting the 
sample to the analyzer unit. Separation of each sample from the subsequent sample is 
accomplished by the carrier reagent (Ruzicka & Hansen, 1981), bordering from the gas-segmented 
fl ow analysis according to Skeggs (1957) which uses air bubbles for separation.  In the literature, 
enzyme assays are often described in combination with FIA in which the enzyme reaction is 
performed prior to injecting the reaction products into the fl ow system. Nicolas et al. (1990) 
described a method to determine proteolytic enzymes including the mixing with substrate, 
enzyme reaction and UV spectroscopic detection within the FIA (Figure 40).
In the 1990s, development of the FIA concept has led to new generations: SIA (Sequential Injection 
Analysis) and LOV (lab-on-valve), which use programmable, bi-directional discontinuous fl ow 
instead of continuous fl ow via a multi position selector valve (Figure 41). Due to miniaturization 
of the manifold, sample and reagent consumption are smaller than using traditional FIA, but 
the analysis time may be longer caused by the syringe pump (Hansen, 2004). Additionally, 
FIA-manifold for proteolytic enzymes determination and schematic Figure 40. 
representation of the timer program. The sample was injected into the buffer 
stream which was then merged with the substrate stream before reaching the 
measurement cell. A second pump was used to clean with pure buffer at a high 
fl ow rate (according to Nicolas et al., 1991).
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LOV features an integrated microconduit, designed to perform all necessary unit operations 
required for a given assay such as mixing points for the analyte and reagents (Hansen, 2004). 
Cos et al. (2000) developed an on-line monitoring of lipolytic activity using SIA. A stop-fl ow 
technique was used to increase the conversion of the enzymatic reaction. Therefore the authors 
stopped the fl ux for 10 min in the heating coil (reactor) before passing the detector. 
 
The stopped-fl ow mode is also used to monitor the enzymatic reaction in real-time, whereas 
the reaction mixture is held within the fl ow-through cell for monitoring (according to FIAlab®). 
Several commercial instruments for SIA and LOV are available on the market, but mostly in 
combination with UV/Vis spectroscopy or fl uorescence (e.g. FIAlab®). No literature was about 
SIA and LOV for ultrasonic measurements.
In summary, FTS measurements have led to a better repeatability of ultrasonic measurements 
as compared to the build-in systems. Using the titration equipment, instabilities of pancreas 
powder-containing samples were identifi ed leading to amylase and protease activity losses after 
approx. 20 min. Concerning PAT, this is not relevant as PAT requires data to be obtained virtually 
in “real-time”. Long time intervalls between sampling and analysis are not suitable for PAT as 
they make a prompt intervention impossible. Adopting FIA or SIA/ LOV for autosampling might 
allow the complete automation of the system. Due to short holding times of the sample in the 
FIA system, enzyme activity losses can be eliminated. Kroner (1988) refers to this advantage, 
particularly concerning enzyme analysis at high temperatures.
Ultrasonic measurements have advantages and disadvantages in view of 4.13 
PAT 
The applicability of turbid sample preparations, quick analysis times and the possibility of 
automation are advantages of ultrasonic spectroscopy that have frequently been stressed in 
the literature and motivated to explore ultrasonic spectroscopy for the determination of 
pancreatic enzyme activities for quality control and PAT. As a result, ultrasonic methods proved 
to be applicable to pancreas und pancreatic powder-containing samples with advantages and 
disadvantages as compared to pharmacopoeia methods (Table 39).
Typical SIA system based on selection valve and bidirectional syringe Figure 41. 
pump [D = detector]. For explanation see text (Hansen, 2004).
 
115
 
In the present thesis, it was shown that ultrasonic spectroscopy allows the use of turbid substrate 
preparations based on the pharmacopoeias, such as starch solution, casein solution or olive oil 
emulsion to determine amylase, protease and lipase activities in API and drug product. The 
great challenge was to determine the activity of a single enzyme class in the presence of both 
other enzyme classes and in the presence of disturbing substances in the sample matrix of liquid 
process samples which are e.g. substrates for one of the other enzyme classes. Only in the context 
of liquid proteolysis samples matrix effects were observed. The trypsin method proved not to be 
reliable with respect to proteolysis samples supposably caused by high concentrations of fat and 
isopropanol (4.5 - 4.8). Furthermore, instabilities of the substrate preparation, especially the olive 
oil emulsion (4.3), which were not caused by the enzyme reaction itself had to be eliminated 
to ensure a reliable measurement of enzyme activity. Instabilities of the starch solution could 
not be overcome in all instances and often led to disturbances during ultrasonic determination 
of amylase activity. Coupland (2004) described the simultaneous change of multiple sample 
variables as a practical problem concerning the use of low-intensity ultrasound. 
The sensitivity of ultrasonic methods to temperature changes (Coupland, 2004) was addressed 
by the use of instruments that allow a reference calibrant cell to be in close proximity  to 
the sample cell in a temperature-controlled environment. However, tempering delays led to 
different analysis times using URT and HR-US.
According to Coupland (2004), disturbances by air bubbles in the sample occur during 
ultrasonic measurements. Large air bubbles act as refl ector and are imaged ultrasonically, 
while smaller air bubbles attenuate the sound leading to impossible propagation or prevented 
resolution (Povey, 1997). In order to avoid this, substrate preparations were degassed under 
vacuum (HR-US), however, injected samples were not degassed. Mixing was always performed 
carefully to avoid generation of air bubbles. Working in this way, no negative infl uences of air 
bubbles on the measurement were observed.
Another problem pointed out by Coupland (2004) is sensor erosion, especially caused by high 
temperatures and corrosive solvents or fouling of the transducer surface. Indeed, deposits of 
calcium soaps on the transducers reduced the amplitudes by 50 % in the perfomed measurements. 
Due to the non-applicability of corrosive solvents and the poorly visible and fi xed sample cells, 
Advantages and disadvantages of ultrasonic spectroscopy to determine pancreatic enzyme activities in different Table 39. 
kinds of samples.
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cleaning was complicated. For FTS, cleaning was additionally hampered as mechanical cleaning 
was not possible. 
The determination of absolute values of enzyme activity by ultrasonic methods is not 
conceivable as the ultrasonic signal during enzyme reaction is a complex interplay between 
substrate degradation, product generation and matrix effects (4.1). Therefore, calibration with 
reference standard was done and enzyme activities were determined as relative enzyme activity 
in relation to reference standard. Due to the complexity of the ultrasonic signal, disturbances 
cannot be explained easily. 
Unspecifi c signals (instabilities of substrate preparation, secondary enzyme reactions), 
temperature infl uences and air bubbles are also problematic when other techniques such as 
turbidimetry or NIR are considered (1.3.2). In summary, enzyme activity measurements by 
ultrasonic spectroscopy is feasible for quality control of API and drug product. In addition, 
its use in PAT seems to be possible for amylase, lipase and protease in pancreas and pancreas 
powder-containing in-process samples, although more research is needed to further develop it 
as PAT method for the determination of trypsin in liquid proteolysis samples. Analysis times of 
HR-US and cleaning should be optimized.
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SUMMARY5. 
Ultrasonic Spectroscopy is a fast and automatable technique that uses acoustic waves of low 
power and high frequency propagating through a sample. Due to changes of density and 
compressibility of the substrate-enzyme-mixture, an enzyme reaction can be observed by 
monitoring the change of ultrasonic velocity over time. Enzyme activities can be determined 
relative to a reference standard. In order to avoid infl uences of temperature, reference 
measurements are carried out using one sample cell fi lled with substrate and enzyme solution 
and one substrate-fi lled reference cell. In contrast to most pharmacopoeia methods, Ultrasonic 
Spectroscopy does in principle not require any sample preparation as turbid and undiluted 
samples can be measured. The goal of the present thesis was to test the technique as in-process 
control in view of PAT and as an alternative method for the determination of enzyme activity in 
porcine pancreas powder and porcine pancreas-powder containing product. 
Ultrasonic Resonator Technology (URT, TF Instruments GmbH) and High Resolution Ultrasonic 
Spectroscopy (HR-US, Sonas Technologies Ltd.) were used to develop ultrasonic methods to 
determine amylase, lipase, protease (free and total) and trypsin activities in pancreas powder 
and pancreas and pancreas powder-containing material, in each case in the presence of the other 
pancreatic enzymes.
Basic feasibility tests were carried out using a pancreas powder working standard. The 
temperature was defi ned to 37°C for all enzymes. Although adjuvants and concentrations needed 
to be adjusted to the requirements of ultrasonic spectroscopy, assay conditions and substrates 
were defi ned that they closely resembled those of Ph.Eur. and USP:
Concerning the determination of protease activity, the casein preparation (1.25 % (w/v),  ▪
aqueous) was adopted without modifi cation leading to a repeatability of 1.5 % (URT: 
1.71 %, HR-US: 1.25 %) for the determination of free protease activity and 1.5 % (URT: 
1.45 %, HR-US: 1.48 %) for the determination of total protease activity.
Concerning the determination of amylase activity, a substrate concentration of 6 % and  ▪
the addition of buffering substances and cofactors (Phosphate buffer pH 6.8, sodium 
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chloride 6.7mM) to the system improved the repeatability to 2.0 % (URT: 1.86 %, 
HR-US: 2.28 %). Using a 3 % starch solution the repeatability was 1.5 % (URT: 1.30 %, 
HR-US: 1.71 %).
Replacing the emulsifi er gum acacia with Triton X 100, adding cofactor calcium,  ▪
lowering the pH to 7.2 and using a high pressure homogenizer (Microfl uidizer®) to 
process the emulsion led to a stable emulsion, applicable for ultrasonic measurements to 
determine lipase activity. The repeatability was 1.6 % (URT: 1.80 %, 1.43 %).
Replacing the borate buffer with TRIS buffer as sample solvent enabled the ultrasonic  ▪
determination of trypsin. The repeatability was 1.73 % (URT).
Using working standard, it was also shown that the selectivity of the developed ultrasonic 
methods was adequate for the determination of single enzyme activities in an enzyme mixture. 
The applicability of ultrasonic spectroscopy as in-process control of proteolysis was tested by 
adding several substances to the sample matrix. Substances contained in the sample matrix such 
as sodium chloride, calcium or isopropanol did not infl uence the enzyme activity in the developed 
methods. Protein (model: casein) led to an enhanced ultrasonic signal during determination 
of amylase activity since protease activity was monitored simultaneously. In contrast, high 
concentrations of fat (model: olive oil) led to reduced signals for amylase. Blanks (without 
starch) showed an opposing effect towards fat. Changing the buffer concentration in the sample 
solvent eliminated the disturbances caused by proteins and fat during amylase determination. 
Fat also enhanced the signal during determination of trypsin activity as lipolysis was monitored 
simultaneously. This was avoided by omitting emulsifying agents.
 
Substrate stability was adequate for lipase, protease and trypsin determination. However, 
instabilities of starch solutions disturbed the determination of amylase activity consistently. 
The increased temperature compared to the pharmacopoeia method had a positive infl uence on 
the stability of starch solution.
Time consumption for determination of two replicates using URT is 10 min and approx. 26 min 
using HR-US because of a higher cell volume in HR-US and a different tempering system. 
Automation was tested by using a Flow-through System (FTS). Since the substrate-enzyme-
mixture is automatically tempered before reaching the sample cell, the use of FTS shortened the 
analysis time. Transferring the pre-mix method to the build-in systems of URT and HR-US also 
accelerated the analysis time as the baseline check was omitted and improved repeatability.
In order to compare results obtained with the ultrasonic method with those of the pharmacopoeia 
methods, the change of ultrasonic velocity of reference standard solution and sample solution was 
determined. The enzyme activity was calculated by using the activity label claim of the working 
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standard based on pharmacopoeias. Concerning API and drug product, the enzyme activities 
obtained with HR-US and URT were comparable with the results of the pharmacopoeia methods 
(Ph.Eur. and USP). This confi rms the high selectivity of the ultrasonic methods. Concerning 
in-process proteolysis samples, the determination of amylase activity was optimized by using a 
sample solvent with higher buffer concentration. Lipase and protease (free and total) methods 
appeared to be applicable to in-process samples. In contrast, ultrasonic determination of trypsin 
activity in proteolysis material did not yield reliable results likely due to disturbances of fat and 
isopropanol because of higher sample concentrations as compared to other methods.
A comparison of ultrasonic spectroscopy with alternative techniques (turbidimetry and NIR/ 
MIR) as described in the literature shows similar advantages as well as challenges for all 
techniques in view of IPC of proteolysis. 
In conclusion, ultrasonic spectroscopy can be an alternative to determine pancreatic enzyme 
activity in most process samples, drug substance and drug product. In order to use URT or HR-US 
in the context of PAT for in-process control, additional experiments concerning automation 
(online), analysis times and elimination of disturbing matrix effects are recommended. Based 
on the results presented here, use of URT and HR-US for release testing of pancreas powder 
and porcine pancreas powder-containing product is possible.
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ZUSAMMENFASSUNG6. 
Hinter Ultraschallspektroskopie verbirgt sich eine schnelle und automatisierbare Technik, die 
Ultraschallwellen hoher Frequenz und geringer Intensität nutzt. Durch die Veränderung von 
Dichte und Kompressibilität des Substrat-Enzym-Gemisches kann eine Hydrolysereaktion über 
die zeitliche Veränderung der Ultraschallgeschwindigkeit verfolgt werden. Enzymaktivitäten 
können in Relation zu einem Referenzstandard bestimmt werden. Um Temperatureinfl üsse 
zu vermeiden, werden Differenzmessungen zwischen einer Probezelle, die Substrat- und 
Enzymlösung enthält, und einer mit Substratlösung gefüllten Referenzzelle durchgeführt. Im 
Gegensatz zu den meisten Arzneibuchmethoden ist theoretisch für die Ultraschallspektroskopie 
keine Probenaufbereitung nötig, weil auch trübe unverdünnte Proben vermessen werden 
können. Im Rahmen dieser Arbeit wurde die Ultraschall-Technik in Hinblick auf PAT als 
Inprozesskontrolle und als alternative Freigabeanalytik zur Bestimmung von Enzymaktivitäten 
in Pankreaspulver und entsprechenden Produkten untersucht.
Mit dem Einsatz von URT  (Ultrasonic Resonator Technology, TF Instruments GmbH) und 
HR-US (High Resolution Ultrasonic Spectroscopy, Sonas Technologies Ltd.) wurden Methoden 
zur ultraspektroskopischen Bestimmung von Amylase-, Lipase-, freier und gesamter Protease- 
und freier Trypsinaktivitäten in Pankreaspulver und pankreaspulverhaltigem Material, jeweils 
in Gegenwart der anderen Pankreasenzyme, entwickelt. 
Mit einem Pankreatin-Arbeitsstandard wurde zunächst die grundsätzliche Anwendbarkeit 
untersucht. Für alle Enzyme wurde eine identische Temperatur von 37°C gewählt. 
Obwohl Hilfsstoffe und Konzentrationen teilweise den Bedürfnissen der Ultraschall-
Spektroskopie angepasst werden mussten, wurden die Bedingungen und die Substrate so weit 
wie möglich an den Ph.Eur.- und USP-Vorgaben orientiert: 
Für die Protease-Bestimmung wurde die Casein-Lösung (1,25 % (w/v), wässrig) ohne  ▪
Änderungen vom Arzneibuch-Assay übernommen. Eine Wiederholbarkeit von  ca. 
1,5 % (URT: 1,71 %, HR-US: 1,25 %) wurde für die Methode zur Bestimmung der 
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freien Proteaseaktivität ermittelt. Für die Methode zur Bestimmung der Gesamtaktivität 
war die Wiederholbarkeit ebenfalls ca. 1,5 % (URT: 1,45 %, HR-US: 1,48 %).
Für die Bestimmung von Amylaseaktivität verbesserte eine erhöhte Stärke-Konzentration  ▪
von 6 % (w/v) und die Anreicherung mit puffernden Substanzen und Co-Faktoren 
(Phosphatpuffer pH 6,8, NaCl 6,7 mM) die Wiederholbarkeit auf ca. 2,0 % (URT: 1,86 %, 
HR US: 2,28 %). Mit einer 3 % (w/v) Stärke-Lösung wurde eine Wiederholbarkeit von 
ca. 1,5 % (URT: 1,30 %, HR-US: 1,71 %) ermittelt.
Für dieBestimmung der Lipaseaktivität führte ein Emulgatoraustausch von Arabisch  ▪
Gummi gegen Triton X 100, die Ergänzung von Calcium, eine Erniedrigung des pH-
Wertes (pH 7,2) und die Anwendung eines Hochdruckhomogenisators (Microfl uidizer®) 
zur Emulsionsherstellung zu einer stabilen Emulsion, die für Ultraschallmessungen 
applizierbar ist. Die Wiederholbarkeit war ca. 1,6 % (URT: 1,80 %, 1,43 %). 
Für die Bestimmung der freien Trypsinaktivität musste der Boratpuffer gegen TRIS- ▪
Puffer ausgetauscht werden, um ein Ultraschallsignal zu erzeugen. Die Wiederholbarkeit 
war 1,73 % (URT).
Mit Pankreatin-Arbeitsstandard konnte ebenfalls gezeigt werden, dass die Selektivität der 
entwickelten Ultraschall-Methoden für die Bestimmung von einzelnen Enzymaktivitäten 
im Enzymgemisch ausreichend hoch ist. Inwiefern die Ultraschallspektroskopie auch als 
Inprozesskontrolle der Proteolyse genutzt werden kann, wurde durch den Zusatz verschiedenster 
Substanzen zur Probenmatrix untersucht. 
In der Matrix enthaltende Substanzen, wie Natriumchlorid, Calcium oder Isopropanol 
zeigten keinen Einfl uss auf das Messergebnis. Proteine (Casein als Modell) führten durch 
die gleichzeitige Erfassung von Proteolyse bei der Amylase-Bestimmung zu einer erhöhten 
Veränderung der Ultraschallgeschwindigkeit. Höhere Fettkonzentrationen (Olivenöl als 
Modell) bewirkten dagegen für Amylase eine Erniedrigung des Signals, wobei Blindwerte 
(ohne Stärke) ein entgegengesetztes Verhalten gegenüber Fett zeigten. Eine Erhöhung der 
Phosphat-Pufferkonzentration beseitigte die durch Fett und Proteine ausgelösten Störungen 
bei der Amylase-Bestimmung. Wegen gleichzeitig ablaufender Lipolyse erhöhte Fett auch 
das gemessene Ultraschallsignal bei der Trypsinaktivitätsbestimmung. Nur durch die totale 
Abwesenheit von emulgierenden Substanzen konnte dieser Effekt ausgeschaltet werden.
Substratzubereitungen, die für die Bestimmung von Lipase-, Protease- und Trypsinaktivität 
eingesetzt wurden, zeigten ausreichende Stabilität, lediglich die Instabilität der Stärke-Lösung 
führte durchweg zu Störungen der Amylase-Methode. Die erhöhte Temperatur im Vergleich zur 
Arzneibuchmethode zeigte einen positiven Einfl uss auf die Stabilität der Stärkelösung. 
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Eine Doppelbestimmung einer Enzymaktivität dauert ca.10 min mittels URT und ca. 26 min mit 
HR-US, was im Unterschied von Zellvolumen und Temperiersystem begründet werden kann. 
Automatisierbarkeit wurde durch den Gebrauch einer Durchfl usszelle (FTS) untersucht. Weil 
dabei das Substrat-Enzym-Gemisch vor Erreichen der Messzelle automatisch vortemperiert 
wird, führte der Gebrauch des FTS zu einer Analysenzeitverkürzung. Auch die Übertragung der 
Vormischung von Substrat und Enzym auf die URT und HR-US-Standgeräte beschleunigt die 
Analysenzeit, weil die Basislinien-Überprüfung vor Enzymzugabe wegfällt, und verbesserte 
die Wiederholbarkeit.
Um Ultraschallergebnisse mit denen der Arzneibuchmethoden vergleichen zu können, wurden 
die Änderungen der Ultraschallgeschwindigkeit von Referenzstandardlösung und Probelösung 
bestimmt. Die Enzymaktivität wurde dann über die deklarierte Aktivität des Referenzstandards 
gemäß Arzneibuch berechnet. Für Wirkstoff und Produkt waren die mit HR-US und URT 
bestimmten Aktivitäten vergleichbar mit den Ergebnissen der Arzneibuchmethoden (Ph.Eur. 
und USP), was die hohe Selektivität der Ultraschallmethoden bestätigt. Bezüglich Inprozess-
Proteolyse-Mustern wurde die Amylase-Methode durch den Einsatz eines höher konzentrierten 
Puffersystems verbessert. Für die Lipase- und die Protease-Methoden (frei und gesamt) konnte 
eine gute Anwendbarkeit gezeigt werden. Die Ultraschall-Bestimmung von Trypsin führte 
jedoch nicht zu verlässlichen Ergebnissen. Durch die hohe Probekonzentration bei dieser 
Methode ist eine Störung durch die Anwesenheit von Fett und Isopropanol naheliegender als 
bei den anderen Ultraschallmethoden.
Ein Vergleich der Ultraschallspektroskpie mit alternativen Techniken (NIR/ MIR und 
Turbidimetrie) wie sie in der Literatur beschrieben sind, zeigt für alle ähnliche Vorteile und 
Herausforderungen im Hinblick auf die Inprozesskontrolle der Proteolyse.
Zusammenfassend kann festgehalten werden, dass die Ultraschallmessung eine Alternative 
zu den Arzneibuchmethoden sein kann, um Pankreasenzyme in den meisten Prozessproben, 
im Wirkstoff und im Produkt zu bestimmen. Um URT oder HR-US im Rahmen von PAT als 
Inprozesskontrolle zu nutzen, sind noch weitere Experimente zur Automatisierung (online), 
zur Analysenzeit und zur Ausschaltung von störenden Matrixeffekten zu empfehlen. Gestützt 
auf die erhobenen Daten, ist die Anwendung von URT und HR-US für Freigabeanalytik für 
Pankreaspulver und pankreaspulverhaltige Produkte möglich. 
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Appendix A1
Emulsion development
Conditions of emulsion preparation using Microfl uidizer Fluid Processor M110-EHI. Bile salts (reagents mixture) Table A1. 
were added after Microfl uidization. The behavior of the emulsions in ultrasonic spectrometer were investigated and mean 
droplet size was determined (Laser diffraction: RI: 1.600/ IZ 15).
Appendix A1I
Emulsion development
Conditions of emulsion preparation using Microfl uidizer Fluid Processor M110-EHI. Bile salts (reagents mixture) Table A2. 
were added before Microfl uidization. The behavior of the emulsions in ultrasonic spectrometer were investigated and mean 
droplet size was determined (Laser diffraction: RI: 1.600/ IZ 15).
Table A3.  Pre-emulsion was prepared by adding Reagents mixture (USP/ Ph.Eur.) to the Ph.Eur.-Emulsion. The emulsions 
were processed using a Microfl uidizer at 1200 bar and performing 1 - 6 passages. Droplet sizes were determined (Laser 
diffraction, BI: 1.600/ IZ 15). Ultrasonic velocity changes were determined by URT at 37°C adding 4 μl working standard 
solution (aqueous) to 180μl emulsion (n=2 (1replicate)).
Table A4.  Pre-emulsion was prepared by adding Reagents mixture to the Ph.Eur.-Emulsion. The emulsions were processed 
using Microfl uidizer at 1200 bar and performing 7 - 12 passages. Droplet sizes were determined (Laser diffraction, BI: 1.600/ 
IZ 15). Ultrasonic velocity changes were determined by URT at 37°C adding 4 μl working standard solution (aqueous) to 180μl 
emulsion (n=2 (1replicate)).
Figure A1.   Infl uence of Calcium on emulsion stability 
was tested. 25 ml Olive oil were used to prepare the  pre 
emulsion (400 ml). Bile salts were added before high pressure 
homogenization. The Microfl uidizer (MF) was processed 
at 1200 bar and  3 passages were performed. Shown are the 
content of calcium in the emulsion and the mean diameter 
of the droplets determined by using Laser diffraction (IZ 15, 
BI 1.600). Squares present emulsion preparation when calcium 
was added after MF, triangles represent calicum addition before 
MF.
Figure A2.     Linearity was determined for inital URT lipase 
method. Emulsion: 25 ml Olive oil were used to prepare the  pre 
emulsion (400 ml).  Bile salts were added before high pressure 
homogenization./ The Microfl uidizer (MF) was processed at 
1200 bar and  3 passages were performed. Ultrasonic velocity 
changes were determined with URT at 37°C adding 4 μl 
working standard solution (Maleate buffer solution pH 7.5) to 
180μl emulsion (n=1 (2 rep), mean +/- stdev).
Table A5.  Mean diameter of droplets (Laser diffraction, IZ 15, BI 1.600) and ultrasonic velocity changes during lipase 
reaction (n=2 (1rep)) were determined in dependence of a various content of olive oil and various settings of microfl uidization 
(pressure, number of passages, time of pre emulsifi cation).
Appendix A1II
Emulsion development
Table A6.  Ultrasonic velocity change during lipase reaction (URT) and modal droplet sizes of the used emulsion were 
determined shown according to the number of passages in Microfl uidizer.
Ultrasonic velocity change during lipase reaction (URT) and modal droplet sizes of the used emulsion were Table A7. 
determined shown according to the olive oil concentration in emulsion.
Ultrasonic velocity change during lipase reaction (URT) and modal droplet sizes of the used emulsion was Table A8. 
determined shown according to the Triton X 100 concentration in emulsion.
Ultrasonic velocity change during lipase reaction (URT) and modal droplet sizes of the used emulsion were Table A9. 
determined shown according to the CaCl2 concentration in emulsion (1. part). 
Ultrasonic velocity change during lipase reaction (URT) and modal droplet sizes of the used emulsion were Table A10. 
determined shown according to the CaCl2 concentration in emulsion (2. part). 
Ultrasonic velocity change during lipase reaction (URT) and modal droplet sizes of the used emulsion were Table A11. 
determined shown according to the TRIS concentration in emulsion. 
Appendix A IV  
Control of pH during lipase reaction
Figure A3.    A: The change of ultrasonic velocity over time during lipase reaction was determined using URT and four buffer 
compositions (pH 7.8). Using the ‘standard’ emulsion a strong decrease of ultrasonic velocity after 55 minutes was observed 
that correlated with a strong coalescence of the olive oil droplets monitored with the micrcoscope. Using the other emulsions 
similar courses of the kinetic curves were not observed in the tested time period. B (Detail of A): The change of ultrasonic 
velocity over time (0 - 20 min) during lipase reaction was determined using URT and four buffer compositions (pH 7.8).The 
emulsion with lowest ionic concentration shows the strongest increase of ultrasonic velocity. C: The change of pH over time 
during lipase reaction was monitored using four buffer compositions (pH 7.8). The pH decreased over time. Decrease of pH 
during enzyme reaction was minimized by increasing the TRIS concentration. Coalescence was also reduced at higher TRIS 
concentrations (microscope). Concerning the results, a strong interference was presumed between degradation of olive oil on 
the one hand and droplet coalescence on the other hand when using the low concentrated buffer system (Tris 50mM).
Appendix A V  
Specifi city (general)
Specifi city test for Table A12. amylase activity determination by ultrasonic method (URT). In the complete system (positive 
control), ultrasonic velocity was measured at 37°C after adding 4μl of Amylase solution (URT/ HR-US) to 180 μl of Starch 
solution 6 % (URT/ HR-US). On the left, the system lacked pancreas powder, on the right, the system lacked starch. Shown are 
means of 2 replicates per working standard solution.
Table A13.  Specifi city test for lipase activity determination by ultrasonic method (HR-US). In the complete system (positive 
control), ultrasonic velocity was measured at 37°C after adding 20 μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil 
emulsion (URT/ HR-US). On the left, the system lacked pancreas powder, on the right, the system lacked olive oil. Shown are 
means of 2 replicates per working standard solution.
 
 
Specifi city test for Table A14. free protease activity determination by ultrasonic method (URT). In the complete system 
(positive control), ultrasonic velocity was measured at 37°C after adding 4 μl of 0.5 % Std Work solution (aqueous) to 180 μl of 
casein 0.625 % (URT/ HR-US). On the left, the system lacked pancreas powder, on the right, the system lacked casein. Shown 
are means of 2 replicates per working standard solution.
Table A15. Specifi city test for total protease activity determination by ultrasonic method (URT). In the complete system 
(positive control), ultrasonic velocity was measured at 37°C using a premix of 1800 μl casein 1.25 % (URT/ HR-US) and 80 μl 
Total protease solution (URT/ HR-US) activated with enterokinase. On the left, the system lacked pancreas powder, on the 
right, the system lacked casein. Shown are means of 2 replicates per working standard solution. 
Specifi city test for Table A16. free trypsin activity determination by ultrasonic method (URT). In the complete system 
(positive control), ultrasonic velocity was measured at 37°C after adding 8 μl of trypsin solution (URT/ HR-US) to 180 μl of 
BAEE solution (URT/ HR-US). On the left, the system lacked pancreas powder and Chymotrypsin was used, respectively, on 
the right, the system lacked BAEE. Shown are means of 2 replicates per working standard solution.
  
Appendix A VI  
Different salts in sample matrix
Infl uence of NaCl concentration in sample matrix on ultrasonic determination of Table A17. amylase activity (URT). 
Amylase solutions (URT/ HR-US) with different NaCl concentrations were prepared. Ultrasonic velocity was measured at 
37°C after adding 4μl of Amylase solution (URT/ HR-US) to 180 μl of Starch solution 6 % (URT/ HR-US). Shown are means 
of 2 replicates per working standard solution.
Infl uence of NaCl concentration in sample matrix on ultrasonic determination of Table A18. lipase activity (HR-US). Lipase 
solutions (URT/ HR-US) with different NaCl concentrations were prepared. Ultrasonic velocity was measured at 37°C after 
adding 20μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ HR-US). Shown are means of 2 
replicates per working standard solution.
Infl uence of CaClTable A19. 2 concentration in sample matrix on ultrasonic determination of amylase activity (URT). 
Amylase solutions (URT/ HR-US) with different CaCl2 concentrations were prepared. Ultrasonic velocity was measured at 
37°C after adding 4μl of Amylase solution (URT/ HR-US) to 180 μl of Starch solution 6 % (URT/ HR-US). Shown are means 
of 2 replicates per working standard solution.
Infl uence of CaClTable A20. 2 concentration in sample matrix on ultrasonic determination of lipase activity (HR-US). Lipase 
solutions (URT/ HR-US) with different CaCl2 concentrations were prepared. Ultrasonic velocity was measured at 37°C after 
adding 20μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ HR-US). Shown are means of 2 
replicates per working standard solution.
Infl uence of CaClTable A21. 2 concentration in sample matrix on ultrasonic determination of total protease activity (URT). 
Total protease solutions (URT/ HR-US) with different CaCl2 concentrations were prepared. Ultrasonic velocity was measured 
at 37°C using a premix of 1800 μl casein 1.25 % (URT/ HR-US) and 80 μl Total protease solution (URT/ HR-US) activated 
with enterokinase. Shown are means of 2 replicates per working standard solution.
Infl uence of CaClTable A22. 2 concentration in sample matrix on ultrasonic determination of free trypsin activity (HR-US). 
Trypsin solutions (URT/ HR-US) with different CaCl2 concentrations were prepared. Ultrasonic velocity was measured at 
37°C after adding 20 μl of Trypsin solution (URT/ HR-US) to 1050 μl of BAEE solution (URT/ HR-US). Shown are means of 
2 replicates per working standard solution.
Appendix A VII  
Isopropanol in sample matrix
Infl uence of isopropanol concentration in sample matrix on ultrasonic determination of Table A23. amylase activity (URT). 
Amylase solutions (URT/ HR-US) with different isopropanol concentrations were prepared. Ultrasonic velocity was measured 
at 37°C after adding 4μl of Amylase solution (URT/ HR-US) to 180 μl of Starch solution 6 % (URT/ HR-US). Shown are means 
of 2 replicates per working standard solution.
Infl uence of isopropanol concentration in sample matrix on ultrasonic determination of Table A24. lipase activity (HR-US). 
Lipase solutions (URT/ HR-US) with different isopropanol concentrations were prepared. Ultrasonic velocity was measured at 
37°C after adding 20μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ HR-US). Shown are means 
of 2 replicates per working standard solution.
Infl uence of isopropanol concentration in sample matrix on ultrasonic determination of Table A25. free protease activity 
(URT).  Free protease solutions (URT/ HR-US) with different isopropanol concentrations were prepared. Ultrasonic velocity 
was measured at 37°C after adding 8 μl of Trypsin solution (URT/ HR-US) to 180 μl of Casein solution (URT/ HR-US). Shown 
are means of 2 replicates per working standard solution.
Table A26. Infl uence of isopropanol concentration in sample matrix on ultrasonic determination of total protease activity 
(URT).  Total protease solutions (URT/ HR-US) with different isopropanol concentrations were prepared. Ultrasonic velocity 
was measured at 37°C using a premix of 1800 μl casein 1.25 % (URT/ HR-US) and 80 μl Total protease solution (URT/ 
HR-US) activated with enterokinase. 
Infl uence of isopropanol concentration in sample matrix on ultrasonic determination of Table A27. free trypsin activity 
(URT). Trypsin solutions (URT/ HR-US) with different isopropanol concentrations were prepared. Ultrasonic velocity was 
measured at 37°C after adding 8 μl of Trypsin solution (URT/ HR-US) to 180 μl of BAEE solution (URT/ HR-US). Shown are 
means of 2 replicates per working standard solution.
 
Appendix A VIII  
Protein in sample matrix (model: casein)
Infl uence of protein concentration in sample matrix on ultrasonic determination of Table A28. amylase activity (URT). 
Amylase solutions (URT/ HR-US) with different casein concentrations were prepared. Ultrasonic velocity was measured at 
37°C after adding 4μl of Amylase solution (URT/ HR-US) to 180 μl of Starch solution 6 % (URT/ HR-US). Shown are means 
of 2 replicates per working standard solution.
Infl uence of protein concentration in sample matrix on ultrasonic determination of Table A29. amylase activity (URT). 
Amylase solutions 0.2 M (URT/ HR-US) with different casein concentrations were prepared. Ultrasonic velocity was measured 
at 37°C after adding 4μl of Amylase solution 0.2 M (URT/ HR-US) to 180 μl of Starch solution 6 % (URT/ HR-US). Shown 
are means of 2 replicates per working standard solution.
Infl uence of protein concentration in sample matrix on ultrasonic determination of Table A30. lipase activity (HR-US). 
Lipase solutions (URT/ HR-US) with different casein concentrations were prepared. Ultrasonic velocity was measured at 37°C 
after adding 20μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ HR-US). Shown are means of 2 
replicates per working standard solution.
Infl uence of protein concentration in sample matrix on ultrasonic determination of Table A31. free trypsin activity (URT). 
Trypsin solutions (URT/ HR-US) with different casein concentrations were prepared. Ultrasonic velocity was measured at 
37°C after adding 8 μl of Trypsin solution (URT/ HR-US) to 180 μl of BAEE solution (URT/ HR-US). Shown are means of 2 
replicates per working standard solution.
 
Appendix A IX  
Fat in sample matrix (model: olive oil)
Infl uence of fat concentration in sample matrix on ultrasonic determination of Table A32. amylase activity (URT). Phosphate 
buffer solutions (URT/ HR-US) with different olive oil content, which were used to prepare different Amylase solutions (URT/ 
HR-US), were prepared by mixing in a household blender for 10 min. Ultrasonic velocity was measured at 37°C after adding 
4 μl of Amylase solution (URT/ HR-US) to 180 μl of Starch solution 6 % (URT/ HR-US). Shown are means of 2 replicates per 
working standard solution.
Infl uence of fat concentration in sample matrix on ultrasonic determination of Table A33. lipase activity (HR-US). Maleate 
buffer solutions pH 7.0 (URT/ HR-US) with different olive oil content, which were used to prepare different Lipase solutions 
(URT/ HR-US), were prepared by mixing in a household blender for 10 min. Ultrasonic velocity was measured at 37°C 
after adding 20 μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ HR-US). Shown are means of 
2 replicates per working standard solution.
Infl uence of fat concentration in sample matrix on ultrasonic determination of Table A34. free protease activity (URT). 
Borate buffers pH 7.5 (URT/ HR-US) with different olive oil content, which were used to prepare different Free protease 
solutions (URT/ HR-US), were prepared by mixing in a household blender for 10 min. Ultrasonic velocity was measured at 
37°C after adding 4 μl of Free protease solution (URT/ HR-US) to 180 μl of Casein 1.25 % (URT/ HR-US). Shown are means 
of 2 replicates per working standard solution.
Infl uence of fat concentration in sample matrix on ultrasonic determination of Table A35. total protease activity (URT). 
Calcium chloride solutions 0.02 M (URT/ HR-US) with different olive oil content, which were used to prepare different 
Total protease solutions (URT/ HR-US), were prepared by mixing in a household blender for 10 min. Ultrasonic velocity was 
measured at 37°C using a premix of 1800 μl casein 1.25 % (URT/ HR-US) and 80 μl Total protease solution (URT/ HR-US) 
activated with enterokinase. Shown are means of 2 replicates per working standard solution.
Infl uence of fat concentration in sample matrix on ultrasonic determination of Table A36. free trypsin activity (URT). 
Triton X 100 solutions (URT/ HR-US) with different olive oil content, which were used to prepare different Trypsin solutions 
(URT/ HR-US), were prepared by mixing in a household blender for 10 min. Ultrasonic velocity was measured at 37°C after 
adding 4 μl of Trypsin solution (URT/ HR-US) to 180 μl of BAEE solution (URT/ HR-US). Shown are means of 2 replicates 
per working standard solution.
Infl uence of fat concentration in sample matrix on ultrasonic determination of Table A37. free trypsin activity (URT). 
Triton X 100 solutions (URT/ HR-US) with different olive oil content, which were used to prepare different Trypsin solutions 
(0.031 % Std FIP in Triton solution (URT/ HR-US)), were prepared by mixing in a household blender for 10 min. Ultrasonic 
velocity was measured at 37°C after adding 4 μl of the Trypsin solution to 180 μl of BAEE solution (URT/ HR-US). Shown are 
means of 2 replicates per working standard solution.
Fat in sample matrix (model: olive oil) - Additional tests
Amylase:  Blanks
Infl uence of fat concentration in sample matrix on ultrasonic determination of Table A38. amylase activity (URT) without 
starch (blanks). Phosphate buffer solutions (URT/ HR-US) with different olive oil content, which were used to prepare different 
Amylase solutions (URT/ HR-US), were prepared by mixing in a household blender for 10 min. Ultrasonic velocity was 
measured at 37°C after adding 4 μl of Amylase solution (URT/ HR-US) to 180 μl of Phosphate buffer solution (URT/ HR-US). 
Shown are means of 2 replicates per working standard solution.
Amylase: Preparation of starch and enzyme solution in 0.2 M phosphate buffer
Infl uence of fat concentration in sample matrix on ultrasonic determination of Table A39. amylase activity (HR-US) using 
Phosphate buffer solution 0.2 M for preparation of starch and enzyme solution. Phosphate buffer solutions 0.2 M (URT/ HR-US) 
with different olive oil content, which were used to prepare different Amylase solutions 0.2 M (URT/ HR-US), were prepared 
by mixing in a household blender for 10 min. Ultrasonic velocity was measured at 37°C after adding 20 μl of Amylase solution 
0.2 M (URT/ HR-US) to 1050 μl of Starch solution 6 % (URT/ HR-US modifi ed, prepared in Phosphate buffer solution 0.2 M). 
Shown are means of 2 replicates per working standard solution.
Infl uence of fat concentration in sample matrix on ultrasonic determination of Table A40. amylase activity (URT) using 
Phosphate buffer solution 0.2 M for preparation of starch and enzyme solution. Phosphate buffer solutions 0.2 M (URT/ HR-US) 
with different olive oil content, which were used to prepare different Amylase solutions 0.2 M (URT/ HR-US), were prepared 
by mixing in a household blender for 10 min. Ultrasonic velocity was measured at 37°C after adding 4 μl of Amylase solution 
0.2 M (URT/ HR-US) to 180 μl of Starch solution 6 % (URT/ HR-US modifi ed, prepared in Phosphate buffer solution 0.2 M). 
Shown are means of 2 replicates per working standard solution.
Amylase: Preparation of enzyme solution in 0.2 M phosphate buffer
Infl uence of fat concentration in sample matrix on ultrasonic determination of Table A41. amylase activity (URT) using 
Phosphate buffer solution 0.2 M for preparation of enzyme solution. Phosphate buffer solutions 0.2 M (URT/ HR-US) with 
different olive oil content, which were used to prepare different Amylase solutions 0.2 M (URT/ HR-US), were prepared by 
mixing in a household blender for 10 min. Ultrasonic velocity was measured at 37°C using a premix of 1800 μl Starch solution 
3 % (URT/ HR-US) and 40 μl Amylase solution 0.2 M (URT/ HR-US). Shown are means of 2 replicates per working standard 
solution.
Total protease: Presence of Emulsifi er (Triton X 100)
Infl uence of fat concentration in sample matrix on ultrasonic determination of Table A42. total protease activity (URT) in 
the presence of emulsifi er. Calcium chloride solutions 0.02 M (URT/ HR-US) with different olive oil content in the presence 
of Triton X 100, which were used to prepare different Total protease solutions (URT/ HR-US), were prepared by mixing in 
a household blender for 10 min. Ultrasonic velocity was measured at 37°C using a premix of 1800 μl casein 1.25 % (URT/ 
HR-US) and 80 μl Total protease solution (URT/ HR-US) activated with enterokinase. Shown are means of 2 replicates per 
working standard solution.
Trypsin:  Blanks
Infl uence of fat concentration in sample matrix on ultrasonic determination of Table A43. trypsin activity (URT) without 
BAEE (blanks). Triton X 100 solutions (URT/ HR-US) with different olive oil content, which were used to prepare different 
Trypsin solutions (URT/ HR-US), were prepared by mixing in a household blender for 10 min. Ultrasonic velocity was measured 
at 37°C after adding 8 μl of Trypsin solution (URT/ HR-US) to 180 μl of TRIS buffer (URT/ HR-US). Shown are means of 2 
replicates per working standard solution.
Trypsin:  Sample solvent without Triton X 100
Infl uence of fat concentration in sample matrix on ultrasonic determination of Table A44. trypsin activity (URT) without 
emulsifi er (Triton X 100). 1 mM Hydrochloric acid solutions (URT/ HR-US) with different olive oil content, which were used 
to prepare different Trypsin solutions (URT/ HR-US, modifi ed, without Triton X 100), were prepared by mixing in a household 
blender for 10 min. Ultrasonic velocity was measured at 37°C after adding 8 μl of Trypsin solution (URT/ HR-US, modifi ed, 
without Triton X 100) to 180 μl of BAEE solution (URT/ HR-US). Shown are means of 2 replicates per working standard 
solution.
Trypsin:  Different sample solvents
Infl uence of fat concentration in sample matrix on ultrasonic determination of Table A45. trypsin activity (URT) using 
different sample solvents in the presence and absence of olive oil. Sample solvents with different olive oil content of 5 % 
(v/v), which were used to prepare different Trypsin solutions (URT/ HR-US, modifi ed, other sample solvent), were prepared 
by mixing in a household blender for 10 min. Ultrasonic velocity was measured at 37°C after adding 8 μl of Trypsin solution 
(URT/ HR-US, modifi ed, other sample solvent) to 180 μl of BAEE solution (URT/ HR-US). Shown are means of 2 replicates 
per working standard solution.
 Appendix A VIII  
Protein in sample matrix (model: casein)
Appendix A X  
Linearity
Linearity test of Table A46. amylase activity measurement by ultrasonic method (HR-US). Working standard solutions in 
Phosphate buffer solution (URT/ HR-US) with different enzyme content were prepared. Ultrasonic velocity was measured at 
37°C after adding 20 μl of working standard solution to 1050 μl of Starch solution 6 % (URT/ HR-US). Shown are means of 2 
replicates per working standard solution.
Linearity test of Table A47. amylase activity measurement by ultrasonic method (HR-US FTS). Working standard solutions 
in Phosphate buffer solution (URT/ HR-US) with different enzyme content were prepared. Ultrasonic velocity was measured 
at 37°C by using a premix of 15.75 ml Starch solution 3 % (URT/ HR-US) and 300 μl working standard solution. Shown are 
means of 2 replicates per working standard solution.
Linearity test of Table A48. lipase activity measurement by ultrasonic method (HR-US). Working standard solutions in 
Maleate buffer solution pH 7.0 (URT/ HR-US) with different enzyme content were prepared. Ultrasonic velocity was measured 
at 37°C after adding 20 μl of working standard solution to 1050 μl of Olive oil emulsion (URT/ HR-US). Shown are means of 
2 replicates per working standard solution.
Linearity test of Table A49. free protease activity measurement by ultrasonic method (HR-US). Working standard solutions 
in Borate buffer pH 7.5 (URT/ HR-US) with different enzyme content were prepared. Ultrasonic velocity was measured at 37°C 
after adding 20 μl of working standard solution to 1050 μl of Casein solution 1.25 % (URT/ HR-US). Shown are means of 2 
replicates per working standard solution.
Linearity test of Table A50. total protease activity measurement by ultrasonic method (URT). Drug product I solutions 
in Calcium chloride solution 0.02 M (URT/ HR-US) with different enzyme content were prepared. Ultrasonic velocity was 
measured at 37°C using a premix of 1800 μl casein 1.25 % (URT/ HR-US) and 80 μl Drug product solution activated with 
enterokinase. Shown are means of 2 replicates per working standard solution.
Linearity test of Table A51. free trypsin activity measurement by ultrasonic method (URT). Working standard solutions in 
Triton X 100 solution (URT/ HR-US) with different enzyme content were prepared. Ultrasonic velocity was measured at 37°C 
after adding 4 μl of working standard solution to 180 μl of BAEE solution (URT/ HR-US). Shown are means of 2 replicates 
per working standard solution.
Linearity test of Table A52. free trypsin activity measurement by ultrasonic method (URT) using FIP standard. FIP standard 
solutions in Triton X 100 solution (URT/ HR-US) with different enzyme content were prepared. Ultrasonic velocity was 
measured at 37°C after adding 4 μl of FIP standard solution to 180 μl of BAEE solution (URT/ HR-US). Shown are means of 
2 replicates per working standard solution.
Appendix A XI  
Small temperature differences
Infl uence of small temperature differences on ultrasonic determination of Table A53. amylase activity (URT). Ultrasonic 
velocity was measured at different temperatures after adding 4 μl of Amylase solution (URT/ HR-US) to 180 μl of Starch 
solution 6 % (URT/ HR-US). Shown are means of 2 replicates per working standard solution.
Infl uence of small temperature differences on ultrasonic determination of Table A54. amylase activity (HR-US). Ultrasonic 
velocity was measured at different temperatures after adding 20 μl of Amylase solution (URT/ HR-US) to 1050 μl of Starch 
solution 6 % (URT/ HR-US). Shown are means of 2 replicates per working standard solution.
Infl uence of small temperature differences on ultrasonic determination of Table A55. lipase activity (HR-US). Ultrasonic 
velocity was measured at different temperatures after adding 20 μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil 
emulsion (URT/ HR-US). Shown are means of 2 replicates per working standard solution.
Infl uence of small temperature differences on ultrasonic determination of Table A56. free protease activity (URT). Ultrasonic 
velocity was measured at different temperatures after adding 4 μl of Free protease solution (URT/ HR-US) to 180 μl of Casein 
solution 0.625 % (URT/ HR-US). Shown are means of 2 replicates per working standard solution.
Infl uence of small temperature differences on ultrasonic determination of Table A57. free protease activity (HR-US). 
Ultrasonic velocity was measured at different temperatures after adding 20 μl of Free protease solution (URT/ HR-US) to 
1050 μl of Casein solution 1.25 % (URT/ HR-US). Shown are means of 2 replicates per working standard solution.
Infl uence of small temperature differences on ultrasonic determination of Table A58. total protease activity (URT). 
Ultrasonic velocity was measured at different temperatures using a premix of 1800 μl Casein solution 1.25 % (URT/ HR-US) 
and 80 μl Total protease solution (URT/ HR-US) activated with enterokinase. Shown are means of 2 replicates per working 
standard solution.
Infl uence of small temperature differences on ultrasonic determination of Table A59. total protease activity (HR-US). 
Ultrasonic velocity was measured at different temperatures using a premix of 1800 μl Casein solution 1.25 % (URT/ HR-US) 
and 80 μl Total protease solution (URT/ HR-US) activated with enterokinase. Shown are means of 2 replicates per working 
standard solution.
Infl uence of small temperature differences on ultrasonic determination of Table A60. free trypsin activity (URT). Ultrasonic 
velocity was measured at different temperatures after adding 8 μl of Trypsin solution (URT/ HR-US) to 180 μl of BAEE 
solution (URT/ HR-US). Shown are means of 2 replicates per working standard solution.
Infl uence of small temperature differences on ultrasonic determination of Table A61. free trypsin activity (HR-US). 
Ultrasonic velocity was measured at different temperatures after adding 20 μl of Trypsin solution (URT/ HR-US) to 1050 μl of 
BAEE solution (URT/ HR-US). Shown are means of 2 replicates per working standard solution.
Appendix A XII 
Wide temperature ranges
Infl uence of wide temperature differences on ultrasonic determination of Table A62. amylase activity (URT). Ultrasonic 
velocity was measured at different temperatures after adding 4 μl of a 0.1 % working standard solution (solvent: Phosphate 
buffer solution (URT/ HR-US)) to 180 μl of Starch solution 1 % (aqueous). Shown are means of 2 replicates per working 
standard solution.
Infl uence of wide temperature differences on ultrasonic determination of Table A63. amylase activity (URT). Ultrasonic 
velocity was measured at different temperatures after adding 4 μl of Amylase solution (URT/ HR-US) to 180 μl of Starch 
solution 6 % (URT/ HR-US). Shown are means of 2 replicates per working standard solution.
Infl uence of wide temperature differences on ultrasonic determination of Table A64. free protease activity (URT). Ultrasonic 
velocity was measured at different temperatures after adding 4 μl of a 0.5 % working standard solution (aqueous) to 180 μl of 
Casein solution 0.625 % (URT/ HR-US). Shown are means of 2 replicates per working standard solution.
Infl uence of wide temperature differences on ultrasonic determination of Table A65. total protease activity (URT). Ultrasonic 
velocity was measured at different temperatures using a premix of 1800 μl Casein solution 1.25 % (URT/ HR-US) and 80 μl 
Total protease solution (URT/ HR-US) activated with enterokinase. Shown are means of 2 replicates per working standard 
solution.
Infl uence of wide temperature differences on ultrasonic determination of Table A66. free trypsin activity (URT). Ultrasonic 
velocity was measured at different temperatures after adding 8 μl of Trypsin solution (URT/ HR-US) to 180 μl of BAEE 
solution (URT/ HR-US).
Appendix A XIII 
Concentration of substrate
Infl uence of substrate concentration on ultrasonic determination of Table A67. amylase activity (HR-US). Ultrasonic velocity 
was measured after adding 20 μl of Amylase solution (URT/ HR-US) to 1050 μl of substrate solution with varied starch content. 
Shown are means of 2 replicates per working standard solution.
Infl uence of substrate concentration on ultrasonic determination of Table A68. lipase activity (HR-US). Ultrasonic velocity 
was measured after adding 20 μl of Lipase solution (URT/ HR-US) to 1050 μl of substrate emulsion with varied olive oil 
content. Shown are means of 2 replicates per working standard solution.
Infl uence of substrate concentration on ultrasonic determination of Table A69. free protease activity (HR-US). Ultrasonic 
velocity was measured after adding 4 μl of Free protease solution (URT/ HR-US) to 180 μl of substrate solution with varied 
casein content. Shown are means of 2 replicates per working standard solution.
Infl uence of substrate concentration on ultrasonic determination of Table A70. total protease activity (URT). Ultrasonic 
velocity was measured using a premix of 1800 μl substrate solution with varied casein content and 80 μl Total protease solution 
(URT/ HR-US) activated with enterokinase. Shown are means of 2 replicates per working standard solution.
Infl uence of substrate concentration on ultrasonic determination of Table A71. free trypsin activity (URT). Ultrasonic 
velocity was measured after adding 8 μl of Trypsin solution (URT/ HR-US) to 180 μl of substrate solution with varied BAEE 
content. Shown are means of 2 replicates per working standard solution.
Appendix A XIV 
Stability of substrate preparation (and Lipase: Operating time of Microfl uidizer)
Test of starch preparation stability over time evaluated to test applicability to ultrasonic velocity measurements Table A72. 
for determination of  amylase activity (URT). Ultrasonic velocity was measured after adding 4 μl of Amylase solution (URT/ 
HR-US) to 180 μl of Starch solution 6 % (URT/ HR-US) after varied storage times. Shown are means of 2 replicates per 
working standard solution.
Test of olive oil preparation stability choosing different operating times of the Microfl uidizer (MF) before the Table A73. 
emulsion was processed evaluated to test applicability to ultrasonic velocity measurements for determination of  lipase activity 
(HR-US). The fi nal emulsions were used without storage (0 hours) (1. Trial). Ultrasonic velocity was measured after adding 
20 μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ HR-US). Shown are means of 2 replicates per 
working standard solution.
Test of olive oil preparation stability choosing different operating times of the Microfl uidizer (MF) before the Table A74. 
emulsion was processed evaluated to test applicability to ultrasonic velocity measurements for determination of  lipase activity 
(HR-US). The fi nal emulsions were used without storage (0 hours) (2. Trial). Ultrasonic velocity was measured after adding 
20 μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ HR-US). Shown are means of 2 replicates per 
working standard solution.
Test of olive oil preparation stability over time evaluated to test applicability to ultrasonic velocity measurements Table A75. 
for determination of  lipase activity (HR-US) operating the Microfl uidizer 0 min before the emulsion was processed (1. Trial). 
Ultrasonic velocity was measured after adding 20 μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ 
HR-US) after storage of 7, 14 and 21 d using the original mixture or a mixture of the emulsion and freshly prepared bile salts 
solution. Shown are means of 2 replicates per working standard solution.
Test of olive oil preparation stability over time evaluated to test applicability to ultrasonic velocity measurements Table A76. 
for determination of  lipase activity (HR-US) operating the Microfl uidizer 30 min before the emulsion was processed (1. Trial). 
Ultrasonic velocity was measured after adding 20 μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ 
HR-US) after storage of 7, 14 and 21 d using the original mixture or a mixture of the emulsion and freshly prepared bile salts 
solution. Shown are means of 2 replicates per working standard solution.
Test of olive oil preparation stability over time evaluated to test applicability to ultrasonic velocity measurements Table A77. 
for determination of  lipase activity (HR-US) operating the Microfl uidizer 60 min before the emulsion was processed (1. Trial). 
Ultrasonic velocity was measured after adding 20 μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ 
HR-US) after storage of 7, 14 and 21 d using the original mixture or a mixture of the emulsion and freshly prepared bile salts 
solution. Shown are means of 2 replicates per working standard solution.
Test of olive oil preparation stability over time evaluated to test applicability to ultrasonic velocity measurements Table A78. 
for determination of  lipase activity (HR-US) operating the Microfl uidizer 0 min before the emulsion was processed (2. Trial). 
Ultrasonic velocity was measured after adding 20 μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ 
HR-US) after storage of 7, 14 and 21 d using the original mixture or a mixture of the emulsion and freshly prepared bile salts 
solution. Shown are means of 2 replicates per working standard solution.
Test of olive oil preparation stability over time evaluated to test applicability to ultrasonic velocity measurements Table A79. 
for determination of  lipase activity (HR-US) operating the Microfl uidizer 30 min before the emulsion was processed (2. Trial). 
Ultrasonic velocity was measured after adding 20 μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ 
HR-US) after storage of 7, 14 and 21 d using the original mixture or a mixture of the emulsion and freshly prepared bile salts 
solution. Shown are means of 2 replicates per working standard solution.
Test of olive oil preparation stability over time evaluated to test applicability to ultrasonic velocity measurements Table A80. 
for determination of  lipase activity (HR-US) operating the Microfl uidizer 60 min before the emulsion was processed (2. Trial). 
Ultrasonic velocity was measured after adding 20 μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ 
HR-US) after storage of 7, 14 and 21 d using the original mixture or a mixture of the emulsion and freshly prepared bile salts 
solution. Shown are means of 2 replicates per working standard solution.
Test of casein preparation stability over time evaluated to test applicability to ultrasonic velocity measurements Table A81. 
for determination of  free protease activity (URT). Ultrasonic velocity was measured after adding 4 μl of 0.5 % standard 
working solution (aqueous) to 180 μl of Casein solution 0.625 % (URT/ HR-US) after varied storage times. Shown are means 
of 2 replicates per working standard solution.
Test of casein preparation stability over time evaluated to test applicability to ultrasonic velocity measurements Table A82. 
for determination of  total protease activity (URT). Ultrasonic velocity was measured using a premix of 1800 μl Casein 
solution 1.25 % (URT/ HR-US) after varied storage times and 80 μl Total protease solution (URT/ HR-US) activated with 
enterokinase. Shown are means of 2 replicates per working standard solution.
Test of BAEE preparation stability over time evaluated to test applicability to ultrasonic velocity measurements Table A83. 
for determination of  free trypsin activity (URT). Ultrasonic velocity was measured after adding 8 μl of Trypsin solution 
(URT/ HR-US) to 180 μl of substrate solution after varied storage times. Shown are means of 2 replicates per working standard 
solution.
Appendix A XV 
Extraction (Dissolving) time
Infl uence of Extraction (Dissolving) time of pancreas powder in sample solvent on ultrasonic determination of Table A84. 
amylase activity (URT). Amylase solutions (URT/ HR-US) were prepared dissolving working standard for different times in 
Phosphate buffer solution (URT/ HR-US). Ultrasonic velocity was measured at 37°C after adding 4μl of Amylase solution 
(URT/ HR-US) to 180 μl of Starch solution 6 % (URT/ HR-US). Shown are means of 2 replicates per working standard 
solution.
Infl uence of Extraction (Dissolving) time of pancreas powder in sample solvent on ultrasonic determination of Table A85. 
lipase activity (HR-US). Lipase solutions (URT/ HR-US) were prepared dissolving working standard for different times in 
Maleate buffer solution pH 7.0 (URT/ HR-US). Ultrasonic velocity was measured at 37°C after adding 20μl of Lipase solution 
(URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ HR-US). Shown are means of 2 replicates per working standard 
solution.
Infl uence of Extraction (Dissolving) time of pancreas powder in sample solvent on ultrasonic determination of Table A86. 
free protease activity (URT). Free protease solutions (URT/ HR-US) were prepared dissolving working standard for different 
times in Borate buffer pH 7.5 (URT/ HR-US). Ultrasonic velocity was measured at 37°C using a premix of 1800 μl Casein 
solution 1.25 % (URT/ HR-US) and 40 μl Free protease solution (URT/ HR-US). Shown are means of 2 replicates per working 
standard solution.
Infl uence of Extraction (Dissolving) time of pancreas powder in sample solvent on ultrasonic determination of Table A87. 
total protease activity (URT). Total protease solutions (URT/ HR-US) were prepared dissolving working standard for different 
times in Calcium chloride solution 0.02 M (URT/ HR-US) and subsequently activating with enterokinase . Ultrasonic velocity 
was measured at 37°C using a premix of 1800 μl Casein solution 1.25 % (URT/ HR-US) and 80 μl Total protease solution 
(URT/ HR-US). Shown are means of 2 replicates per working standard solution.
Infl uence of Extraction (Dissolving) time of pancreas powder in sample solvent on ultrasonic determination of Table A88. 
free trypsin activity (URT). Trypsin solutions (URT/ HR-US) were prepared dissolving working standard for different times in 
Triton X 100 solution (URT/ HR-US). Ultrasonic velocity was measured at 37°C after adding 8 μl of Trypsin solution (URT/ 
HR-US) to 180 μl of BAEE solution (URT/ HR-US). Shown are means of 2 replicates per working standard solution. Shown 
are means of 2 replicates per working standard solution.
Appendix A XVI
Lipase: Potential infl uencing factors of lipase activity depending on substrate 
emulsion
Infl uence of bile salt concentration in olive oil emulsion on ultrasonic determination of Table A89. lipase activity (HR-US) 
(1. part). Ultrasonic velocity was measured at 37°C after adding 20μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil 
emulsion (URT/ HR-US) with varied bile salt content. Shown are means of 2 replicates per working standard solution.
Infl uence of bile salt concentration in olive oil emulsion on ultrasonic determination of Table A90. lipase activity (HR-US) 
(2. part). Ultrasonic velocity was measured at 37°C after adding 20μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil 
emulsion (URT/ HR-US) with varied bile salt content. Shown are means of 2 replicates per working standard solution.
Infl uence of  olive oil emulsion pH on ultrasonic determination of Table A91. lipase activity (HR-US). Ultrasonic velocity 
was measured at 37°C after adding 20μl of Lipase solution (URT/ HR-US) to 1050 μl of Olive oil emulsion (URT/ HR-US) 
with varied pH. Shown are means of 2 replicates per working standard solution.
Appendix A XVII
Total protease: Activation parameters
Infl uence of enterokinase concentration on ultrasonic determination of Table A92. total protease activity (URT). Ultrasonic 
velocity was measured at 37°C using a premix of 1800 μl Casein solution 1.25 % (URT/ HR-US) and 80 μl Total protease 
solution (URT/ HR-US) activated by using different concentrations of enterokinase solution. Shown are means of 2 replicates 
per working standard solution.
Blank test evaluated to test infl uence of enterokinase concentration on ultrasonic determination of Table A93. total protease 
activity (URT). Ultrasonic velocity was measured at 37°C using a premix of casein solution 1.25 % and CaCl2 solution (URT/ 
HR-US) “activated” by using different concentrations of enterokinase solution. Shown are means of 2 replicates per working 
standard solution.
Infl uence of storage time of enterokinase solution on ultrasonic determination of Table A94. total protease activity (URT). 
Ultrasonic velocity was measured at 37°C using a premix of 1800 μl Casein solution 1.25 % (URT/ HR-US) and 80 μl 
Total protease solution (URT/ HR-US) activated with enterokinase solution after varied storage times. Shown are means of 2 
replicates per working standard solution.
Infl uence of activation time on ultrasonic determination of Table A95. total protease activity (URT). Ultrasonic velocity was 
measured at 37°C using a premix of 1800 μl Casein solution 1.25 % (URT/ HR-US) and 80 μl Total protease solution (URT/ 
HR-US) activated with enterokinase for different times. Shown are means of 2 replicates per working standard solution.
Infl uence of activation time on ultrasonic determination of Table A96. total protease activity (URT). Ultrasonic velocity was 
measured at 37°C using a premix of 1800 μl Casein solution 1.25 % (URT/ HR-US) and 80 μl Total protease solution (URT/ 
HR-US) activated with enterokinase at varied temperatures. Shown are means of 2 replicates per working standard solution.
Appendix A XVIII
Holding time in dosing system (titration equipment)
Infl uence of holding time in dosing system on ultrasonic determination of Table A97. amylase activity (HR-US) (periodic 
injection). Ultrasonic velocity was measured at 37°C periodically injecting 4 μl of Amylase solution (URT/ HR-US) via dosing 
system through a septum into the measurement cell containing 1050 μl Starch solution 6 % (URT/ HR-US).
Infl uence of holding time in dosing system on ultrasonic determination of Table A98. amylase activity (HR-US) (no periodic 
injection). Ultrasonic velocity was measured at 37°C directly injecting 20 μl/ 30 μl of Amylase solution (URT/ HR-US) through 
a septum into the measurement cell containing 1050 μl Starch solution 6 % (URT/ HR-US). 
Infl uence of holding time in dosing system on ultrasonic determination of Table A99. free protease activity (HR-US) 
(periodic injection). Ultrasonic velocity was measured at 37°C periodically injecting 4 μl of Free protease solution (URT/ HR-
US) via dosing system through a septum into the measurement cell containing 1050 μl Casein 1.25 % (URT/ HR-US).
Infl uence of holding time in dosing system on ultrasonic determination of Table A100. free protease activity (HR-US) (no 
periodic injection). Ultrasonic velocity was measured at 37°C directly injecting 20 μl/ 40 μl of Free protease solution (URT/ 
HR-US) through a septum into the measurement cell containing 1050 μl Casein solution 1.25 % (URT/ HR-US). 
Appendix A XIX
Amylase: Dextrins as alternative substrates
Suitability test of Table A101. Dextrin 5 as alternative substrate for amylase activity measurement by ultrasonic method 
(URT). Ultrasonic velocity was measured after adding 4 μl of Amylase solution (URT/ HR-US) to 180 μl of substrate solution 
with varied Dextrin 5 content prepared in Phosphate buffer (URT/ HR-US). Shown are means of 2 replicates per working 
standard solution.
Suitability test of Table A102. Dextrin 10 as alternative substrate for amylase activity measurement by ultrasonic method 
(URT). Ultrasonic velocity was measured after adding 4 μl of Amylase solution (URT/ HR-US) to 180 μl of substrate solution 
with varied Dextrin 10 content prepared in Phosphate buffer (URT/ HR-US). Shown are means of 2 replicates per working 
standard solution.
Suitability test of Table A103. Dextrin 20 as alternative substrate for amylase activity measurement by ultrasonic method 
(URT). Ultrasonic velocity was measured after adding 4 μl of Amylase solution (URT/ HR-US) to 180 μl of substrate solution 
with varied Dextrin 20 content prepared in Phosphate buffer (URT/ HR-US). Shown are means of 2 replicates per working 
standard solution.
Appendix A XX
Proteolysis-like material
Relative Table A104. amylase activities (Ph.-Eur.-u/ g) in three batches of proteolysis-like material with four samples each 
determined by ultrasonic method (URT). Ultrasonic velocity was measured at 37°C after adding 4 μl of Amylase solution 
(URT/ HR-US) (sample or working standard) to 180 μl of Starch solution 6 % (URT/ HR-US). Shown are means of 2 sample 
solutions with 1 replicate each.
Relative Table A105. free protease activities (Ph.-Eur.-u/ g) in three batches of proteolysis-like material with four samples 
each determined by ultrasonic method (URT). Ultrasonic velocity was measured at 37°C after adding 4 μl of Free protease 
solution (URT/ HR-US) (sample or working standard) to 180 μl of Casein solution 1.25 % (URT/ HR-US). Shown are means 
of 2 sample solutions with 1 replicate each.
Relative Table A106. free protease activities (Ph.-Eur.-u/ g) in three batches of proteolysis-like material with four samples 
each determined by ultrasonic method (URT). Ultrasonic velocity was measured at 37°C after adding 4 μl of Trypsin solution 
(URT/ HR-US) (sample or working standard) to 180 μl of BAEE solution (URT/ HR-US). Shown are means of 2 sample 
solutions with 1 replicate each.
Appendix A XXI
Proteolysis material I
Relative amylase, free protease and free trypsin activities (Ph.-Eur.-u/ g) in Table A107. proteolysis I material (Batch I) 
determined by ultrasonic method (URT). Ultrasonic velocity was measured at 37°C after adding Amylase/ Free protease/ 
Trypsin solution (URT/ HR-US) (sample or working standard) to 180 μl of the respective substrate solution (URT/ HR-US). 
Shown are means of 2 sample solutions with 1 replicate each.
Relative amylase, free protease and free trypsin activities (Ph.-Eur.-u/ g) in Table A108. proteolysis I material (Batch II) 
determined by ultrasonic method (URT). Ultrasonic velocity was measured at 37°C after adding Amylase/ Free protease/ 
Trypsin solution (URT/ HR-US) (sample or working standard) to 180 μl of the respective substrate solution (URT/ HR-US). 
Shown are means of 2 sample solutions with 1 replicate each.
Relative amylase, free protease and free trypsin activities (Ph.-Eur.-u/ g) in Table A109. proteolysis I material (Batch III) 
determined by ultrasonic method (URT). Ultrasonic velocity was measured at 37°C after adding Amylase/ Free protease/ 
Trypsin solution (URT/ HR-US) (sample or working standard) to 180 μl of the respective substrate solution (URT/ HR-US). 
Shown are means of 2 sample solutions with 1 replicate each.
Appendix A XXII
Proteolysis material II
Relative Table A110. amylase activities (Ph.-Eur.-u/ g) in three batches of proteolysis II material determined by ultrasonic 
method (URT). Ultrasonic velocity was measured at 37°C using a pre-mix of 1800 μl Starch solution 3 % (URT/ HR-US) and 
40 μl Amylase solution (URT/ HR-US). Shown are means of 2 sample solutions with 2 replicates each.
RelativeTable A111.  free protease activities (Ph.-Eur.-u/ g) in three batches of proteolysis II material determined by 
ultrasonic method (URT). Ultrasonic velocity was measured at 37°C using a pre-mix of 1800 μl Casein solution 1.25 % (URT/ 
HR-US) and 40 μl Free protease solution (URT/ HR-US) . Shown are means of 2 sample solutions with 2 replicates each.
Relative Table A112. total protease activities (Ph.-Eur.-u/ g) in three batches of proteolysis II material determined by 
ultrasonic method (URT). Ultrasonic velocity was measured at 37°C using a pre-mix of 1800 μl Casein solution 1.25 % (URT/ 
HR-US) and 80 μl Total protease solution (URT/ HR-US). Shown are means of 2 sample solutions with 2 replicates each.
Relative Table A113. lipase activities (Ph.-Eur.-u/ g) in three batches of proteolysis II material determined by ultrasonic 
method (URT). Ultrasonic velocity was measured at 37°C using a pre-mix of 1800 μl Olive oil emulsion (URT/ HR-US) and 
33 μl Lipase solution (URT/ HR-US). Shown are means of 2 sample solutions with 2 replicates each.
Relative Table A114. free trypsin activities (Ph.-Eur.-u/ g) in three batches of proteolysis II material determined by ultrasonic 
method (URT). Ultrasonic velocity was measured at 37°C using a pre-mix of 1800 μl BAEE solution (URT/ HR-US) and 80 μl 
Free trypsin solution (URT/ HR-US) . Shown are means of 2 sample solutions with 2 replicates each.
Relative Table A115. free trypsin activities (Ph.-Eur.-u/ g) in three batches of proteolysis II material determined by 
Pharmacopoeia method (Ph.Eur.). Ultrasonic velocity was measured at 25°C and pH 8 using 0.02 M NaOH as titration solution. 
Shown are means of 2 sample solutions with 2 replicates each.
Appendix A XXIII
Active Pharmaceutical Ingridient (API)
Relative Table A116. amylase activities (Ph.-Eur.-u/ g) in several API samples were determined by ultrasonic method (URT/ 
HR-US) using one-point and three-point-calibration. Ultrasonic velocity was measured at 37°C after adding Amylase solution 
(URT/ HR-US) to starch solution 3 % (URT/ HR-US) in the sample cell or using a pre-mix. Shown are means of 2 sample 
solutions with 2 replicates each.
Relative Table A117. free protease activities (Ph.-Eur.-u/ g) in several API samples were determined by ultrasonic method 
(URT/ HR-US) using one-point and three-point-calibration. Ultrasonic velocity was measured at 37°C after adding Free 
protease solution (URT/ HR-US) to Casein solution 1.25 % (URT/ HR-US) in the sample cell or using a pre-mix. Shown are 
means of 2 sample solutions with 2 replicates each.
Relative Table A118. total protease activities (Ph.-Eur.-u/ g) in several API samples were determined by ultrasonic method 
(URT/HR-US) using one-point and three-point-calibration. Ultrasonic velocity was measured at 37°C after adding Total 
protease solution (URT/ HR-US) after activation with enterokinase to Casein solution 1.25 % (URT/ HR-US) in the sample cell 
or using a pre-mix. Shown are means of 2 sample solutions with 2 replicates each.
Relative Table A119. lipase activities (Ph.-Eur.-u/ g) in several API samples were determined by ultrasonic method (URT/ 
HR-US) using one-point and three-point-calibration. Ultrasonic velocity was measured at 37°C after adding Lipase solution 
(URT/ HR-US) to Olive oil emulsion (URT/ HR-US) in the sample cell or using a pre-mix. Shown are means of 2 sample 
solutions with 2 replicates each.
Appendix A XXIV
Drug product III - VIII 
Relative Table A120. amylase activities (Ph.-Eur.-u/ g) in several Drug product batches were determined by ultrasonic method 
(URT/ HR-US). Ultrasonic velocity was measured at 37°C after adding Amylase solution (URT/ HR-US) to starch solution 3 % 
(URT/ HR-US) in the sample cell or using a pre-mix. Shown are means of 2 sample solutions with 2 replicates each.
Relative Table A121. free protease activities (Ph.-Eur.-u/ g) in several Drug product batches were determined by ultrasonic 
method (URT/ HR-US). Ultrasonic velocity was measured at 37°C after adding Free protease solution (URT/ HR-US) to Casein 
solution 1.25 % (URT/ HR-US) in the sample cell or using a pre-mix. Shown are means of 2 sample solutions with 2 replicates 
each.
Relative Table A122. total protease activities (Ph.-Eur.-u/ g) in several Drug product batches were determined by ultrasonic 
method (URT/HR-US). Ultrasonic velocity was measured at 37°C after adding Total protease solution (URT/ HR-US) after 
activation with enterokinase to Casein solution 1.25 % (URT/ HR-US) in the sample cell or using a pre-mix. Shown are means 
of 2 sample solutions with 2 replicates each.
Relative Table A123. lipase activities (Ph.-Eur.-u/ g) in several Drug product batches were determined by ultrasonic method 
(URT/ HR-US). Ultrasonic velocity was measured at 37°C after adding Lipase solution (URT/ HR-US) to Olive oil emulsion 
(URT/ HR-US) in the sample cell or using a pre-mix. Shown are means of 2 sample solutions with 2 replicates each.
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